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Therapeutic proteins are freeze-dried to improve storage stability. However, any changes in
conformation of the protein molecule induced by stresses encountered during freeze-drying can
influence the storage stability. Fourier Transform Infrared spectroscopy (FTIR) is very useful for
monitoring secondary structural changes in protein solid state, but is much less sensitive to smaller
tertiary structural changes associated with tryptophan, tyrosine and phenylalanine residues, that
may be more predictive of stability. The aim of the present study was development and evaluation
of a solid-state Raman spectroscopic method capable of detecting both tertiary and secondary
structural solid-state changes in the spectral region from 600 to 1850 cm-1.
Conformational changes in α-lactalbumin, induced at various pH levels, were detectable in the
Raman spectra in both the solution and freeze-dried solid states. Principle component analysis
(PCA) was able to distinguish the pH induced spectral differences that were visually obscured by
large peaks from sucrose, an often-used stabilizer. Principal components (PCs) separated spectral
variation in the samples largely due to sample state, protein structural differences, and the presence
of sucrose. Using this model protein, the new method proved capable of detecting the protein
structural changes in the solid state.
Raman spectral analysis of lyophilized human serum albumin (HSA) detected protein structural
changes that occurred during storage and were related to protein instability. Use of chemometrics
tools (PCA) identified many small spectral differences, even with overlapping peaks
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from stabilizers. A PLS regression model was used to evaluate correlation of spectral changes in
the entire region to aggregation rate (R2 > 0.98). Protein stability followed the same rank order as
the extent of Raman spectral changes in HSA formulations immediately after lyophilization.
Similar data suggested that a material-sparing approach reusing protein samples is representative
of protein stored as lyophilized cake.
Changes in Raman scattering associated with tertiary structural changes in the solid-state analyzed
by PLS and PCA provides an additional tool for identifying the formulation of therapeutic proteins
providing optimal stability. The ultimate goal is a high-throughput screening method to predict
rank order in protein storage stability from the Raman scattering spectra of product in situ.
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Chapter 1
Introduction, Aims and Organization of the Dissertation

1

Introduction
Protein drugs treat a wide range of diseases. However, there are drawbacks for biologic
medicine advancement, such as shelf life instability (defined as < 2 year shelf life). [1, 2].
Regulatory authorities require drug products to be fully characterized, with all possible
degradation products monitored (ICH Q5C). Even small amounts of protein degradation or
aggregation can decrease efficacy, along with causing serious safety risks and immunogenic
responses in patients who develop neutralizing antibodies [3, 4]. New studies have also focused
on the need for more sensitive detection of aggregate formation in solution [5]. The focus of the
current work will be on detection of the structural contribution to protein physical stability and
the corresponding formation of aggregates. Aggregation studies support the presence of a molten
globule intermediate present in aggregation pathways [6]. The molten globule formation is
characterized by significant loss in tertiary structure with a retention of secondary structure in the
protein.
Structural changes have been linked to protein aggregation [6] and immunogenicity [7],
however structural characterization techniques do not correlate with stability consistently,
especially in very stable formulations [8]. Structural conformation changes have been studied
using a combination of circular dichroism (CD), fluorescence spectroscopy, Raman
spectroscopy, Fourier transform infrared spectroscopy (FTIR), and differential scanning
calorimetry (DSC), in addition to hydrogen deuterium exchange (HDX), which indirectly
monitors structural changes through unfolding kinetics [9-11]. Many of these analytical methods
require dilution of higher concentration samples [12]. Non-ideal behavior, which often occurs at
high concentrations, decreases the prediction of high concentration behavior based on studies
performed at dilute conditions [13]. Raman spectroscopy has been applied to systems at much
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higher concentration (65 mg/mL) [14] than would be possible in CD. In addition to differences in
solution concentration, these studies have primarily focused on secondary structural changes
rather than smaller tertiary structural changes. It has been proposed that these smaller
conformational changes including side chain disordering may occur initially before aggregation
but not be detected in all studies [15].
Approximately 30% of protein drugs are freeze dried and stored in solid form [16].
Structural effects during freeze drying due to processing conditions [17] or formulation [15, 18]
have been confirmed. Mechanisms for protein protection during lyophilization and protein
structural stabilization during storage are still being investigated. Two theories for protein
stabilization are currently being studied [8, 19]. The first theory relates to vitrification of the
protein in the glassy matrix, which inhibits the motion required for degradation processes. The
other, water replacement theory, hypothesizes that stabilizers form hydrogen bonds with the
proteins conferring thermodynamic and structural stability [8].
The degree of conformational change may impact both in-process and storage stability,
with partially unfolded protein molecules expected to be less stable against both aggregation and
chemical degradation [15, 20]. Detailed structural information in the solid state linked with
formulation or process development steps, available during early product development, would
lower the risk of selecting a formulation with inadequate stability. Raman spectroscopy has been
applied to detect protein structural changes in lyophilized solids [21]. However, tertiary structural
changes have not been the focal point of previous Raman studies in solids. The objective of this
study is to develop a new Raman spectroscopic method that focuses on changes in protein both
tertiary and secondary structure in the solid state.

3

Objectives and Aims
The overall objective of the present work was development of a Raman spectral method,
starting with a well characterized model protein in solution, and then extended to further
application in solid state analysis. Principal Component Analysis (PCA) was used to explore
both tertiary and secondary structural peaks in Raman spectra. Partial Least Squared (PLS)
regression analysis, based on structural differences measured in Raman spectra, was used for
prediction of aggregation rates in reconstituted solutions. Model systems with structural
differences immediately after lyophilization and during storage were explored to show
application of the method in aggregating systems. The addition of the Raman method to the
current characterization “toolbox” allows unique insights into mechanisms and fast screening for
formulation and process development studies.

The specific aims are:
1. Adapt the current Raman method to detect tertiary structural changes in solutions and
explore spectral differences using PCA.
2. Develop a solid-state Raman method to detect tertiary and secondary structural changes.
3. Evaluate the ability of the Raman method to detect the effect of formulation “in process”
changes immediately after lyophilization
4. Evaluate the ability of the Raman method to detect structural changes during storage.

Organization of the Dissertation
Changes in structure were originally the focus of protein folding/unfolding studies [2224]. These studies correlated change in structure with aggregate formation in the protein
solution. Many of the proteins studied in solution form a non-native “molten globule”
conformation with secondary structure essential conserved in the native state, while relatively
larger changes are observed in tertiary structural moieties (aromatic amino acids) during the
4

pathway to aggregate formation [6, 11, 22, 25]. Chapter 2 presents solutions studies with
detection of forced changes due to a wide range of pH levels in the model protein, α-lactalbumin
(ALA). Principal component analysis (PCA) was used to explore the very small yet meaningful
changes in structure that are expected to correlate with physical stability of the protein during
storage. PCA differentiates between variances in the data set, which can be linked to different
chemical and physical sources of variation in the formulations, thus enabling detection of small
variation as would be expected for tertiary structural changes. The Raman method combined
with PLS/PCA allowed quantitation of spectral changes and expedited evaluation of specific
peak changes in the rich Raman spectrum.
Due to insufficient solution storage stability, approximately one third of protein drugs are
lyophilized [16]. However, lyophilization, especially when under sub-optimal processing
conditions, has been known to cause structural damage due to the stress experienced during
processing conditions (cold denaturation, freeze concentration, pH changes, dehydration and
surface induced stresses). Chapter 3 presents development of the solid-state Raman method,
based on the solution state method implemented in Chapter 2. The same model protein, ALA, is
explored and logical conclusions are drawn from comparison of the induced structural changes in
solutions and the resulting solid spectra. Spectral results support earlier work asserting a “molten
globule” conformation in aggregates [6, 26], with Raman spectra of “pH 8” solid samples
showing a similar structural conformation as the pH 2 solution samples. Discussion regarding
interpretation of Raman spectral changes in relation to protein conformation in the solid-state
and comparison with “native” solution state delves into the interpretation of the spectral results.
Commonly added stabilizers to preserve activity during protein lyophilization and storage
include carbohydrates, buffer salts, surfactants, polymers or other proteins [15, 27-29]. The
5

nature of the mechanisms for excipient stabilization of proteins during the lyophilization process
are not yet fully understood [8]. Chapter 4 presents the application of the Raman solid-state
method to detection of structural changes immediately after freeze drying in several formulations
with both sugar and salt excipients. Use of the Raman spectral range from 1530-1780 cm-1
enabled evaluation of primarily protein structure related variance and eliminated the large Raman
scattering observed from both sucrose and trehalose. As shown in ALA studies, addition of sugar
excipients results in a more “native” structure, especially in the amide I peak width, and lower
aggregation rates. PLS models of Raman spectra in both regions were explored.
As an extension of the work in Chapter 4, Chapter 5 presents PLS models and PCA
exploration of changes in Raman spectra over time. It was postulated that if large changes
occurred during storage in the solid state, these changes may correlate differently than those
observed at time zero. If the spectral changes measured are directly correlated with a partially
unfolded and reactive state, which yields a larger percentage of soluble aggregates after
reconstitution, a better correlation was expected to be observed. Models from accelerated (heat
stressed) samples were not significantly different than those obtained immediately after freeze
drying. Small spectral differences were apparent after high temperature exposure in the least
stable formulations. The overall results and significance of the research will be summarized in
Chapter 6 along with suggestions for additional areas of inquiry.
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Chapter 2
Evaluation of a Raman Chemometric Method for Detecting Changes in
Structural Conformation in Protein Solutions

9

Introduction
Since the approval of Humulin ® in 1982, the FDA approval rate for biologics has been
increasing steadily [1]. However, there are challenges for the advancement of therapeutic
biologics, such as the need for administration by injection and relatively poor stability of the
solutions (< 2 year shelf life) compared to small molecule counterparts. [2, 3]. Regulatory
agencies require full characterization of the drug product and all possible degradation products to
ensure adequate product quality on release and to prove stability over the shelf life (ICH Q5C).
Even small fractions of protein degradation or aggregation are considered a physical risk (e.g.,
blockage of an injection device), a risk of reduction in product efficacy, and potentially serious
safety risk of immunogenic responses in patients who develop neutralizing antibodies [4, 5].
Improved protein drug delivery modalities intended to expand the biologics market, change the
administration route, or alter the release rate are also underway [5, 6]. New studies have also
focused on the need for more sensitive detection of aggregate formation in solution [7].
Extensive research into protein stability reveals both dynamic mobility and structural
contributions to biologic instability [8]. Early studies on protein folding/unfolding showed that
changes in structure correlated with aggregate formation in solution [9-11]. Many of the proteins
studied in solution form a non-native “molten globule” conformation with secondary structure
essentially conserved, while large changes in tertiary structures are associated with aggregate
formation [8, 9, 12, 13].
Although structural changes have been linked to protein aggregation [13] and
immunogenicity [14], current characterization of structural changes, immediately after
processing, do not consistently correlate with protein stability on storage, especially in more
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advanced drug delivery systems [5, 15-17]. Structural changes have been studied using a
combination of circular dichroism (CD), Fourier transform infrared spectroscopy (FTIR),
fluorescence, Raman spectroscopy, differential scanning calorimetry (DSC) and hydrogen
deuterium exchange (HDX) for unfolding [12, 18, 19]. Many of these analytical methods require
dilution of higher concentration samples [20]. However, proteins have been shown to exhibit
concentration-dependent behavior with non-ideal behavior at high concentrations [21], making it
challenging to extrapolate results from dilute solution-requiring methods to the high
concentrations in the product. Raman spectroscopy has been applied to protein solutions at much
higher concentration (65 mg/mL) [22] than is possible using other protein characterization
techniques , such as CD. In addition to differences in solution concentration, protein
characterization studies have primarily focused on secondary rather than tertiary structural
changes. However, the side chain rearrangement, which is a much smaller tertiary structural
change, has been suggested as a signal of aggregation, since it may be a prerequisite to the larger
secondary structural changes associated with aggregation [8, 15].
The protein, α-lactalbumin (ALA), has been utilized as a model protein for investigating
protein structure since the 1970s [23]. Extensive studies have confirmed that it has a “molten
globule” conformation in an acidic environment [9, 24, 25]. This conformation is associated with
a compact structure that is not completely unfolded and maintains secondary structure similar to
the native state. Unlike the molten globule state, proteins that are denatured chemically with urea
exhibit an extended “unfolded” state with almost no far UV CD absorbance representing a total
loss in secondary structure. In contrast, the molten globule state has a loss in the native
environment of the tertiary side chains, allowing more flexibility and motion without total loss of
secondary structure.
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Raman structural analysis of proteins has been evolving over the past fifty years [23, 26,
27]. Raman was used recently to study structural changes in protein solutions which are
associated with aggregation [28-31]. Raman spectroscopy also has the ability to monitor
structural changes in a variety of sample conditions such as solutions, gels, and solid state [30].
Secondary structural peaks in the Raman spectrum of insulin have been shown to be sensitive to
agitation and temperature-induced aggregation through indirect measurement of the aggregated
species using a drop coating deposition Raman method and multivariate regression analysis of
aggregated species from the resulting protein films [32].
Monitoring of protein stability in both the solution and solid states was the overall
motivation for the current Raman method development effort. The focus of the present report is
evaluation of the ability of a Raman spectral method to detect known changes in ALA structure
due to pH. Principal component analysis (PCA) was applied to identify the very small spectral
changes, due to meaningful changes in structure, that were expected to link with physical
stability of proteins. PCA is an unsupervised data analytical technique that can explore data sets
for trends and clusters. It was used here to separate and quantify the differences in chemical
species (protein conformations) in the sample without prior knowledge of the sample conditions.

Materials and Methods
Materials
Distilled deionized water was used for solution preparation. Bovine α-lactalbumin (ALA;
>85%, lyophilized powder, Sigma-Aldrich, St. Louis, MO) was used as the model protein.
Sucrose (>99.5%, Sigma-Aldrich) was used as a formulation excipient. The pH of protein
solutions was adjusted using hydrochloric acid 1N solution (standard grade, Thermo Fisher
Scientific, Waltham, MA). Regenerated cellulose centrifugal filter units (MWCO 10KDa,
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Amicon Ultra, Millipore Sigma, Burlington, MA) were used for dialysis. All final protein
solutions were filtered (0.45 μm PVDF syringe filters, Millipore Sigma, Burlington, MA or
CELLTREAT, Pepperell, MA).

Methods
Sample Preparation
Protein powder as received (500 mg) was dialyzed against water (15 mL) at least four
times using centrifugal filter units on a centrifuge (Allegra X-15R, Beckman Coulter, Brea, CA)
at 3000 RCF and 10°C. After dialysis, protein concentration was adjusted by addition of water.
Protein solution pH was adjusted using diluted (<0.1 N) hydrochloric acid to within ±0.05 of the
target value, measured at room temperature using a pH meter (model 710, Thermo Orion,
Waltham, MA). Protein concentrations were determined by absorbance at 280 nm (Cary 100Bio
UV-Visible spectrophotometer, Agilent, Santa Clara, CA) using an absorptivity of 2.01 mL / (mg
cm) [33]. Diluted protein solution pH was readjusted if needed immediately before analysis.
ALA solutions were prepared at target pH levels of 2.0, 3.8, 5.8, and 7.8 to achieve different
structural conformations [22]. For ease of discussion, the solutions are referred to as pH 2, 4, 6,
and 8, respectively.
Circular Dichroism
Circular dichroism (CD) of protein solutions was measured (Model J715, Jasco
Spectropolarimeter, Easton, MD) in a 4.0 mm path length cell. The average of 5 accumulations,
with a scan speed of 50 nm/min, pitch of 1 nm and a bandwidth of 1 nm was collected for each
solution. Near UV CD at a protein concentration of 1.2 mg/mL ranged from 260 to 320 nm. Far
UV CD analysis at a protein concentration of 0.05 mg/mL ranged from 195 to 260 nm.
Ellipticities were normalized for concentration and pathlength.
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Raman Spectroscopy
Spectral Acquisition
Raman spectra were acquired using a bulk sampling probe (3 mm PhAT probe, Kaiser
Optical Systems Inc, Ann Arbor, MI) connected to a spectrometer (RXN1, Kaiser Optical
Systems Inc, Ann Arbor, MI) with a fiber optic bundle, and a 785 nm diode laser (Invictus,
Kaiser Optical Systems Inc, Ann Arbor, MI) utilizing iC Raman 4.1 software (Mettler Toledo/
Kaiser Optical Systems Inc.) [34]. A focal length of approximately 120 mm ensured the solutions
were exposed to the 3mm spot size with laser power >150 mW. The larger laser spot size,
designed for bulk sampling, has been shown to reduce error associated with a smaller sampling
area in the case of heterogenous samples [35]. The spectrometer was calibrated in the following
order with the HCA accessory (Kaiser Optical Systems Inc, Ann Arbor, MI): wavelength
calibration (internal neon standard), instrument spectral intensity (white light source), and laser
wavelength calibration (cyclohexane Raman shift standard). Cooling of the detector to -40°C
minimized dark noise. Six accumulations of 3 minutes each were collected from shifts of 150 to
1875 cm-1 at 4 cm-1 intervals, with cosmic ray filter, intensity calibration and dark scan
subtraction options selected. Except as noted in the discussion section, all sample volumes were
400 uL of 50 mg/mL solution, filled into a custom aluminum pan described below.
Sample Chamber
The spectrometer was set up with an optional sample chamber (P/N 2004018, Kaiser
Optical Systems Inc, Ann Arbor, MI) that allowed the sampling probe to be placed in either a
horizontal (Figure 1B) or vertical (Figure 1D) position and used for off-line bench scale analysis
in cuvettes. The sample chamber door allowed access to the platform to place the sample and
was closed during sample acquisition to block extraneous radiation. A custom base for the
sample chamber was fabricated from aluminum which reduced interference due to its weak
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Raman signal as described in the Results and Discussion. Other modifications and adjustments
are also described in the section, Method Optimization.
Pre-processing of Raman Spectra
Spectral analysis was performed using Spectragryph-optical spectroscopy software (F.
Menges, version 1.2.11d, 2018, http://www.effemm2.de/spectragryph/). The average spectrum of
water (3-6 accumulations) was subtracted from each individual Raman spectrum; the resulting
spectrum was truncated to the region of interest, 600 - 1850 cm-1, and underwent further adaptive
baseline correction at a 22% level (described in more detail in the Spectral Pre-processing
Results and Discussion section). The baseline corrected spectra were normalized to the amide I
(1600-1700 cm-1) peak intensity unless otherwise noted. Individual spectral accumulations, not
averaged, were analyzed by principal component analysis (PCA) as described below. For clarity,
spectra shown in all figures are averages of 6 replicate accumulations unless otherwise stated.
Evaluation of Minimum Sample Concentration
Protein solutions were prepared at 211 mg/mL (pH 8) and serially diluted to obtain 25,
50, 100, and 150 mg/mL solutions in order to investigate how spectral instrument related noise
influenced the minimum protein concentration required for spectral repeatability. Raman spectra
of protein solutions were collected in: i) 1 cm pathlength quartz cuvettes (555 μL) with
aluminum foil lining of the sample chamber, ii) aluminum pans (75 μL) (Part# 900825.902, TA
Instruments/Water Corporation, Milford, MA) usually used for differential scanning calorimetry
(DSC), or iii) custom large volume aluminum pans (400 μL) as shown in Figure 1A. Specific
effects of the container materials are discussed in the Modifications to Sample Chamber and
Sample Container section.
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Measurement of Sample Heating by Raman Laser
A 36-gauge copper-constantan (type T) thermocouple (Omega Engineering, Inc,
Norwalk, CT) was located at the inside bottom center of the custom aluminum pan (Figure 5)
and attached to a data logger (model SD-947, REED, Wilmington, NC). Due to the small sample
size, natural convection, and the penetration of the incident laser light, the temperature
throughout the sample volume was not expected to differ significantly; the location of the
thermocouple at the bottom center was selected to assure that the probe would remain submerged
in the solution. Thermocouples were calibrated at the ice/water interface (0°C) and verified at
healthy external human body temperature (32°C) by holding it tightly in the center of the palm
until stable.
Principal Component Analysis
Principal components of mean-centered, pre-processed individual spectra were identified
using MATLAB (R2017b, The MathWorks Inc., Natick, MA) equipped with the PLS_Toolbox
8.6.1 2018 (Eigenvector Research Inc., Manson, WA, http://www.eigenvector.com) Mean
centering, but not autoscaling, at each wavenumber (within the PLS Toolbox software) was used
to ensure proper weighting of the contributions of smaller peaks relative to larger peaks [36-38].

Results and Discussion
Protein structural changes have been linked to aggregation in pharmaceutical solutions.
The negative consequences of protein aggregate formation in many drug products have led to
increased scrutiny and control of this critical quality attribute. An increasing number of methods
are being developed to support analysis of aggregate size [4, 28] and protein conformation within
the aggregate [6, 19]. The purpose of the present study is development of a Raman bulk sampling
method to determine structural changes in pharmaceutically relevant proteins [8, 13]. To evaluate
a method that includes analysis of the Raman spectra of proteins by PCA, protein solutions were
16

prepared at several pH levels known to change the structure of a model protein, α-lactalbumin
(ALA) [22, 25]. For comparison, CD spectra were also evaluated by PCA. Furthermore, the
ability of the Raman/PCA method to detect structural changes in the presence of sucrose in the
solution was also evaluated, since sucrose is a common excipient in pharmaceutical protein
formulations. However, first, several aspects of the method were optimized as described below.

Raman Spectral Analysis of Protein Conformational Changes
Method Optimization
Modifications to Sample Chamber and Sample Container
Initially, protein solutions were analyzed in quartz cuvettes in the cuvette holder provided
in the sample chamber. However, Raman scattering from the material comprising the empty
sample chamber (Figure 2, black dashed line) was very intense compared to the protein solutions
(Figure 2, red solid line). The interference from the sample chamber was strongest at 1200 –
1700 cm-1 coinciding with important protein structural peaks corresponding to vibrations within
secondary structures (amide I, amide III) and tertiary structures (Trp, Tyr). In fact, water alone
analyzed in quartz cuvettes gave the appearance that protein was present in the cuvette based on
these background peaks (Figure 2, red dash line). Lining the sample chamber with aluminum foil
(Figure 2, grey dashed line) resolved baseline issues due to sample chamber composition.
However, aluminum foil, was not robust enough for repeated use. Instead, a solid aluminum base
for the sample chamber was custom fabricated, such that any light that penetrated the sample or
its container would encounter a material with only weak Raman scattering, possibly from a
contaminant in the aluminum. The custom base consisted of solid aluminum blocks which could
be stacked to position the sample roughly within the focal volume (Figure 1D). The top block
had an adjustable stage to provide finer positioning (Figure 1C). All blocks were etched with
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cross lines to indicate the point in line with the center of the laser spot, which allowed
reproducible placement of samples.

Figure 1. Sample chamber with PhAT probe and custom sampling accessories: (A) DSC and
custom aluminum pans (B) Horizontal placement of cuvette with aluminum foil behind (C)
Custom aluminum stage accessories (D) Vertical placement of aluminum pan showing custom
aluminum stage blocks and base.

After eliminating the spectral interference by the sample chamber, several sample
containers were evaluated using water and > 200 mg/mL ALA solutions (Figure 2). The Raman
scattering of protein solutions (555 μL) in quartz cuvettes was of high intensity (Figure 2, solid
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orange line). However, Raman spectra of water in the cuvette (Figure 2, dashed orange yellow
line) revealed a strong broad peak between 750-850 cm-1, with a shoulder below 700 cm-1, and
moderately intense broad split peak between 1000 and 1250 cm-1. These peaks were from the
quartz cuvette and interfered with the spectra of protein at concentrations below 230 mg/mL. At
25 mg/mL, quartz spectral features could not be removed by subtraction due to the weak protein
signal in comparison to the strong quartz signal.

Figure 2. Overlay of unprocessed Raman spectra from various sample materials: sample
chamber material (black), quartz cuvette with sample holder exposed (red), quartz cuvette with
sample holder blocked with foil as shown in Figure 1B (orange), DSC pan as shown in Figure
1A (green), custom aluminum pan as shown in Figure 1A (blue). Solid lines are for ALA
solutions, dashed lines are for water.
Due to the success of using aluminum as the base of the sample chamber, DSC aluminum
sample pans with capacity of 75 μL of ALA solution were evaluated as sample containers
(Figure 2, solid green line). Smaller Raman peaks, in comparison to quartz, were observed at
775-825 cm-1, 1050-1100 cm-1 and 1550 cm-1 in water (Figure 2, green dashed line). These peaks
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were not found in either aluminum foil or the larger custom aluminum pans eventually used. The
source of the peaks from the DSC pans was not identified. The Raman spectra of protein
solutions in DSC pans at 25 mg/mL were devoid of Raman spectral contributions from the
container but had a variable baseline presumably due to instrument noise. Consequently, it was
possible with adequate baseline subtraction, though not optimal, to use DSC pans as containers
for collection of Raman spectra of lower concentration protein solutions. However, the low
capacity of the DSC pans yielded a weak protein Raman spectral signal. In addition, the small
pans were more difficult to handle and center under the Raman probe on the stage. Of further
concern, the volume of solutions in the low volume pans decreased during replicate sampling,
resulting in a decrease in spectral intensity of successive replicates. The decrease was attributed
to a combination of a decreased volume due to laser heating of the small sample (75 μL) in the
DSC pan and photobleaching. Sample heating was not significant in larger volumes as discussed
later in this section. Thus, possible volume changes and extra manual focusing steps to center the
smaller pan made the DSC pan format time consuming and challenging for reproducibility.
To overcome the challenges of using the DSC pans, larger aluminum pans were
fabricated which held 400 μL of sample solution (Figure 2, blue solid line). The larger aluminum
pan took advantage of the weak Raman signal of aluminum, was easier to manipulate, and had
the added advantage of fitting inside a lab glass vacuum cuvette washer (Part # C1295, Millipore
Sigma, Burlington, MA) to clean the container between samples, including any adsorbed protein.
The Raman spectrum of water in the larger custom aluminum pans was negligible relative to
protein solutions (Figure 2, blue dashed line)).
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Minimum Protein Concentration
The intensity of Raman scattering from protein increased with concentration as expected.
In both the quartz cuvette and the custom aluminum pan, due to a larger volume, the scattering
intensity was higher than in the DSC pan [39]. In the smaller capacity DSC pan, a higher
concentration of protein was required to obtain a similar intensity. However, when normalized to
intensity at the Amide I peak (1600-1700 cm-1), which accounted for increased intensity in the
raw spectrum due to both sample volume and concentration, the protein spectra from different
sample containers overlaid reasonably well (Figure 4). The Raman spectrum from the lowest
protein concentration (25 mg/mL) was noisier than higher concentrations in all sample containers
(Figure 3). To minimize the amount of protein needed for this and future studies, 50 mg/mL was
selected as the lower concentration limit for method development. It should be noted that higher
concentrations had less noisy Raman spectra, but were otherwise equivalent after intensity
normalization. The ability to use Raman spectral analysis of protein solutions from 50 mg/mL to
at least 230 mg/mL is an advantage of the method for the study of high concentration biologics
in various formulations, without the need for sample dilution which may alter the protein-protein
interactions of interest.
The minimum concentration required for adequate spectral analysis of protein structure
depends on the protein primary structure, and the structural changes to be monitored [40].
Protein Raman spectral band assignments are well documented based on group frequencies and
spectral structure correlations [23, 26, 27, 41-49]. Raman scattering is a bulk measurement of
protein group frequencies over all possible conformations within the volume sampled by the
laser. Amide secondary structural vibrations, although relatively weak, dominate the Raman
spectra due to the large number of amide bonds in the protein with near identical conformations.
The percentages of α-helix and β-sheet in the protein structure govern the intensity and
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wavenumber of Raman spectra of amide peaks due to differences in both conformation and
hydrogen bonding patterns. The Raman spectral features that can be used to monitor changes in
tertiary structure are largely due to the aromatic amino acids and can be more complicated.
Aromatic amino acid residues (tyrosine, tryptophan and phenylalanine) are stronger Raman
scatterers than amide groups, but are generally not a large fraction of the amino acids in a
protein. Certain proteins do not have all three aromatic sidechain groups, or one or more
aromatic residues are present at insufficient levels (i.e., one amino acid out of hundreds of amino
acids) to provide a peak. Due to structural similarity of the aromatic amino acid residues, tertiary
peaks may be combinations of side chain structural vibrations of more than one aromatic side
chain. Furthermore, adequate study of conformational changes requires a change in the amino
acid side chain environment, preferably buried to unburied during unfolding. Since Raman
scattering samples vibrations from residues in many positions, detection of changes in structure
is enhanced if a significant portion of side chain residues shift conformation, such as 50%.
Detection of structural change is more challenging as this percent decreases.

Figure 3. Minimum concentration determination in aluminum pans
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Minimum Spectral Acquisition Time
Signal intensity of Raman spectra is proportional to the power of the laser [50]. Using a
constant power laser system, such as used in this study, signal intensity can be increased with
laser exposure either by adding acquisitions or lengthening the acquisition time. For example, a
sample that has been scanned 50 times with a 3 second acquisition will theoretically have an
equivalent signal intensity to a sample scanned 3 times with a 50 second acquisition time.
However, for samples with weak Raman scattering, such as protein solutions, a long acquisition
time is required to gain appropriate signal intensity compared to baseline values, and avoid data
issues associated with fluorescence and low pixel fill in the CCD detector [51]. Increasing the
intensity also improves the signal to noise ratio. However, each acquisition is also associated
with read noise, which can be minimized through averaging a number of spectral acquisitions. In
addition, the acquisition software used automatically compensates for read noise with an
equivalent number of background dark scans and a filter for removal of cosmic rays.
Spectral acquisition time for 50 mg/mL ALA solutions in DSC pans (75 μL) was varied
between 15 seconds and 5 minutes, while in custom aluminum pans (400 μL) time was varied
from 10 seconds to 10 minutes (Figure 4). The signal to noise ratio qualitatively improved over
the range of 10 seconds to 3 minutes exposure for spectral acquisition in the larger sample
container. No further reduction in noise was noted between 3- and 10-minute exposure times.

23

Figure 4. Effect of acquisition time on spectral noise.

A single 5-minute acquisition time was compared to 10 accumulations of 0.5 minutes.
Careful inspection of single-acquisition spectra compared to the average of 10 half-minute
accumulations showed more noise in the latter. Due to the lower signal to noise for single
exposure acquisition and no reduction in noise beyond the 3-minute acquisition time, 3 minutes
was selected as the acquisition time to achieve high throughput sample measurement.
Repeat acquisitions of Raman scattering from the protein solutions without moving the
sample pan were often lower in intensity possibly due to photo bleaching [48, 52, 53]. This effect
was found for all sample acquisition times and could be corrected by baseline subtraction and
normalization.
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Sample Heating by Raman Laser Exposure
The bulk sampling probe used in this study had a wide sample focal area and volume,
decreasing the Raman laser intensity per volume and sample damage [35]. However, since
proteins can be unstable at elevated temperatures, sample heating was explored as a possibility at
the laser power (>150mW) of the equipment used here. The thermocouple probe was placed at
the bottom center of the custom aluminum pan (Figure 5). Except for the reduction in intensity,
which was corrected by normalization, there were no obvious changes in the spectrum on
repeated acquisitions. And there was no visible change in the solution samples.

Figure 5. Thermocouple placement in the custom
aluminum pan.

The temperature of 400 μL of water in the custom aluminum pan before laser exposure
matched the benchtop ambient temperature of 24.5°C. Six spectra (3 min acquisition time) were
collected to mimic the expected experimental pace that included a delay between acquisitions to
account for the time taken change the sample container. The highest recorded temperature,
28.1°C, occurred immediately after the sixth 3-minute acquisition. The solution returned to
ambient temperature in < 2 min after laser exposure. These small temperate fluctuations (< 4°C)
were not expected to affect most proteins. For samples with greater sensitivity to temperature
fluctuations, a temperature-controlled aluminum container may be required.
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Spectral Pre-processing
The term pre-processing applies to any manipulation of the raw signal obtained before
final interpretation or further analysis. Raw spectra were pre-processed to minimize spectral
inconsistencies such as background scattering, fluorescence and minor variation in analyte
concentration before comparing spectra and interpreting any differences [48, 52-55]. The
purpose of pre-processing spectra prior to principal component analysis (PCA) for the current
method was to: (1) reduce the effect of instrument noise and day-to-day variation and (2)
conserve lower intensity, but meaningful, spectral features, without introducing artifacts. Any
instrument noise (i.e., variation at each wavenumber) not removed by pre-processing could
contribute to the variance corresponding to the first several PCs reducing the sensitivity of PCA,
which is based on analysis of variance within the data set. Relative to PCA of processed spectra,
PCA of raw spectra of protein solutions was able to distinguish changes in principal component
1 (PC1) for solutions of different pH; however, score clusters were wider, less uniform and
showed differences due to day to day variation. In the presence of sucrose, the large variation in
clusters did not allow samples to be distinguished, meaning that raw spectra could only be
analyzed for major trends, but precision was much lower and not suitable for the present study.
Thus, pre-processing was necessary.
Several baseline subtraction options were evaluated. Linear baseline subtraction did not
remove “within day” variation or “day-to-day” variation effectively, resulting in PC scores with
wider confidence intervals and inconsistent score values for some “day-to-day” or “within day”
sample replicates. The inconsistent PC scores were presumably be due to the linear baseline
method’s inability to remove the non-linear background fluorescence. An “adaptive baseline”
correction method, which subtracted a non-linear baseline from the spectrum, was better able to
remove broad background peaks such as those due to fluorescence, and still conserve sharper
26

Raman scattering peaks. The adaptive baseline was adjustable in coarseness of fit from 100%
(corresponding to a linear baseline) to 0% (corresponding to the spectrum itself). Adaptive
baseline settings from 22% to 30% removed wide background effects while leaving the protein
peaks largely unaffected. More importantly, PC score cluster spread and expected solution trends
of Raman spectra, from ALA at four pH levels, using either the 22% or 30% adaptive baseline
subtraction were not different (data not shown). However, Raman spectra from other proteins
such as human serum albumin (HSA), with elevated baselines (data not shown) revealed the
need for 22% adaptive baseline correction to reduce instrument-based variation and improve
PCA of subtle structural changes. Therefore, in order to make the new method applicable to
more proteins, the 22% adaptive baseline correction was implemented in this study.
In preliminary analyses, the adaptive baseline was subtracted from each spectrum over
the full range of wavenumbers. However, end-effects were observed with all baseline methods
due to difficulty of each method in fitting the steep slope below 300 cm-1 due to spectral filter
effects during removal of Rayleigh scattering. End effects were minimized by truncating each
spectrum to the region of interest 600 - 1850 cm-1 before adaptive baseline correction.
Intensity normalization was evaluated to further minimize variation due to small
differences in protein concentration, background spectral inconsistencies such as fluorescence or
photobleaching. Intensity normalization was evaluated at two alternative peaks (~1450 cm-1 [CH bending] and ~1650 cm-1 [Amide I]). Ashton et al. normalized the intensity to the ~1450 cm1

peak in their investigation of pH effects in ALA structure using two-dimensional Raman

correlation variance [22]. The strong phenylalanine peak near 1004 cm-1 is also used for
normalization, because this peak does not often change intensity due to large numbers of
phenylalanine side chains in in various environments in many proteins [46]. Spectra were
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normalized to the amide I peak for in situ studies utilizing freeze-drying microscopy [56]. The
ultimate goal of the current method, and others [56], is application to formulation development
of pharmaceutical proteins, where there is substantial spectral contribution below ~1530 cm-1
from many excipients used for stabilization. These excipient peaks would interfere with intensity
normalization below ~1530 cm-1. Therefore, the amide I peak was most suitable for intensity
normalization, due to the absence of excipient peaks in this spectral region.
Analysis of Raman Spectra of ALA Solutions at Four pH Levels
Changes in the Raman scattering of α-lactalbumin induced by pH are apparent
throughout the spectrum (Figure 6A). Peak shifts related to both secondary and tertiary structures
follow two general patterns: (i) gradual change in the spectrum over the range in pH from 8 to 2
and (ii) little to no change in the spectrum from pH 8 to 4, followed by an abrupt change at pH 2.
The gradual changes between 1380 cm-1 represented small changes in the secondary structure of
the protein. Peaks associated with tertiary structure, such as 1585 cm-1 (Trp [41, 47]), 1460 cm-1
(-CH deformation [27, 29, 47, 48, 57]) and 1619 cm-1 (Tyr [41, 44]) were also gradual. Some of
the more abrupt changes in spectral features at pH 2 corresponded to secondary structure, such as
at 955 cm-1 (N-Cα-C stretch [48, 49]), 1600-1730 cm-1 (amide I [39, 44, 50, 58]) and 1230-1340
cm-1 (amide III [23, 26, 27, 39, 41, 44, 50, 58, 59]). However, more of the abrupt changes at pH
2 were associated with tertiary structure, such as peaks at 830/850 cm-1 (Tyr [26, 27, 41, 44, 60]),
760, 880, 1360, and 1553 cm-1 (Trp [26, 27, 41-45]), 1004 cm-1 (Phe [26, 27, 41]), and 1175 cm-1
(Tyr & Phe [26, 27, 41, 44]). Difference spectra (relative to pH 8) (Figure 6B) highlight the
gradual changes in protein structure with pH (e.g., 1400-1450 cm-1) and abrupt change at pH 2
alone (e.g., 1004 and 1650-1730 cm-1). The difference spectrum of ALA at pH 2 relative to at pH
8 represents the largest changes in the model system for the protein, ALA.
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Figure 6. (A) Raman spectral overlay of ALA solutions: pH 8 (blue), pH 6 (green), pH 4 (orange),
pH 2 (red). (B) Difference spectra compared to pH 8: pH 6 (green), pH 4 (orange), pH 2 (red). (C)
Overlay of the difference spectrum between pH 2 minus pH 8 (blue) and the loading intensity (red)
from principal component 1 (PC1).
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ALA has 4 tyrosines, 4 tryptophans and 4 phenylalanines out of 124 total amino acids
with a MW of 14.2 kDa [57]. Raman intensity of the aromatic side chains, indicative of tertiary
structure, are based on their position within the 3-dimensional structure, differences in hydrogen
bonding and hydrophobicity of the microenvironment. There are more tertiary structural changes
related to tryptophan than to the other two aromatic amino acids. Previous authors suggested that
2 of the 4 tryptophan residues in ALA move from buried to unburied in the molten globule
conformation at pH 2 in solution [9, 24]. In the current study, relative to pH 8, there were small
changes in the Raman spectrum of ALA at pH 6 and pH 4 and much larger changes (mostly
associated with tertiary structure) at pH 2; these changes were also observed by circular
dichroism as discussed in more detail later, confirming the Raman spectral changes due to pH
represented structural changes.
Many current methods for detecting protein structural changes, such as far UV CD, and
FTIR, often limit the analysis to secondary structural features. Raman scattering captures changes
in both secondary and tertiary structure simultaneously. In addition, since there are numerous
peaks in the spectra of protein solutions that shift with pH, analysis of just one or a few peaks
would be an underutilization of the rich data set represented by all wavenumbers of the spectrum.
Numerous small, but meaningful, differences in the spectrum when analyzed as a collection are
expected to be able to detect very small changes relevant to protein stability. Therefore, in order
to fully utilize the Raman spectral data, including all the nuanced information that is contained in
small spectral differences at each wavelength, principal component analysis (PCA) was employed
to quantify the change over the full Raman spectrum of ALA. More specifically, PCA statistical
methods were applied to the protein Raman spectra from 600-1850 cm-1. PCA is a variable
reduction technique that represents the variation among samples using a new set of axes or
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principal components. This statistical technique simplified the spectral intensity changes at 1250
individual wavenumbers into a single (or a very few) values or scores, one for each principal
component. In the current study, PCA was also used to link detected changes back to specific
wavenumbers via their loading vectors. Linking the statistical analysis back to shifts in individual
wavenumbers is not possible using data analysis by spectral correlation statistics which are often
utilized to compare changes in large regions of data. Another benefit of PCA was that native and
“non-native” protein states could be analyzed indirectly using PCA without direct knowledge of
the content of each conformation in the samples. PCA, as used in chemometric studies,
differentiates between multiple chemical and physical sources of variation in the data, enabling
separation of small variation within the system such as is expected for tertiary structural changes.
The score plot for the first principal component (PC1) captures 53% of the variation in the
protein structure with pH (Figure 7). The PC1 scores for the spectrum of the protein at pH 2 were
1.5-2, which were fully separated from the negative PC1 scores of the protein at higher pH,
meaning PCA can statistically distinguish between the spectrum of ALA at pH 2 from the protein
at other pH levels. PC1 scores for protein at pH 4 are closer to PC1 scores of protein solution
spectra at pH 6-8. In contrast, PCA was not able to distinguish between the spectra of ALA at pH
6 and 8, based on their overlapping score values, i.e., the variation in PC1 scores for the spectra at
both pH 6 and 8 was on the order of the sample-to-sample variation at each pH. Thus, the PC1
score appears to quantify changes in the ALA structure as a function of pH, with the highest
resolution, corresponding to the largest structural changes between pH 4 and pH 2.
Ashton and Blanch applied two-dimensional correlation spectroscopy (2DCOS) of Raman
spectra to the examination of ALA structure as an alternate visualization method for identifying
the wavenumbers at which the intensity changes occurred. 2DCOS revealed more numerous and
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intense spectral changes below pH 3.6 than above, which is consistent with the PC1 scores in the
present study. Moreover, other CD studies of ALA generally included compared only the native
forms (pH 7.0-7.6) and the acidic “molten globule form at pH 2.0 [24], presumably due to the very
small changes at intermediate pH.

Figure 7 Score plot for samples with formulation pH 2 (red square), pH
4 (orange star), pH 6 (green diamond), and pH 8 (blue circle). Each
symbol represents an individual spectral acquisition.

PC1 is comprised of contributions at each wavenumber over the entire Raman spectrum of
ALA. The changes at each wavenumber that contribute to the principal component (PC)
collectively describe the loading of that PC which ranges from -1 to 1 (defined as the cosine of the
angle between the variable axis and the principal component axis). In an effort to link the principal
components to known structural changes in the protein, insofar as possible, the PC loading
intensity vector can be compared to difference spectra (Figure 6C) to provide molecular
understanding. The difference in the Raman spectrum of ALA at pH 2 minus pH 8 represents the
largest structural change. Comparison of this difference spectrum with the loading vector for PC1
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shows excellent agreement, supporting the use of PCA of the Raman spectrum of ALA to
quantitatively describe pH induced variations by a single value, PC1 score. Unlike many spectral
correlation methods of analysis, which also provide a single value, however, PCA loading plots
also identify the peaks that change for greater molecular-level understanding of the structural
change. Additional interpretation of these changes in the solutions will be discussed in the next
chapter, when comparing solutions and solids.

Analysis of Raman Spectra of ALA Solutions Containing Sucrose
Sucrose is often used as a protein stabilizer [61], particularly in the solid state [62] .
Spectra of aqueous sucrose solutions, without protein, have many intense peaks overlapping the
protein spectrum in the region, 600-1530 cm-1(Figure 8B). The Raman spectra of replicate ALA
solutions at pH 8 with 2:1, 1:1 and 1:2 protein to sucrose weight ratios (Figure 8A) were
analyzed by PCA, along with the initial ALA pH 2 to pH 8 solutions without sucrose. Protein
formulations with sucrose at low pH could not be investigated due to acid hydrolysis of sucrose
and subsequent Maillard reaction [63-65].
Sucrose is a strong scatterer relative to protein and has overlapping peaks in the region of
interest. Particularly at higher concentrations of sucrose in the solution (e.g., 1:2
protein:sucrose), the sucrose contribution overwhelmed many protein spectral features (Figure 8
A). For example, sucrose has many intense peaks overlapping tertiary features, such as those
corresponding to tyrosine at 830/850 cm-1. Additionally, sucrose has large peaks that interfere
with secondary structural peaks, such as the amide III region.
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Figure 8 (A) Normalized Raman spectral overlay of ALA:sucrose solutions: pH 8 (blue), pH 6
(green), pH 4 (orange), pH 2 (red) and sucrose containing solutions: ALA:sucrose 2:1 (teal), 1:1
(pink), and 1:2 (black). (B) Overlay of the Raman difference spectrum of the pH 8 1:2 protein:
sucrose formulation and pH 8 without sucrose (blue), sucrose Raman spectrum (black) and the
loading intensity (red) from principal component 1 (PC1). Note: Sucrose Raman intensity divided
by scaling factor of 636 not normalized. (C)Overlay of the difference spectrum pH 2 – pH 8 from
first freeze drying run (blue), difference spectrum pH 2 – pH 8 from second freeze drying run
(black) and the loading intensity (red) from principal component 1 (PC2) showing method
consistency.
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Application of PCA such a complex data set, with contributions due to protein structural
changes and the presence of sucrose, demonstrates the power of PCA to separate spectral
variation largely attributable to each factor. PCA of the ALA spectra at four pH levels and at pH
8 with 3 sucrose concentrations yields two principal components. PC1 describes 96% of the
variation in the spectra (Figure 9A).

A

B

Figure 9 (A) PC1 score plot for formulation pH 2 (both red square), pH 4 (orange star), pH 6
(green diamond), and pH 8 (both blue circle), ALA:sucrose 2:1 (teal triangle down), 1:1 (pink
triangle up), 1:2 (black triangle left). (B) PC2 score plot for the formulations.
All ALA solutions without sucrose have PC1 scores of -4 regardless of solution pH
(Figure 9A). In contrast, PC1 scores of the protein solution spectra containing sucrose increase to
> 15 with increasing sucrose content. Since PCA assigns the largest spectral variation to PC1 and
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sucrose is a strong Raman scatterer relative to ALA, it is not surprising that the first principle
component trends with the concentration of sucrose. The PC1 loading intensity vector was
compared with i) the difference between spectra of ALA:sucrose 1:2 formulation and ALA
alone, both at pH 8, and ii) the spectrum of only sucrose in solution at 50 mg/mL (scaled). Good
agreement of the PC1 loading and both relevant spectra (Figure 10) indicates PC1 describes the
majority of variation related to spectral changes due to the presence of sucrose. Agreement of
PC1 is better with the difference spectrum than with the sucrose spectrum demonstrating that
PC1 may be influenced by the differences between protein:sucrose and protein alone, possibly
attributable to interactions in solutions, as well as just sucrose concentration itself. The spectrum
of pure sucrose has the largest deviation from the both the PC1 loading intensity and the
difference spectrum between 1200 and 1400 cm-1, which includes Amide III peak and
contributions from aromatic amino acids. More work is needed to determine whether this shows
an interaction of sucrose with protein, a change in structure due to the presence of sucrose in the
solution (without specific interactions), or simply a spectral change due to a lowering of the
dielectric constant of the medium by sucrose.
PC2 describes 2% of the variation in the data set which shows a trend with pH level
(Figure 9B), with PC2 scores of 1-2 for pH 2 solutions and scores of -1 to 0.5 for pH 4 to pH 8.
PC2 statistically separates the spectrum of ALA at pH 2 from other pH levels as observed
previously (Figure 7). However, there is obvious contribution from sucrose peaks, which
increases with the level of sucrose. ALA: sucrose 2:1 solution (teal triangle down), containing
the least sucrose, are still correctly categorized with pH 8 ALA only solutions. Yet, the spectra of
the solution with highest sucrose concentration, ALA:sucrose 1:2 (black triangle left), have
scores corresponding to between pH 4 and pH 2 samples; thus, the spectra of ALA at pH 4, and
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presumably its structure, cannot be distinguished from pH 8 samples containing sucrose based on
PC2. This could be due to the inclusion of some of the variation due to sucrose spectral
contributions into this principal component (PC2). PCA is an unsupervised statistical technique.
Thus, it is possible for any factor to be described by two PCs or for two factors to be described
together in one PC as seen here for both PC1 and PC2 [36].
Comparison of the PC2 loading intensity with the difference spectrum representing
changes in pH confirms that PC2 is largely capturing variation related to pH induced
conformational changes (Figure 8C). However, we see differences in the 1250-1400 cm-1 region
where both sucrose and protein have large peak contributions, in addition to the 800 – 900 cm-1
region, where sucrose has a large peak obscuring important tertiary structural peaks (Tyr fermi
doublet). This may be due in part to interference from large spectral contributions of sucrose.
Although less robust than in the absence of sucrose, the PCA method is still capable of detecting
larger pH-induced structural changes in protein from their Raman spectra even in the presence of
overwhelming and overlapping sucrose peaks, in addition to possible protein:sucrose
interactions.
Investigation of a Limited Spectral Range for Raman Analysis
The region from 1530 to 1780 cm-1 has negligible spectral contribution from sucrose
(Figures 8A and B). In an effort to identify any interactions or effects of sucrose on the structure
of ALA, Raman spectra from all sample solutions truncated to this limited region was analyzed
by PCA. An overlay of all of the formulations in this region (Figure 10A) reveals both gradual
changes with pH at 1585 cm-1 (Trp) and abrupt changes for the pH 2 formulation in the amide I
peak region (1650-1700 cm-1), in comparison with pH 8 (native conformation).
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Figure 10 (A) Raman spectral overlay of ALA:sucrose solutions in the region from 1530 to
1780 cm-1: pH 8 (blue), pH 6 (green), pH 4 (orange), pH 2 (red) and sucrose containing
solutions: ALA:sucrose 1:2 (teal), 1:1 (pink), and 2:1 (black). (B) Overlay of the difference
spectrum pH 2 – pH 8 from first freeze drying run (blue) and the loading intensity (red) from
principal component 1 (PC1).

The region from 1530 to 1780 cm-1 is dominated by the amide I peptide C=O stretch,
secondary structural peak, with one tertiary tyrosine peak (1619 cm-1), and two tertiary
tryptophan peaks (1553 cm-1 and 1585 cm-1). Analysis of this limited spectral region with PCA
confirms that the pH effect is dominant, representing 60% of the variation in the system
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described by PC1 (Figure 11). Therefore, analysis of the limited region (1530 to 1780 cm-1)
removed some interference by sucrose scattering. This is evident in the decreased variation in the
PC1 scores for pH 8 formulations (Figure 11) containing sucrose relative to the PC2 scores based
on the full spectrum (Figure 9B).

Figure 11. PC1 score plot for samples with formulation pH 2 (both red square), pH 4
(orange star), pH 6 (green diamond), and pH 8 (both blue circle), ALA:sucrose 2:1
(teal triangle down), 1:1 (pink triangle up), 1:2 (black triangle left).

An overlay of the PC1 loadings with the difference spectrum representing change due to
pH shows good alignment and confirms that PC1 scores largely represent pH-induced structural
changes in the protein (Figure 10B). Other PCs describing the limited spectral range showed no
meaningful trends or clustering. In summary, analysis of the limited region from 1530 to 1780
cm-1 shifted sucrose variation from the dominant variation to undetectable.
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Analysis of CD Spectra of ALA in Solution
Few studies of protein structural change include results from both CD and Raman
methods. These studies are usually focused on structure elucidation in microscopic samples for
mechanistic purposes rather than on Raman spectroscopy as a screening tool in the process
development laboratory. ALA is approximately 43% α-helix and 9 % β-sheet with the remaining
structure unordered [66]. The far UV CD spectra (Figure 12A) confirms that ALA at low pH
retains a majority of its secondary structure compared to the native pH 8 solution, as is expected
in the molten globule conformation [9-11, 24, 25].
In contrast, a protein which has been fully denatured with urea, shows almost no
ellipticity in the far UV range [9]. All ALA solutions retained greater than 95% of the native αhelix structure at both 208 nm and 220 nm, calculated by dividing the ellipticity value of
potentially non-native forms by the ellipticity of the native structure (pH 8), and multiplying by
100 [67, 68]. Solutions at pH 2 had >120% retention at 208 nm, therefore a small change in
native structure is indicated but does not support a change from α-helix to β-sheet. Similar
findings at low pH for ALA [24, 25] and IFNα2a [12] also suggest molten globule formation [9].
Human interferon-α2a at various pH levels in solution [12] shows a similar trend in CD as
observed with Raman analysis ALA, with small overlapping differences between pH 8 and pH 6,
slightly larger differences observed at pH 4 and larger changes observed at pH 2, especially in
the tertiary structural peaks.
The CD spectrum in the region from 260nm to 320 nm is due to differential absorption
from aromatic amino acids. Tryptophan (Trp) has a peak in the region from 290 – 305 nm.
Tyrosine (Tyr) shows a peak between 275 and 282 nm with a shoulder at longer wavelengths that
can be obscured by tryptophan. Phenylalanine peaks occur between 255 and 270 nm. In
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comparison to pH 8 solution, there is a small change in the near UV CD spectrum of ALA at pH
4 (Figure 12B), followed by an almost complete loss in ellipticity at pH 2, similar to PC1 scores
of the full Raman spectra, confirming greater tertiary structural change with only a small
secondary structural change.

A

B

Figure 12. (A) Far UV CD spectra of ALA at various solution pH. (B) Near UV CD spectra of
ALA at various solution pH with aromatic amino acid regions highlighted.
The near UV CD spectra reported here agree well with literature references [12, 25] of
proteins known to form molten globules at low pH. The molten globule conformation has a loss
in the native environment of the tertiary side chains, allowing more flexibility and motion,
resulting in decreased ellipticity in CD [9] due to the large distribution of possible states. In
41

addition, the molten globule conformation has been linked with changes in protein folding during
many previous aggregation studies [8, 9, 13].
Analysis of the CD spectra of ALA at 4 pH levels by PCA was compared to the
corresponding analysis of the Raman spectra. When analyzed separately, the PC1 scores of both
Far UV CD and Near UV CD results both trend with pH. In an attempt to combine secondary
and tertiary features into one equally weighted system for PCA analysis, the normalized Far UV
and Near UV CD spectra were combined into one data set. Due to inherent differences in signal
strength after concentration normalization, the Near UV CD signal was multiplied by a factor of
30 to achieve similar scales of molar ellipticity. Although on a different absolute scale, PC1
scores of ellipticity (Figure 13) agreed well with the same analysis of the Raman spectra. PCA
was able to describe the majority of relevant variation in PC1 (97%), with overlapping scores for
pH 6 and pH 8 similar to results observed in the Raman PCA analysis.

Figure 13. Score plot for samples with formulation pH 2 (red square), pH 4 (orange star),
pH 6 (green diamond), and pH 8 (blue circle).
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The PC1 loading vector intensity agreed well with the difference CD spectrum of ALA
obtained from the pH 2 solution minus the pH 8 solution (Figure 14), verifying that the PC1
score was largely due to pH-induced structural changes. Significant spectral features include the
Far UV peaks at 208 nm, 222 nm and the complete lack of ellipticity in the Near UV CD.

Figure 14. Overlay of the difference spectrum (blue) between the pH 2 minus the pH 8 CD
spectrum and the loading intensity (red) from principal component 1.

CD of ALA confirmed the concomitant perturbation in protein structure caused by pH
and formation of a molten globule structure with a fairly conserved secondary structure and
extensive changes in tertiary structure. The consistency in results of the two methods provides
support for the newly developed Raman-PCA method for quantitatively identifying alterations in
protein structure. In addition, PCA is equally effective for analyzing Raman and CD spectra, at
least at the lower concentration used in this study (50 mg/mL). However, CD is problematic at
higher protein concentrations, where Raman scattering remains the better option.
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Conclusions
A Raman scattering-PCA method was developed for use in protein solution formulation
development. Accuracy of the results from ALA was confirmed by comparison with literature
data using Raman [22] and CD [25]. These methods require different protein concentration in
solution (i.e., high concentration for Raman scattering and low concentration for CD spectra) and
are therefore not often compared directly. For the first time, CD and Raman spectra have been
compared quantitatively using PCA, providing new insights into the application of each method.
Both methods were equivalent in the analysis of ALA where non-ideality that occurs at
concentrations > 50 mg/mL did not exist. However, in order to simultaneously analyze both
secondary and tertiary structural changes simultaneously, both near UV and far UV CD spectra
were analyzed together. In contrast, Raman spectra had contributions from both structures.
Analysis of Raman and CD spectra of ALA at 4 pH levels by PCA agreed well. The new RamanPCA method can be applied to protein solutions in the concentration range from 50-200 mg/mL
without the need for dilution, which may show concentration-dependent protein-protein
interactions [21]. In addition, analysis by PCA of the entire CD spectrum added a semiquantitative method which is not traditionally applied to CD, except in the ellipticity difference
at 208 nm and 220 nm, attributed to α-helix or β-sheet structures.
A range of sample preparation, sampling, spectral acquisition, and preprocessing
techniques were investigated to optimize Raman spectra and their analysis. Laser exposure did
not damage the protein solution over the acquisition times investigated. Small structural changes
induced by adjustments in solution pH were represented by simultaneous Raman spectral
changes in peaks associated with multiple tertiary and secondary structural. PCA allowed
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simultaneous analysis of the spectral changes in over 600-1850 wavenumbers, and reduced the
information to just a few useful principal components.
Inclusion of sucrose, a common stabilizing excipient in protein formulations, complicated
the analysis of Raman spectral features from protein. However, PCA effectively described and
separated the majority the sucrose contribution in principal component one, allowing the trend in
pH-induced protein structural change to be captured in the second principal component.
Analysis of a smaller region of the Raman spectrum in which sucrose had negligible
scattering, but contained some secondary and tertiary structural contributions, was also able to
detect pH-induced structural changes in the first principal component. The new Raman method
with PCA provided semi-quantitative understanding of the pH-induced protein structural
changes. Therefore, this result supports the detailed analysis of multiple protein samples with
subtle structural changes in solution which have been linked with resultant pharmaceutical
instability. A study extending these results to lyophilized protein in the solid state follows.
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Chapter 3
Development of a Method to Detect Structural Differences in
Lyophilized Proteins using Raman Scattering
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Introduction
Over 100 biologic drugs have been approved by the FDA to treat a wide range of diseases
[1]. Commercially, many biologic drug products are injectable protein solutions ready for patient
administration. However, product formulations for protein drugs in solution must be carefully
designed to meet stability criteria over the shelf-life period that balances both product quality for
the patient and industry economics [2].
Proteins are subject to various physical and chemical degradation processes in solution [3].
Protein unfolding and physical degradation processes resulting in aggregation have been studied
extensively [2, 4, 5]. Aggregation studies support the presence of a molten globule intermediate in
both protein folding and aggregation pathways [6]. The molten globule formation is characterized
by retention of secondary structure in the protein, but with significant loss in tertiary structure,
using spectroscopic techniques, such as circular dichroism (CD) and tryptophan fluorescence.
Recently, protein aggregates in solution have gained even more interest due to a potential link
between aggregates and immunogenic reactions in patients [7].
Due to inadequate stability in the solution state, approximately 30% of protein drugs are
freeze dried and stored in solid form [8]. However, conformational changes in protein structure
can occur during the freezing [9, 10] and drying steps [11]of the freeze-drying process [12]. Protein
structural changes during freeze drying due to processing conditions [13] or formulation [14, 15]
have been confirmed. However, exact mechanisms for protein protection during the harsh
lyophilization process and protein structural stabilization during storage are still being
investigated. Two theories for protein stabilization are often used to explain results [16, 17]. One
theory is based on vitrification of the protein in a glassy matrix, which inhibits the motion required
for degradation processes. There are many studies supporting a link with mobility and storage
stability [18-20]. The other, known as the water replacement theory, hypothesizes that stabilizers
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form hydrogen bonds with the proteins conferring thermodynamic and structural stability. There
are additional studies investigating the effects of structure on the stability of solid-state proteins
[14, 15, 21, 22]. In reality, both mechanisms may be acting together to stabilize the proteins. The
present report is concerned with the structural component of stability consistent with the water
substitution hypothesis.
The degree of structural change may impact both in-process and storage stability of
proteins, with partially unfolded protein molecules expected to be less stable against both
aggregation and chemical degradation [14, 23]. Additional information on structural changes in
the protein molecule, particularly in the solid state, available during early product development
would lower the risk of selecting a formulation with inadequate stability, resulting in safer and
more effective drugs reaching the patient faster.
Studies have shown that changes in protein structure due to drying, may reverse during
reconstitution [24, 25], making solution state tertiary structural characterization, CD for example,
inadequate to fully characterize the effects of storage in the solid state. Current methods do not
fully characterize all protein structural changes in solids, as there is not a well-established method
for fully characterizing tertiary structure in the solid state. Fourier Transform Infrared
Spectroscopy (FTIR), commonly used to analyze solid state protein, only evaluates the secondary
structure; water interferes in some spectral regions decreasing its widespread use in solutions.
Smaller tertiary structural changes purported to take place in proteins in the solid state [20]are not
detected by FTIR, unless these changes are highly coupled to the secondary structural changes
amenable to analysis by FTIR. A lack of critical structural information on proteins in the solidstate affects the ability to make formulation decisions during development that affect the
manufacture and commercialization of protein drugs.
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Raman spectroscopy has long been known to detect changes in protein tertiary and
secondary structure in solutions, and in solids to a lesser extent [26]. However, recent advances in
instrumentation and software analysis methods have increased the ease of use and quantitation of
this method. Raman scattering has been used in solutions to quantify changes in protein structure
(Chapter 2 & [27]). Raman spectroscopy has been applied to the study of protein structural changes
in lyophilized solids [28] and investigation of phase composition of excipients [29-31]. Raman
combined with principal component analysis (PCA) was applied to differentiate native vs nonnative states of lactate dehydrogenase in lyophilized product in vials [32]. Protein aggregation in
human insulin was also detected by a combination of PCA and a drop-coat deposition Raman
method [33].
Surprisingly, tertiary structural changes were not the focus of previous Raman studies of
proteins in solids. The objective of this study is to develop a new Raman spectroscopic method
that focuses on changes in protein tertiary structure, along with secondary structure, in the solid
state that are associated with decreased protein stability. With a new tool to provide protein tertiary
structural information in the solid state, drug developers can more efficiently evaluate the optimum
formulation and process design.

Materials and Methods
Materials and Sample Preparation
Bovine α-Lactalbumin (ALA; >85%, lyophilized powder) and sucrose (>99.5%) were
purchased from Sigma-Aldrich (St. Louis, Missouri). Protein solutions were prepared as
described previously (Chapter 2). Briefly, protein powder as received was dialyzed against water
at 3000 RCF and 10°C using centrifugal filter units (Regenerated cellulose, MWCO 10KDa,
Millipore Sigma, Burlington, MA) on a centrifuge (Allegra X-15R, Beckman Coulter, Brea,
CA). After dialysis, protein concentration was determined using an absorptivity of 2.01 mL / (mg
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cm) at 280 nm (Cary 100Bio UV-Visible spectrophotometer, Agilent, Santa Clara, CA) [34].
Final protein solution concentration and pH was adjusted using water and diluted (<0.1 N)
hydrochloric acid (standard grade, Thermo Fisher Scientific, Waltham, MA) to target pH levels
of 2.0, 3.8, 5.8, and 7.8 using a pH meter (model 710, Thermo Orion, Waltham, MA) to achieve
different structural conformations [27]. Although pH in the solid state is not defined, for the
remainder of the data analysis and discussion, the formulations will be referred to as pH 2, 4, 6,
and 8 in both solution and solid state. Sucrose formulations were prepared from pH 8 ALA
solutions at 2:1, 1:1 and 1:2 protein to sucrose weight ratios. All solutions were prepared at 50
mg/mL (ALA), filtered through 0.45 μm PVDF syringe filters (Millipore Sigma, Burlington, MA
or CELLTREAT, Pepperell, MA). Protein solutions were analyzed on the Raman spectrometer,
diluted and freeze dried at 15 mg/mL (ALA) for further solid analysis.
Lyophilization Cycle
Protein solution aliquots (1 mL) were filled into 10 mL glass tubing vials and partially
stoppered with bromobutyl rubber stoppers with a fluorinated polymer coating (20mm igloo,
FM457/0 Omniflex3G, Datwyler Pharma Packaging Int. NV, Alken, Belgium). Product
temperature was monitored through the use of 30-gauge copper-constantan (Type T)
thermocouples Omega Engineering, Inc, Stamford, CT) placed at the center bottom of 4 vials
(both edge and center vials). Thermocouples were calibrated using an ice-water slush. The
protein solutions were lyophilized in a MicroFD® small R&D freeze dryer with LyoSIM® and
LyoPAT® technology (Millrock Technology, Kingston, NY). Solutions were frozen using
FreezeBooster® controlled nucleation at -5°C and frozen with AccuFlux controlled heat flow (450 W/m2). Primary and secondary drying proceeded according to the recipe (Table 1), then
stoppered, sealed and stored at 5°C for further analysis. In an effort to reduce the edge effect
observed in traditional tray freeze drying the LyoSIM® ring had an offset of 0°C (Freezing), 54

2°C (Primary Dry), -1°C (Secondary Dry) from the center vial temperature. Freeze drying was
performed without visible collapse.

Table 1. Lyophilization cycle settings. Time to end of primary drying shown for reference,
end point determination by convergence of Pirani and capacitance manometer.

Raman Spectroscopy
Acquisition and Pre-Processing of Raman Spectra
Raman spectral acquisition followed the same procedure developed in previous studies
(Chapter 2). Briefly, Raman spectra were acquired using a 785 nm diode laser and fiber optic
PhAT probe on a calibrated RXN1 spectrometer (Kaiser Optical Systems, Ann Arbor, MI)
utilizing iCRaman 4.1 software (Mettler Toledo/ Kaiser Optical Systems Inc). A custom
aluminum sample holder, as described previously, held the samples at a focal length of
approximately 120 mm, ensuring a 3 mm laser spot size and > 150 mW laser power. Six
accumlations for each sample (3 on each side of the pellet) were collected from 150-1875 cm-1 at
1 cm-1 intervals. Except as noted in the discussion section, acquisition times were 3 minutes for
protein solutions and 1 minute for lyophilized solids. Unless stated otherwise, sample formats
consisted of 400 uL of 50 mg/mL solution filled into a custom made aluminum pan, 4.5 mm
hand pressed solid protein pellets. Samples were exposed to ambient temperature and humidity
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during spectral acquisition (< 30 minutes). Effects due to uptake of water during this brief
interval in time were not observed in the spectra.
Raman spectra were pre-processed before principal component analysis. The spectrum
was truncated to the region of interest (600 - 1850 cm-1), adaptive baseline corrected at a 22%
setting, and normalized to the ~1650 cm-1 (Amide I) peak intensity. Spectral analysis was
performed using Spectragryph-optical spectroscopy software (F. Menges, version 1.2.11d, 2018,
http://www.effemm2.de/spectragryph/). Individual spectral accumulations, not averaged, were
analyzed by principal component analysis (PCA) as described below. For clarity, spectral
averages of 6 replicate accumulations are shown in all figures unless otherwise stated.
Solid Protein Pelleting Procedure for Raman Analysis
Lyophilized cake material was gently broken up, removed from sample vials and
weighed before compression. The freeze-dried solids were then transferred to a pellet press in a
glove bag purged with dry air. Amorphous solid pellets were formed by two methods; i) 10 mg
of solid was compressed manually in a bench top press (Model 2811, Parr, Moline, IL) with a 4.5
mm die or ii) 20 mg of solid was compressed in a laboratory press (Carver Inc. Wabash, IN) at
5000 psi for 1 minute using a 12 mm (1/2”) die, as described previously [29, 30]. For a
discussion of Raman spectral differences obtained from pellet type see below in the section
“Impact of Pellet Thickness”.
FTIR Spectroscopy
Amorphous solid pellets were formed by gently grinding 1- 2 mg of protein solid with
150 mg of dried potassium bromide (KBr; 99%, infrared grade, Acros Organics, Morris Plains,
NJ) using a mortar and pestle in a glove bag purged with dry air, followed by compression in a
laboratory press (Carver Inc. Wabash, IN) at 10,000 psi for 2 minutes using a 12 mm (1/2”) die,
and transferred to the Fourier transform infrared (FTIR) spectrometer sample holder as described
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previously [35]. FTIR spectra of lyophilized protein pellets were measured with a FTIR
spectrometer (Nicolet Magma 560, Thermo Fisher Scientific, Waltham, MA) in single beam
mode with 128 scans over a range of 400-4000 cm-1 with 4 cm-1 resolution. Spectra were
processed using GRAMS/AI (9.3) software (Thermo Fisher Scientific, Waltham, MA) as
described previously [35]. Second derivative analysis was performed on the spectra in order to
provide more resolution of small changes in underlying component peaks [36]. Spectra were area
normalized to the amide I region (1600-1700 cm-1). This region has been established to be
sensitive to protein secondary structural vibrations and is dominated by the C=O stretch of the
peptide bond [37].
Principal Component Analysis
Principal component analysis followed the same procedure developed in previous studies
(Chapter 2). MATLAB (R2017b, The MathWorks Inc., Natick, MA) equipped with the
PLS_Toolbox 8.6.1 2018 (Eigenvector Research Inc., Manson, WA,
http://www.eigenvector.com) was used to identify relevant principal components of meancentered, pre-processed individual spectra [38].

Results and Discussion
Freeze-drying is used to stabilize proteins that are relatively “unstable” in liquid
formulations. However, conformational changes may also occur during the freeze-drying
process itself [14, 25]. The degree of protein structural change is expected to impact final
aggregation levels in the drug product before injection. Recent studies link aggregation in protein
formulations with immunogenic reactions in patients [7]. Analysis of aggregation requires
reconstitution of the drug product to the liquid state. In addition, aggregation in solution has been
linked with protein structural changes in solution [39]. In “unstable” solids, storage results in
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increasing levels of aggregation after reconstitution [23]. This leads us to question if structural
changes in the solid-state during processing or storage are contributing to increased aggregation
levels during reconstitution. Detection of structural changes in protein solids has been largely
limited to secondary structural analysis by FTIR [40], with the extent of changes correlating with
stability [23], but only in some cases [16]. The objective of the current study is to evaluate
additional tertiary structural changes in protein solids and compare the ability of Raman
spectroscopy and FTIR to detect protein structural changes in the solid state. The longer-term
goal is to find a structural method to monitor in-process protein stability during lyophilization
and predict storage stability in the dry state.
Raman Spectral Analysis of Protein Conformation Changes
Method Optimization
Analysis of Lyophilized Cake in Vials
Early efforts during method development to analyze the cake in-situ in the glass vial
revealed a large effect due to the Raman scattering of glass that could not be easily overcome.
Glass (3 minute acquisition time) has a large scattering intensity that interfered with the low
solid concentration protein (15 mg/ml, 1 ml fill volume) scattering signal (10 minute acquisition
time) from 1100 – 1900 cm-1, completely obscuring protein backbone structural peaks (Figure
1). Based on the same principal as a thicker pellet, additional pH 8 ALA was lyophilized at 100
mg/ml (1 mL fill volume), to increase the total solids and density of the protein cake in the glass
vial. It was postulated that additional protein solids might “block” the Raman scattering of the
glass. Due to vial glass height, the “in vial” spectra were acquired with the glass vial on 2
aluminum height blocks rather than 4 aluminum height blocks as pictured in Chapter 2. This
height exceeded the Raman laser probe 120 mm focal length and could not ensure a 3mm laser
spot size. For accurate comparison of raw spectra of solid samples, the pellet was also analyzed

58

at this distance with identical acquisition time (1 minute). This sample, with higher total solids,
did not appear to have extreme interference from glass Raman scattering, yet it had a much lower
protein spectra compared to a pellet (Figure 1) possibly due to the lower sample density (i.e. less
protein molecules in the sampling volume).
A

B

Figure 1. Comparison of Raman spectra from 50 mg/mL solutions (blue), solid pellets (red),
and cake in the vial (orange, 15 mg/mL; black, 100 mg/mL). (A) Raw spectra, not including
solution (due to scale), including sample container materials of aluminum (grey) and glass
(green). (B) Normalized and average spectra for protein after baseline subtraction.
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Raman spectra of ALA samples at pH 8 in “cake in vial” configurations (50 mg/mL and
100 mg/mL) were compared with ALA pellet (100 mg/mL) and solution spectra to determine
whether pre-processing with the 22% adaptive baseline and normalization to 1650 cm-1 could
successfully remove the broad glass background scattering peak (Figure 1). Pre-processing could
not remove the glass interference from spectrum of the cake at the lower concentration (15
mg/mL), resulting in peak anomalies between 1200 and 1900 cm-1 (Figure 2). However, at the
higher ALA concentration (100 mg/mL), pre-processing appeared to remove the relatively less
intense “blocked” glass interference from the spectrum of the lyophilized cake. The processed
scattering spectrum of the cake lyophilized from higher ALA concentration more closely
matched the processed spectrum of the ALA pellet than the solution spectra, with similar
broadening or decreased intensity of some peaks (Amide III, 1240-1340 cm-1) and shifting of
other peaks (Amide I, 1600-1700 cm-1) in relation to the solution spectra as discussed later. Nondestructive Raman spectra obtained in-situ as “cake in the vial” may be a material saving
advantage for high total solid products in early stage development provided significant resolution
is obtained to determine appropriate structural differences during formulation or process
development studies.
Analysis of Lyophilized Solids Compressed into Pellets
Pellet Thickness

Preliminary studies found that lyophilized cakes in glass vials with low total solids (< 2
%) had low protein Raman scattering intensity, which was overwhelmed by interference from
Raman scattering of glass. Therefore, an alternative solid sample preparation method was
explored for low total solids samples to decrease the material requirements of the assay.
Amorphous protein from lyophilized cakes was compressed into solid pellets for Raman
analysis. Compression into pellets has two advantages. First, a flat surface is prepared to improve
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focus and backscattering. Secondly, compression increases the density of the sample, increasing
the concentration of protein within the laser sampling volume, thus improving signal intensity.
Pellets will be evaluated for a balance of theoretical assay requirements such as low sample
weight, high spectral intensity, less invasive sample preparation, and ease of sample handling
Two pellet sizes were compared: 4.5- and 12-mm diameter (Figure 2A). Henceforth they
will be referred to as the “4.5 mm” and “12 mm” pellet without further reference to diameter.
The 4.5 mm die required a lower sample weight (10 mg) and less compression pressure (hand
compression for <15 seconds) to prepare a 0.6mm thick pellet. In comparison, the 12 mm die
required a larger sample weight (20 mg) and required greater pressure during compression (5000
psi for 60 seconds) to prepare a 0.25 mm thick pellet. Pellets were required to be larger than 3
mm diameter, as the Raman laser probe with 120 mm focal length ensured the exposed laser area
was 3mm indiamter. The 4.5 mm pellets provided a smaller surface area for analysis then the
12mm pellets, but met the 3mm requirement. Thus the 4.5 mm pellet had a lower sample weight
and less invasive sample preparation than the 12 mm pellet.
The thicker 4.5 mm pellet had higher Raman signal intensity. After baseline subtraction
pre-processing to reduce broad baseline features, the protein-related peaks were higher for the
4.5 mm pellet (Figure 2B). Although spectra from both pellet sizes aligned after normalization
(Figure 2C), higher raw signal intensity is preferred to decrease the signal to noise in the spectra.
Previous studies of small molecule pharmaceutical wet granulation techniques have estimated
penetration depth for the PhAT probe to be in the range of 1.7 - 2 mm [41]. The effect was also
observed here, with increasing signal above 0.25 mm thickness. However, the pellets compared
here also include changes in density due to the difference in geometric shape and pressure
between the two pelleting methods. Calculating for changes in geometry only, the 4.5 mm pellet
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had a density of 1 mg/ mm3 vs 0.75 mg/mm3 for the 12 mm pellet. It is postulated that due to the
increased thickness of the 4.5 mm pellet, more molecules were within the laser focal volume
contributing to the increased intensity in addition to the density. Thus the 4.5 m pellet had a
higher signal intensity than the 12 mm pellet.
A

B

C

Figure 2. Comparison of 4.5 mm and 12 mm Pellet: (A) 12 mm Pellet, 4.5 mm Pellet, Penny
(Left to Right), (B) Truncated and baseline subtracted spectra, (C) Normalized spectra.
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A thicker more robust pellet was preferred for better sample handling. The 4.5 mm pellet
was thicker and more robust to remove from the die press for sample handling. The 12 mm pellet
was thin and fragile making it more difficult to remove from the die press and handle without
breakage. Due to the small diameter, the 4.5 mm pellet was more difficult to manually center;
however, centering was improved with cross lines etched onto the custom aluminum stage blocks
in the modified sample chamber (Chapter 2). Thus the 4.5 mm handling issues were resolved
making it more robust for sample handling than the 12 mm pellet.
Effect of Compression Forces on Protein Structure
It has been suggested that compression forces during pelleting may cause additional
structural changes. FTIR pellets are routinely made with higher compressive force than the
Raman pellets manufactured for this study, without noticeable sample preparation effects [25].
Any protein structural changes induced by compression used to prepare pellets have the
potential to complicate analysis of pH- or formulation-induced structural change. In addition to
comparing ALA spectra from the lyophilized cake in the vial with that from pelleted cakes,
another method to confirm the absence of significant protein structural change induced by
compression to form the pellets was sought. For example, protein structural changes are known
to lead to protein aggregation in some cases, which would be an indicator for compressioninduced changes. However, ALA is not known to aggregate after freeze drying and
reconstitution [25]. Instead, a protein known to aggregate due to small structural changes, ,
human serum albumin, was pelleted using the same force and dwell time as used for ALA
pellets; on reconstitution of the pellets, there was no difference in aggregation (0.9 %) relative to
the aggregation of the reconstituted lyophilized, but not pelleted, sample (0.9 %). Therefore, no
significant structural changes in solids were found to be induced by compression to form the
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pellet. In addition, visual inspection of the spectra from lyophilized cakes in vials and pellets
(Figure 1) demonstrates a reasonable amount of spectral overlap, with incomplete overlay
attributed to glass interference.
Minimum Pellet Spectral Acquisition Time
Solids pH 8 samples were freeze dried at 100 mg/mL (1 mL in 10 mL tubing vials, same
cycle) to investigate solution and solid differences observed during pre-processing. These ALA
samples were also used to investigate differences between pellet and vial spectra (above) and the
minimum pellet spectral acquisition time with the custom sample holder. Acquisition times were
varied as follows: 3 minutes, 1 minute, 30 seconds, 15 seconds, 10 seconds, and 5 seconds.
Raman scattering intensity of the protein increased proportionally with laser exposure time as
expected (Figure 3A). Normalization of the spectra to the 1650 cm-1 (Amide I) peak showed no
systematic trend in the spectra with exposure time (Figure 3B). In order to minimize effects due
to the pellet sampling handling and centering, all acquisition time data were generated from one
side of the pellet (3 acquisitions for each of 6 acquisition times) before it was flipped over and
repeated. This was a deviation from normal pellet analysis where a fresh pellet would be
measured only 3 times before flipping and measuring the other side three more times for a total
of 6 acquisitions per pellet. In addition to minimizing any noise due to sample handling, this
procedure would highlight possible spectral changes due to laser induced degradation of the
sample. No degradation in signal quality was observed, other than photobleaching. In addition,
replicate samples obtained on the same pellet after 1 month stored at 5°C in a tightly sealed
container (day 2) were higher intensity than originally obtained (day 1). This may be due to
either centering or day-to-day variation, but indicates no significant damage to the protein
structure from repeated sampling or storage at 5°C. Longer acquisition time is expected to yield
less noisy Raman spectra, however the time of exposure of the sample to the laser that is
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required for longer scattering acquisition time has been reported to induced sample degradation
due to localized heating [42]. Shorter Raman spectral acquisition times, from 5 seconds to 15
seconds, were visibly noisier than longer time intervals. No significant difference was observed
at time intervals greater than 30 seconds. A spectral acquisition time of 1 minute was used to
simultaneously optimize both analysis time and spectral reproducibility. However, in this study 3
replicates of all acquisition times were taken (18 acquisitions) before flipping the pellet with no
apparent change in the spectra due to protein damage.

A
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Normalized Raman Intensity

B

Figure 3. Overlay of Raman spectra collected in solid state at various time intervals: 3 minutes
(dark blue), 1 minute Day 1 (orange), 1 minute Day 2 (grey), 30 seconds (yellow), 15 seconds
(blue), 10 seconds (green) 5 seconds (black). (A) raw spectra, (B) intensity normalized spectra.

Although the exposure/acquisition time of 1 minute was used in this study, the optimal
exposure time may be different for other proteins, based on the 3-dimensional structure and the
fraction of aromatic amino acids relative to the molecular weight of the protein (Chapter 2
Amide backbone structures dominate the protein Raman spectrum with fine details contributed
by tertiary structure, usually based on the scattering from aromatic residues (for assignments of
peaks and bands, see [43-54].

Evaluation of Pellet and Solution Spectral Differences for Artifacts due to Spectral Preprocessing
The Raman spectrum of ALA in solution (50 mg/mL) at each pH was different from the
spectrum of the corresponding lyophilized solids, as will be discussed in more detail later. Most
notable was the lower intensity of the raw spectra of the solutions relative to the solids. Before
ascribing any spectral differences to protein structure or microenvironments of the aromatic
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residues, an attempt was made to test for the possibility that the differences were not simply
mathematical artifacts created by preprocessing of raw spectra of such different intensity.
Spectra of comparable intensities were collected by adjusting the concentration of ALA in pH 8
solution up to 211 mg/mL and using a 3-minute acquisition time while lowering the acquisition
time for the corresponding solid pellet format from 1 minute to 30 seconds. Similarly, at 50
mg/mL ALA in pH 8 solution also with a 3-minute acquisition time, the intensity was
approximated by the pellet with an acquisition time of 10 seconds. After intensity normalization
to the intensity at the 1650 cm-1 peak, spectral differences could not be eliminated (Figure 4)).
Thus, the spectral differences between the solution and corresponding lyophilized solid could not
be explained simply as mathematical artifacts introduced by preprocessing of spectra that simply
differed in raw intensity. These differences will be discussed below in the section “Interpretation
of Solid-State Spectral Changes in Relation to Forced Changes in Solution ”. Both sampling
formats have a noisier baseline at lower raw spectral intensity, although solution spectra were
consistently lower intensity with a noisier baseline than solid spectra. This was attributed to the
pelleting method used in solid samples, which resulted in a higher number of protein molecules
in the laser sampling volume in solids compared to solutions. Spectral smoothing was
investigated (data not shown) but could not remove the differences observed between solutions
and samples, especially the large differences as discussed below. Notably, after normalization,
spectra of samples from either phase (either liquid or solid) are reproducible with no major effect
due to repeated sampling, changing solution concentration or solid acquisition time.
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A

B

Figure 4. Comparison of average Raman spectra from pH 8 solutions and solid pellets collected at
equivalent raw spectral intensity. (A) Baseline pre-processed spectra (B) Normalized spectra. Colors as
follows: solutions at 211 mg/mL (blue dashed) and 50 mg/ml (red dashed) or solid pellets with acquisition
times of 30 seconds (blue solid) and 10 seconds (red solid).
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Raman Spectral Changes in Lyophilized Protein Solution at 4 pH Levels
The Raman scattering spectra of protein in the solid state obtained by freeze-drying
solutions at 4 pH levels were visually different. (Figure 5A). Differences in the spectra for the
solid protein prepared from solutions at pH 4, 6, and 8 were much smaller and more gradual as
pH changed, the difference at pH 2 was greater. Spectral changes were consistent with peak
changes observed with different pH levels in solution (Chapter 2) with a mix of gradual changes
over the whole range and abrupt changes from pH 4 to pH 2. However, some peaks associated
with tertiary structures that abruptly changed from pH 4 to 2 in solution, did not show similar
behavior in the corresponding solid state.
The difference spectrum of ALA lyophilized from a pH 2 solution with a perturbed
conformation compared with lyophilized solids prepared from the native solution conformation
(pH 8) represents the largest changes in the model system for the protein, ALA, as shown in the
difference spectra. (Figure 5B) A comparison of the difference spectra in solids from all
perturbed conformations before freeze drying (i.e., at pH 2, 4, and 6) against pH 8 (not shown) is
also able to highlight the gradual changes with pH (e.g., 1400-1450 cm-1) and abrupt change at
pH 2 alone (e.g., 1008 and 1650-1730 cm-1). Some changes which occur abruptly at pH 2 can be
attributed to differences in ionization state. Peak shifts that occur at low pH in the amide I region
have been ascribed to 1710 cm-1 (protonated) and 1580 cm-1 (deprotonated) forms of COOH
[55]. A slight shift in the peak amide I maxima from 1660 cm-1 in solution to 1664 cm-1 with low
pH in solution was also observed, with an even larger shift to higher 1670 cm-1 wavenumbers
seen in solids along with increased peak broadening [44].
Many differences which occur at low pH have also been observed in the solid state.
Broadening of several peaks such as Amide III (near 1250 cm-1) were observed in both
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lyophilized and crystalline solid forms in comparison to solution state, in addition to occurring
with pH shifts (pH 6.6 to pH 2.1) [44].The tyrosine fermi doublet ratio 850/830 cm-1 (Tyr [43,
45, 46, 49, 56]) is lower than the solution spectra, which will be discussed in detail below [57].
Many peaks such as 1551 cm-1 (Trp [43, 45-50]).or 1181 cm-1 (Tyr & Phe [43, 45, 46, 49]) show
the trend with pH less strongly in solids, due to the fact that Raman spectra of the pH 8 solid
already closely resembles the spectra of pH 2 in solution with less intense peaks in these regions.

A
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Raman Difference Intensity

B

Figure 5. (A) Spectral overlay of solid pellets from formulations pH 8 (blue), pH 6 (green), pH
4 (orange), and pH 2 (red) (B) Overlay of difference spectra of pH 8 minus pH 2 (blue) and
PC1 loading intensity (red).

There are many peaks associated with tertiary structural vibrations in a Raman spectrum
due largely to the aromatic residues [44, 49]. These may vary due to the sensitivity of detection
based on the ratio of the number of side chain residues in comparison to the entire amino acid
sequence. For example, a protein with 1 or no tryptophans will not show strong peaks for
tryptophan, ALA has 4 tyrosine, 4 tryptophan and 4 phenylalanine out of 124 total amino acids
[58] which allows for good peak resolution of tertiary structures. In solution, Raman shifts due to
changes in tertiary structures occur with many changes in local interactions, including changes
such as hydrogen bonding, local hydrophobicity of the environment experienced by the aromatic
side chains and position within the 3-dimensional structure during unfolding (interior/exterior).
Interpretation of spectral shifts in solids is more challenging due to the differences in interactions
(hydrogen bonding) and environmental conditions (decreased dielectric constant compared to
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water) expected in the solid versus solution state. Previous authors suggested that 2 of the 4
tryptophan residues on ALA move from “buried” at higher pH to “unburied” or solvent exposed
in the molten globule conformation at pH 2 [44]. It has also been postulated that the Trp shoulder
/ peak at 1360 cm-1 decreases in solid state compared to solution state due to changes in the
environment of the 2 buried Trp, this peak decrease also occurs in solution at low pH.[44, 48,
59].
Many of the changes observed during pH transitions in solution, were not as strong in
solids. In addition, many spectral features in solids, even at pH 8, were similar to the spectra in
solution at pH 2, such as the observed decrease in the peak intensity at 1360 cm-1. We tentatively
interpret these to signify that all of the solid proteins had a non-native conformation as observed
in solution at pH 2 to a certain extent. FTIR analysis also had a similar extent of secondary
structural change in solids in comparison with pH 8, with small changes observed at pH 4 and
pH 6 and a much larger change observed ay pH 2, and will be discussed later (Figure 12),
confirming the Raman spectral changes represent secondary structural changes observed with
well accepted analysis methods. Tertiary changes in solids are not yet routinely observed with
methods other than Raman spectroscopy.
Interpretation of Solid-State Spectral Changes in Relation to Forced Changes in Solution
The spectrum of lyophilized ALA at each pH was different than its corresponding prelyophilized solution (Figure 6). As discussed in the section “Evaluation of Pellet and Solution
Spectral Differences for Artifacts due to Spectral Pre-processing ”, these spectral differences
could not be explained by differences in intensity of the raw spectra or data preprocessing
methods. The tyrosine doublet ratio, I850/I830, was higher in solution spectra than in pellet
spectra. The ratio in solutions from pH 8 to pH 6 varied with the respective pH values from 1.25
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(pH 8 solution), to 1.23, 1.27 and 1.20 (pH 2 solution). However, in all solid samples values are
lower and vary from 1.09 (pH 8 solid), 1.07, and 1.08 to 0.97 (pH 2 solid). Typically the
intensity ratio from 850/830 has been attributed to the hydrogen bonding state of the tyrosine
phenolic hydroxyl group with high values (2.5) representing the group as an acceptor of strong
H-bonds, intermediate values (1.25) representing both donor and acceptor H-bonds occurring
and low value (0.3) representing the group acting as a H-bond donor [56]. Physical interpretation
in solids is not easily based on similar observations in solutions, due to differences in the local
dielectric constant and often the shifted pKa of ionizable groups in the solid state. However, a
new interpretation based on solid powders, recently suggested that the low 850/830 intensity
ratio values obtained in solids are due to π-π interactions from stacked phenol rings which results
in theoretical values < 1 confirmed with density functional theory [57].
Many other peaks are also less intense in the solid than solution spectra, such as those at
760 and 880 (ascribed to Trp), and 955 cm-1 (ascribed to the N-Cα-C stretch) or1400 cm-1 (-CH).
These are due to a mix of both tertiary and secondary structure vibrations. The split peak
ascribed to Phe (1000 cm-1) seen in solution spectra appeared more like a shoulder on the Phe
main peak in solids. Similarly, the shoulder at 1360 cm-1 (ascribed to Trp) seen in the solution
spectrum was less pronounced in the solid, often ascribed to changes in the local environment of
the aromatic amino acid [44]. The secondary structural peaks were also influenced by state, with
amide III peaks broader and shifted to lower wavenumbers, consistent with pioneering Raman
work by Yu which attributed the shift to a change in the hydrogen bonding pattern [44], whereas
the amide I peak shifted to higher wavenumbers, is which has associated with an increase in beta
sheet [49]. The peak at 1450 cm-1, related to -CH vibrations of back bone methylene groups, was
also more intense in solids which may be due exposure of these groups. Less intense peaks may
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be due to either a change in structure of all molecules or an increase in the diversity of energy
states or “possible structural configurations” among the molecular vibrations contributing to the
peak. Amorphous solid peaks, in small molecules, are often wider and less intense because
molecules are all “kinetically frozen” across a broad distribution of multiple protein
configurations without the ability to reach a normal distribution or low energy states as occurs in
solution. It has also been postulated that these differences are due to different hydrogen bonding
patterns in solid state proteins compared to proteins in solution [44].

A
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Figure 6. Spectral overlay of solutions and pellets. (A) Overlay of pH 8 spectra. (B) Overlay of
pH 2 spectra. (C) Overlay of pH 8 solution (blue dashed), pH 8 pellets (green solid), pH 2
solution (red dashed) and pH 2 pellets (orange solid). (D) Difference spectra representing
differences due to solution pH (S8-S2, red), differences due to physical state at pH 8 (S8-P8,
green) and combined differences due to physical state and pH (S8-P2, orange).

The difference between solid and solution spectra at pH 8 are greater than at pH 2. The
spectral differences between solids and solutions at pH 8 (Figure 6A) are similar to the
differences in solutions at pH 8 (native) and pH 2 (molten globule) as shown in Figure 6C. There
are some regions with expected differences. For example, near1400 cm-1 both the solid and
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solution spectra at pH 2 overlap (Figure 6B). However, closer to 1450 cm-1 the spectra of the two
solids (lyophilized from pH 2 and pH 8) overlap, but deviate from the solution at pH 2 (Figure
6C). However, the majority of spectral differences represent iii) the combined effects of both pH
(solution pH 2 minus solution pH 8) and results for differences in state (pellet minus solution pH
8), showing similar trends for all 3 difference spectra (red, orange and green) trending together at
762, 1000, 1240 and 1670 cm-1. Thus, the low pH “molten globule conformation” studied
previously, is similar to changes in structure that may occur during the freeze-drying process.
Spectral changes due to physical state (solution or solid), were larger than the pH induced
changes, although not as large as those due to sucrose addition to the formulations, which will be
discussed later. This was confirmed in PCA with physical interpretation of scores and loadings in
the resulting PCs as discussed below. Therefore, PCA on a complete data set of protein in solids
and solutions was not applicable to our development goal of a Raman spectral method in the
solid state.
PCA Analysis of ALA Raman Spectra of ALA Lyophilized from Solutions at a Range of pH

Protein structural changes in solids are often limited to analysis of secondary structural
features in FTIR spectra. The ability of Raman spectroscopy to capture changes in both
secondary and tertiary structural changes simultaneously in either solution or solid state provides
the opportunity for more in-depth structural characterization. In addition, due to the numerous
major and minor changes in the spectra of protein solids lyophilized from solutions over a range
of pH, analysis of one or just a few peaks would underutilize the large data set represented by the
intensity at each wavenumber over the entire spectrum. Many meaningful, though often small,
peak shifts in the Raman spectra of proteins may not be immediately obvious, but when analyzed
as a whole may be able to detect relevant structural changes which impact protein stability.
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Principal component analysis (PCA) was employed to fully utilize the entire range of Raman
spectral data to quantify the change of ALA structure, including all the nuanced information that
is contained in small spectral differences at each wavelength. As described previously (Chapter
2), PCA statistical methods were applied to the 600-1850 cm-1 region of protein spectral data.
PCA is a variable reduction technique, using linear algebra, which represents the variation
present in the data using principal components, or a new set of axes. PCA transforms the spectral
intensity differences at each of the 1250 wavenumbers into values (or scores) for 1-3 reduced
variables (or principal components). As a means to evaluate the importance of changes at each
specific wavenumber, PCA also yields loading vectors which link the principal components back
to the wavenumber, so that the spectral change described in each principal component can be
interpreted. An alternate analytical method, spectral correlation, which has also been used to
compare changes in large regions of data [25], provide an overall degree of similarity between
the spectra over the full range of wavenumbers, but cannot link back to individual wavenumber
changes.
The score plot for the first principal component (PC1), representing 78% of the variation
in the sample set (Figure 7), appears to describe pH induced spectral changes in solid ALA. The
pH 2 protein samples are fully separated from other formulations with a scores from -1.5 to -0.75.
The PC1 scores of protein samples formulated at pH 4-8 overlap with scores between -0.25 and 1,
for pH 4, 6, and 8, respectively., consistent with the smaller structural changes known to occur in
this pH range in solution (Chapter 1).
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Figure 7. PCA scores plot for solid pellet formulations: pH 8 (blue), pH 6 (green), pH 4
(green), pH 2 (red).

The difference spectrum (solid protein at pH 8 minus pH 2) represents the largest changes
in the model system, ALA (Figure 5B). This difference spectrum aligns well with the loading
vector intensity from PC1 (Figure 5B), suggesting that PCA is detecting pH-induced variation in
the solid protein spectrum and describing these variations by scores in the first principal
component. However, although PC1 captures 78% of total variation in the data set of 72 spectra
of protein pellets prepared from solutions at 4 pH levels, compared to an equivalent study in
solutions (Chapter 2) which only captured 53% of system variation, alignment in solids was
visibly similar to that in solution. As discussed above, solution spectra are noisier than solid
spectra and that may result in a reduced percent of variation attributed to pH changes as the total
system variation may have a larger contribution from instrument noise.
Analysis of Raman Spectra of Lyophilized ALA Containing Sucrose
Additional ALA solutions which included sucrose, a stabilizing excipient for lyophilized
solutions [60], were lyophilized to investigate the ability of the method (spectral acquisition, preprocessing, and principal component analysis of the spectra) to discern small protein structural
changes in the spectra dominated by the intense sucrose spectrum. ALA (15mg/mL) at pH 2 and
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at pH 8 without sucrose as well as ALA (15 mg/mL) pH 8 containing 7.5, 15, and 30 mg/mL of
sucrose were lyophilized and pelleted. The sucrose-containing pellets corresponded to 2:1, 1:1
and 1:2 protein to excipient ratios, resulting in 33%, 50% and 67% sucrose in the amorphous
solids. In solutions, the Raman spectrum of sucrose had many intense peaks overlapping that of
the ALA protein in the 600-1530 cm-1 region (Chapter 2). Raman spectral intensity is linear with
concentration, so high concentrations of sucrose in the solid samples also overwhelm important
protein spectral features such as such as the tyrosine doublet peaks at 830/850 cm-1 and amide III
peaks (1240-1340 cm-1) (Figure 6). In addition, the overlapping sucrose peaks complicated direct
interpretation of small spectral shifts due to changes in the protein spectrum. Direct use visual
comparison with the difference spectrum is also complicated by the presence of overlapping
sucrose peaks.
A
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Figure 8. (A) Spectral overlay of sucrose formulations. (B) Overlay of sucrose spectra (not
normalized, scaled by factor of 10,000) (grey), difference spectra of ALA:Sucrose 1:1 and
ALA (blue) and PC1 loadings (red). (C) Overlay of difference spectra representing pH
changes (blue) and PC2 loadings (red).

PCA was able to identify the majority of the variation in the spectra that was due to
sucrose. In this data set that included both a difference in pH and concentration of sucrose in the
ALA samples, the spectral variation due to the overwhelming sucrose peaks were largely
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captured in the first principal component (PC1), which accounted for 96% of the variation within
the data set. Due to the overwhelming nature of sucrose in the spectrum, pH-induced variation in
ALA was described by the second component (PC2), accounting for only 2% of the variation in
the data set (Figure 7C). Due to the overwhelming sucrose contribution in the spectrum of the
1:2 protein: sucrose sample, this sample was removed from further analysis. In the data set
without the 1:2 protein:sucrose sample, PC1 captured 87% of the variation (mostly due to
sucrose as will be shown below) and PC2 captured 8% (primarily due to pH-induced protein
changes).
The PC1 scores trend with sucrose fraction in the ALA pellets (Figure 7) with 33%
sucrose solids having a score close to 4 and 50% sucrose solids score close to 8. This trend is
confirmed by examination of the PC1 loading vector intensity which aligns well with the
difference spectra highlight the sucrose contribution (Figure 8B). The trend with sucrose is
further confirmed by the overlay of the spectra for sucrose (not normalized, scaled down by 10,
000). Pellets containing only protein, without sucrose, at all pH levels have overlapping scores
slightly below 0. However, scores for PC2 are not as well resolved based on pH. Formulations at
pH 2, none of which contained sucrose, are still well resolved, with scores from -0.75 to -1.5.
However, the spectra of pH 8 samples, both with and without sucrose, have a wide range of PC2
scores from -0.25 to 1.25, that do not overlap those of pH 2 sample spectra, but completely
overlap those of pH 4 and 6, neither of which included sucrose. The difference spectrum (of
protein at pH 8 minus at pH 2) representing pH changes did not align as well with the PC2
loading intensities (Figure 8C) as they did with PC1 loading intensities when the analysis did not
include sucrose-containing samples (Figure 5B). Regions in which the alignment of this
difference spectrum with PC2 loading intensities is poorest, such as 1300-1400 cm-1, have major
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contributions from both protein and sucrose (with the intensity of sucrose always larger), which
complicates spectral analysis in this region. The PC2 loading intensities in other regions such as
800 -900 cm-1 still show some alignment with spectral differences (e.g., 830/850 cm-1 Tyr
doublet) associated with pH-induced protein changes, but there is additional signal that appears
to be residual contribution of the sucrose signal carrying over onto PC2. Since PCA is an
unsupervised approach, meaning there is no assignment of samples prior to analysis, it is
possible to have variation from multiple sources captured within one principal component or
assigned in part to more than one principal component, especially if they overlap or trend
together in the samples [38].
However, poor alignment of PC2 with the difference spectrum (pH 8 minus pH 2) in the
region 1600-1700 cm-1 cannot be explained by this reason as sucrose does not contribute spectral
peaks in this region. In solution only studies (chapter 2), the PC2 loading intensity, compared to
the difference spectrum, was in better agreement than the solid sample set. However, the regions
that did not overlap well were the same in each system, providing more evidence that this PC is
detecting variation in the system due to spectral changes related to structure and less likely
including random instrument noise. Although PCA in the presence of overlapping sucrose peaks
does not have the same resolution as previously observed in solution, this method is still capable
of detecting small spectral variations related to pH changes in protein spectra in the presence of
sucrose.
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B

Figure 9. PCA scores plots for PC1 (A) and PC2 (B) for the data set including protein:sucrose
2:1 and 1:1 formulations.

Analysis of the Spectral Range with no Overlapping Sucrose Scattering
When analysis of protein in solution was limited to a spectral range (1530-1780 cm-1)
where sucrose has little to no Raman scattering (Chapter 2), spectral changes due to the presence
of sucrose shifted from PC1 to PC2. Lyophilized protein formulations at the 4 pH levels and
formulations containing sucrose at pH 8 were re-analyzed with PCA focusing on the 1530-1780
cm-1 region to determine whether the pH effect on the spectrum was still dominant in this region
(Figure 10A). The region has two tertiary tryptophan peaks (1551 cm-1 and 1585 cm-1), one
tyrosine peak (1619 cm-1) and is dominated by the amide I secondary structural peak. Therefore,
we have the capacity to see both types of changes, both gradual changes with pH at 1585 cm-1
(Trp) and abrupt changes visible in the amide I peak in the sucrose formulations include a peak
narrowing (compared to pH 8) (Figure 10A).
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Figure 10. (A) Overlay of all formulations from 1530-1780 cm-1. (B) Overlay of ALA solids
(solid) and solutions (dashed) at pH 8 (green solid, blue solution) and pH 8 ALA:sucrose 1:2
formulations (pink solid, black solution). (C) PC1 loading vector overlaid with difference
spectra representing pH changes. (D) PC2 loading vector overlaid with difference spectra
representing sucrose contributions.
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Sucrose does not have any direct spectral contribution in this region. So, the presence of
sucrose was not necessarily expected to appear as a variation in PC1. Instead, in this region
variation representing structural changes due to pH is described by PC1 (62%) (Figure 11).
Therefore, using the limited region from 1530 to 1780 cm-1, removes direct interference from
sucrose spectral peak overlap evident in other regions. Examining the score plot closely, the pH
2 formulation is resolved, yet significant overlap still exists between pH 4- pH 8, especially for
the sucrose formulations (Figure 11). Also, there is some lack of agreement between the
difference spectrum and the loading intensity of PC1 in the region from 1680 to 1780 cm-1,
particularly at 1700 cm-1 (Figure 11Figure 10).

B

A

Figure 11. PCA scores for PC1 (A) and PC2 (B) in the 1530-1780 cm-1 region.

Interestingly, although it does not have any direct spectral contribution in this region, the
sucrose-containing protein samples had a large enough shift in the amide I peak that the changes
due to sucrose were largely captured in PC2 (23%) (Figure 11). The PC2 score plot shows a
definite trend with increasing sucrose content. In addition, the difference spectrum of the
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protein:sucrose 1:2 formulation minus pure protein, representing indirect protein spectral
changes due to interaction between sucrose and protein, aligns well including the region from
1680 to 1780, which did not overlay well with the difference spectrum representing pH-induced
structural changes with PC1 loadings.
As discussed above when investigating solution solid differences, structural changes
induced by low pH acidic conditions resulted in the amide I peak broadening and shifting to
higher wavenumbers and the amide III peak to broaden and shift to lower wavenumbers. Peak
shifts may be a result of a difference in either hydrogen bonding or conformation. Lyophilized
proteins, in the region without sucrose peaks (1530-1780 cm-1), also experience a shift in amide I
peak in the same direction as pH 2 solution samples, with the amide I peak shifting to higher
wavenumbers compared to native pH 8 solutions (Figure 10B). This shift would indicate
formation of the molten globule conformation in the solid state. However, addition of sucrose as
a stabilizer to ALA solids, results in the pH 8 ALA:sucrose 1:2 formulation shifting to lower
wavenumbers relative to the pH 8 solid formulation without a stabilizer (Figure 10B). This shift
moves the amide I peak in stabilized solids closer to a more “native” state as reference by pH 8
solution spectra (Figure 10B). peak width may be attributed to distribution of conformational
states, with a wider peak due to a larger number of possible conformations. Similar results were
observed in lyophilized proteins, with and without trehalose, observed by FTIR spectroscopy,
which had a similar shift to higher wavenumbers in the amide I peak after freeze drying,
compared to solution state, which reversed direction after the addition of a stabilizer [3, 61]. The
FTIR spectral shift was attributed to a hydrogen bonding interaction between the protein and the
sugar. Raman spectral data of the amide I peak in this study also support an interaction between
the protein and the sugar in the formulation. Due to this interaction analysis of the limited region
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from 1530 to 1780 cm-1, with decreased spectral contribution from sucrose, shifted pH variation
to the dominant variation in the system, but was not able to completely eliminate the sucrose
effect. The peak shift observed is attributed to proteins:sucrose interaction. More in-depth studies
are need to be performed in order to confirm these observations.

FTIR Spectra of ALA Lyophilized Solids
The most common method for secondary structural analysis in lyophilized solids in FTIR
spectroscopy. Changes in structure of proteins lyophilized with and without a disaccharide
stabilizer have been compared to native secondary structure in solution [25]. Structural changes
in ALA samples, with and without sucrose, were analyzed using FTIR and compared with the
new Raman method. Second derivative analysis of the amide I region, highlights the shoulder at
1730 cm-1 due to the reaction with the carbonyl group at low pH ([62]) (Figure 12))

Figure 12. FTIR second derivative spectra of ALA formulations.

Also, sucrose containing formulations have a more intense peak at 1650 cm-1 associated
with increased native structure [14]. Principal component analysis was performed on the data to
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enhance the quantitative analysis. PCA with the pH only formulations showed a trend with pH
induced structural changes (PC1, 78%) (Figure 13A). The loading intensity aligns well with the
difference spectrum for the pH only formulations (Figure 13B).

A

B

Figure 13. PCA on second derivative FTIR spectra for pH 2, pH 4, pH 6 and pH 8
formulations. (A) Scores plot. Formulations colors follow those in Figure 12. (B) Overlay of
Raman difference spectra (left vertical axis) and PC1 loading vector intensity (right vertical
axis).
However, when including the sucrose containing formulations in the analysis, sucrose in the
formulations is confounding the analysis with both pH and sucrose levels included in
contributions to variation described in both PC1 (48%) and PC2 (38%) (Figure 14). With the
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sucrose component dominating both LV trends in the 1650 – 1730 cm-1 region and pH
dominating trends below 1650 cm-1 and above 1730 cm-1. In addition to the increased negative
intensity of the second derivative spectra in the sucrose formulations, pure sucrose does have a
relatively weak absorbance peak centered at 1650 cm-1 in the FTIR spectra which is not
subtracted and may be contributing to the inability to resolve the sucrose contribution in this
system.

A

B

90

C

D

Figure 14. PCA on second derivative FTIR spectra of all formulations. (A) Scores on PC1. (B)
Overlay of difference spectra and PC1 loading intensity. (C) Scores on PC2. (D) Overlay of
difference spectra and PC2 loading intensity. Score formulations colors follow those in Figure
12.

FTIR second derivative pre-processing is a data transformation with the intent to
highlight small peak shifts and peak shoulders occurring in the absorbance data. However, these
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extra steps require a lot of experience and some judgement calls from a trained spectroscopist,
such as the extent of water interference in the transmission spectra, water subtraction during
processing and multiple manual baselining procedures which may be difficult for the
inexperienced analyst and may contribute to inconsistencies in data analysis. PCA can also be
used before the second derivative transformation, to analyze the variation observed in the FTIR
absorbance data (Figure 15), after a decreased number of initial pre-processing steps
(transforming the transmittance data into absorbance data and performing water vapor
subtraction), therefore reducing the processing time, simplifying analysis and possibly reducing
some operator variability.
PCA of FTIR absorbance data in the region 1000-1900 cm-1 (area normalized to the
amide I peak) was dominated by the sucrose variation (PC1, 97%) with a much weaker pH
contribution to the overall system variation (PC2, 2%), unless analyzing pH formulations without
sucrose (PC1, 95%). Sucrose has a weak FTIR signal intensity between 1500-1800 cm-1 in the
amide I region, but a more intense signal below 1500 cm-1. FTIR is known to have a strong
amide II peak (centered at 1535 cm-1) than Raman, but a weaker amide III peak (centered at
1390 cm-1). Therefore, PCA analysis of a large region of the FTIR spectra (1000-1900 cm-1)
enhances the percentage of sucrose peak contributions, but unlike Raman spectra, does not add
additional protein secondary or tertiary structural peaks. Due to the extent of sucrose
contributions to the spectral variance in both spectroscopic methods, PCA analysis with samples
containing high sucrose content showed a similar level of interference due to sucrose in both
methods, FTIR and Raman.
Analysis for a smaller FTIR region from 1500-1800 cm-1(Figure 15), including
contributions from both amide I (area normalized) and amide II secondary structural peaks, will
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be compared with PCA analysis of a similar more focused Raman spectral region including the
amide I region (intensity normalized) and several tertiary (Trp, Tyr) structural peaks (Figure 10).

Figure 15 FTIR absorbance spectra (1500-1800 cm-1) of ALA formulations.

Sucrose and pH effects in the FTIR spectra had more overlap in PCA scores plots and
loadings from the more focused region in FTIR (Figure 16) than observed with the focused
region in Raman PCA analysis. PC1 scores plots of the focused FTIR region trended with pH
levels but a wide range of score values were obtained for the sucrose containing formulations.
Loadings plots for PC1 align well at most wavenumbers with the difference spectra for pH as
observed with the Raman PCA analysis on a limited spectral range (Figure 16B).
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Figure 16. PCA score plots and loading from analysis of the FTIR absorbance spectra from
1500-1800 cm-1.. (A) Scores on PC1. (B) Overlay of difference spectra and PC1 loading
intensity. (C) Scores on PC2. (D) Overlay of difference spectra and PC2 loading intensity.

However, there are noticeable deviations between 1650-1700 cm-1, where the sucrose
formulations have a narrower peak and resulting peak in the difference spectra of the high
sucrose formulation and pH 8. Similarly, loading plots of PC2 overlaid with difference spectra
from sucrose contributions reveal alignment between 1650-1700 cm-1, however, do not align
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well in between 1550-1600 cm-1 (Figure 16) where the difference spectra representing pH
changes has a large peak. Interestingly, although sucrose has a small direct spectral contribution
in this region for FTIR, the resulting variation is not able to be separated as strongly from the
structural changes due to pH as in the Raman PCA where sucrose has no direct spectral
contribution in this region yet trends in the PC2 scores.

Conclusions
A method combining Raman and PCA analysis was developed. The Raman solid state
off-line method is able to be adjusted to various freeze-drying formats with only the requirement
for 10 mg of amorphous solids compressed into a pellet. No difference was observed when
analyzing solid pellets that were freeze dried at 15 mg/mL compared to samples freeze dried at
100 mg/mL. Therefore, it is expected that during initial research studies of high concentration
freeze dried formulations (>100 mg/mL), 10 mg can be used for the Raman assay method and
the remaining cake material may be retained for use in other assays. No effect was detected due
to the pelleting method. Raman scattering of glass impeded “in-vial” measurements, but showed
promise with high total solids formulations. This would provide a non-destructive method,
enabling multiple analysis on one vial. Eventually a non-destructive method may be adapted for
use in development scale lyophilization equipment to monitor process induced structural changes
“in-situ” during process development studies.
Investigations into the observed difference in Raman spectra between solution and solid
sample formats concluded that differences were consistent, repeatable, and not due to a math
artifact from spectral pre-processing. However, the changes in physical state were larger than the
changes induced by pH levels in the pre-lyophilized solutions. This precluded joint analysis of
these samples when looking for small structural changes as the variance due to physical state was
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generally described in a PC with a larger % of the system variance. Simple systems, without
sucrose, were able to describe the effect of sample state and structural changes due to pH.
However, due to the large Raman scattering of sucrose, the effect due to pH was swamped (<1%)
in systems analyzed which included solutions, solids, and sucrose containing formulations.
Spectral changes were observed in solid samples lyophilized from different pH levels in
solution. Interestingly, the change in solids over the ‘pH” range was not as extreme as that
observed in solutions (Chapter 2). Solid spectra at pH 8 trended more closely with solution
spectra at pH 2, than solution spectra at pH 8. This implies that the molten globule state obtained
in solution is present in solid state formulations. Sucrose Raman scattering overlaps strongly in
the region from 600-1530 cm-1. This large spectral contribution is overwhelming for visual
analysis of small protein spectral changes expected due to varying pH levels. However, PCA is
able to separate most of the variance in the system due to the presence of sucrose, yielding
analysis of the remaining PCs for protein related changes.
Close analysis of the region from 1530-1780 cm-1 where sucrose does not have strong
Raman scattering, shows that sucrose and protein are interacting in the amide I peak. The
presence of sucrose shifts the peak to lower wavenumbers and a more “native like” structure.
More interactions may be occurring in the rest of the spectra that are not easily detectable by eye.
Studies analyzing the data from 600-1530 cm-1 (without the amide I peak), were still able to
detect changes due to pH (data not shown), thus this peak is not driving all the conclusions from
PCA.
FTIR spectra with PCA also showed a trend with pH as expected. However, PCA was not
able to separate the effects of sucrose and pH. This method could still be used for rank ordering
using PCA. Interpretation of loadings however is difficult with pH effects and sucrose effects co97

varying together. These effects co-varied in the FTIR spectra more strongly than in the Raman
spectra. This may be due to the interaction of sucrose and protein peaks in the amide I region.
However, within this region, PCA was still able to separate these effects in Raman spectra. This
may be due to the additional tertiary peaks in the Raman spectra that are not available in the
FTIR spectra.
A new off-line Raman method is available for complimentary structural analysis. Some
additional work must be done to optimize the method for use with excipients that have Raman
scattering. It may be possible to normalize at a different wavenumber and include a pure sucrose
formulation into the study. This may separate the pH8 with a without sucrose effects which are
currently confounded.
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Introduction
Manufacturing recombinant protein pharmaceuticals has proved challenging due to the
complexity of protein production and purification as well as the limited physical and chemical
stability of the final purified protein in solution [1, 2]. In many cases, therapeutic protein
solutions are lyophilized to improve shipping and storage stability [3-5]. Unfortunately, the
lyophilization process itself generates significant freezing and drying stresses to the protein,
often resulting in differences in the conformation of the protein in the solid state, which in turn
can lead to lower in-process and storage stability. The storage stability of a protein depends upon
the structural state of the protein molecule, with partially unfolded protein molecules expected to
show increased reaction rates for both aggregation and chemical degradation pathways [6-8].
Stresses may include low temperatures, freeze concentration, pH changes, dehydration,
interactions at ice/water interfaces and container/closure components [9-13]. Excipients are
added to stabilize the protein drug and preserve activity during processing and storage.
Commonly added stabilizers are carbohydrates, buffer salts, surfactants, polymers or other
proteins [6, 14-16]. The nature of the mechanisms for excipient stabilization of proteins during
the lyophilization process are not yet fully understood. Two main hypotheses are commonly
advanced in the literature [3, 5, 17]. The first is that the excipients affect the dynamics of the
glassy matrix of the amorphous cake such that a successful stabilizer depresses the molecular
mobility enough to slow the degradation process kinetically, even if the system is
thermodynamically unstable. The second hypothesis is that the excipients replace the water in the
hydration shell of the protein and this interaction via hydrogen bonding thermodynamically
stabilizes the native protein structure. However, these complex protein structures may require
one type of interaction (hydrogen bonding) to stabilize native structure during the freeze-drying
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process but another mechanism, such as depressed molecular mobility, to retain that structure
and decreased reactivity during stability. Regardless of the exact mechanism responsible for the
stabilization, there is often a reasonably good correlation between the degree of stabilization and
the ability of that formulation to maintain a secondary structure in the solid that is close to the
secondary structure in the “native” solution state, especially when distinguishing between a very
unstable or a very stable system during rough screening [5, 6]. Historically it has been observed
that addition of stabilizers helps to retain “native” protein structure throughout harsh processing
conditions [18]. However, the correlations with structure mentioned above are not reliable in all
cases [5, 12] and struggle to determine differences among very stable formulations to determine
the “best of the best” formulation to move forward in development. Therefore, each protein and
stabilizer combination must be evaluated empirically due to the complexity of the interactions
involved [8]. Hence, formulation optimization often proceeds slowly and with significant
uncertainty. The key to better development of solid-state protein pharmaceuticals is to
understand the effect of the various stresses on the protein structure and the protective nature of
potential stabilizers. This can only be accomplished if additional tools are available to increase
our knowledge base and enhance our understanding of fundamental aspects of the system.
Various methods have been used to monitor or predict protein quality during formulation and
process development. These methods include vibrational spectroscopy techniques such as FTIR
and Raman, electronic spectroscopy such as CD, UV/VIS absorption or fluorescence
spectroscopy, and calorimetric methods such as DSC [19]. However, many of these methods are
limited to use in the solution state. If the structural differences induced by lyophilization are at
least partially reversible upon reconstitution, solution structural characterization cannot be
expected to be predictive of stability of the freeze dried solid [11, 13]. Some methods can only
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assess structural differences in the solid state indirectly such as the changes observed in
calorimetry. In addition, none of these methods have been developed to extensively characterize
small tertiary structural differences in solids in addition to larger secondary structural
differences. Consequently, the characterization of protein structural differences in the solid state
upon freeze drying is very relevant to pharmaceutical development efforts. [20, 21].
A commonly used tool to evaluate protein secondary structural conformation in the solid
state is FTIR spectroscopy. Prestrelski et al. used FTIR to optimize development of a
lyophilization cycle for Interleukin-2 (IL-2) [8]. They evaluated the lyophilized cakes at the time
of release and correlated the measured differences in the protein solid state with differences from
native structure, as indicated by the correlation coefficient (r). They demonstrated a strong
correlation between retention of protein secondary structure and increased stability. At higher
storage temperatures, the correlation of the FTIR spectrum of the protein structure to that of
native structure decreased. In addition, substantial decreases in recovery of soluble proteins were
observed in the reconstituted solution. The extent of soluble protein in the reconstituted solution
decreased linearly with the solid state “r-value”, especially for the pH 7 samples. The authors
suggested that there were additional factors such as chemical or physical changes that were not
being measured in this study. Raman spectroscopy may be able to answer some of these
questions as it will be able to show more detailed structural data regarding tertiary differences
than are usually monitored using FTIR spectroscopy.
Recently, myoglobin solid state stability was studied using solid state amide hydrogen /
deuterium exchange with mass spectrometric analysis (ssHDX-MS). [22] In this study,
myoglobin was lyophilized at 3.4 mg/mL in 2.5mM potassium phosphate buffer, pH 7, with
sucrose (1:1 or 1:8 w/w), mannitol (1:1 w/w), or NaCl (1:1 w/w), or without excipients. Sucrose
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and mannitol are known to be stabilizers, provided the mannitol does not crystallize. Sodium
chloride at this level will depress the Tg’ of the solution, if the salt does not crystallize and is
expected to have a negative impact on protein stability. The various formulations were expected
to display a wide range of stability behavior enabling a better assessment of the predictive ability
of the assay. FTIR spectra of the solids were collected before storage. ssHDX-MS of the solids
was monitored over 240 hours. Myoglobin in all formulations was stored at 25°C and 45°C and
protein aggregation was monitored by size exclusion chromatography (SEC) for 360 days. FTIR
and ssHDX-MS of freshly lyophilized myoglobin were compared as potential screening tools to
predict aggregation. The results supported the hypothesis that ssHDX-MS data correlated with
the extent of myoglobin aggregation during storage stability (R2 >0.9), and were superior to
correlations from either α-helix band intensity or position from FTIR (R2 <0.5). The authors
suggested that ssHDX-MS showed better correlation with protein stability, because ssHDX-MS
can detect partial unfolding when secondary structure (by FTIR) is largely retained. This is the
same logic that supports the analysis of tertiary structural differences using Raman scattering as
potentially superior to FTIR analysis.

Materials and Methods
Materials
Potassium phosphate monobasic and potassium phosphate dibasic anhydrous (>98%, ACS
grade) were purchased from Thermo Fisher Scientific (Waltham, MA). Sucrose (>99.5%) and
trehalose (>99%) were purchased from Sigma-Aldrich (St. Louis, Missouri). Recombinant
human serum albumin stock solution (HSA, 50mg/mL >99%, Albagen Ultra Pure, >99%,
Albumin Bioscience, Huntsville, AL) was used as a model protein.
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Sample Preparation
Protein Solution Preparation
Protein solutions were prepared as described previously (Chapter 2). Briefly, buffer pH was
verified using a pH meter (model 710, Thermo Orion, Waltham, MA). HSA solution, as
received, was dialyzed against 5 mM potassium phosphate pH 7 buffer at 10°C using centrifugal
filter units (Regenerated cellulose, MWCO 10KDa, Millipore Sigma, Burlington, MA) on a
centrifuge (Allegra X-15R, Beckman Coulter, Brea, CA) at 3000 RCF . Protein concentration
after dialysis was determined by absorbance at 280 nm using an absorptivity of 0.58 mL / (mg
cm) [23] (Cary 100Bio UV-Visible spectrophotometer, Agilent, Santa Clara, CA) (ref HSA
absorptivity). Final HSA solution concentration was adjusted by combining HSA stock solution,
stock excipient solutions and buffer to target concentration levels of HSA solutions. All solutions
were prepared at 50 mg/mL (HSA), filtered through 0.45 μm PVDF syringe filters (Millipore
Sigma, Burlington, MA or CELLTREAT, Pepperell, MA) for pre-lyophilization analysis by
Raman scattering (details below), diluted and freeze dried for further solid analysis. HSA was
lyophilized at 3 mg/mL with stabilizers, sucrose and trehalose, added at 1:1 and 1:0.25 weight
ratios. An additional possibly destabilizing formulation with sodium chloride at a 1:1 weight
ratio was also explored along with protein only formulations

Formulation HSA:Excipient
HSA
Sucrose
Trehalose
NaCl

% Excipient
(w/w)

1:0

0

1:1
1:0.25
1:1
1:0.25
1:1

50
20
50
20
50

Table 1. HSA formulations and excipient weight ratios.
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Lyophilization Cycle
Protein solution aliquots (1 mL) were filled into 10 mL glass tubing vials and partially stoppered
with bromobutyl rubber stoppers with a fluorinated polymer coating (20mm igloo, FM457/0
Omniflex3G, Datwyler Pharma Packaging Int. NV, Alken, Belgium). Product temperature was
monitored by 30-gauge copper-constantan (Type T) thermocouples Omega Engineering, Inc,
Stamford, CT) placed at the center bottom of 4 vials (both edge and center vials). Thermocouples
were calibrated using an ice-water slush. The protein solutions were lyophilized in a lab freezedryer (LyoStar 3, SP Scientific, Gardiner, NY with ControLyoTM nucleation technology).
Solutions were frozen at a shelf temperature of -5°C. Final freezing, primary and secondary
drying proceeded according to the protocol in Table 2, after which the drying chamber was
backfilled with nitrogen, and the vials were stoppered, sealed and stored at 5°C for further
analysis. Vials were inspected before and after storage and there was no visible collapse in any
product in the vials. Raman and FTIR spectra were collected immediately after lyophilization.
Amorphous cakes were also reconstituted and analyzed for the presence of soluble aggregates.
The remaining lyophilized samples were placed on stability at 40°C or 50°C for 6 months.
Samples were removed at intervals and analyzed for % soluble aggregation by SEC to determine
formulation rank order

Table 2. Lyophilization cycle recipe. Time to end of primary drying shown for reference.
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Analysis of the Lyophilized Protein
Physical Stability of HSA Formulation During Storage
The physical stability of HSA in lyophilized formulations was assessed by the formation of
soluble aggregates using size exclusion chromatography (SEC). The protein cakes were gently
broken and subsampled. The cake solids were reconstituted with water to a final concentration of
3 mg/mL. The reconstituted solution was filtered through a 0.22 μm low protein binding filter
(PVDF, 4mm, Millipore Sigma, Burlington, MA or CELLTREAT, Pepperell, MA) and 50μL
was injected onto a size exclusion column (TSKgelTM G3000SWXL, 7.8 mm x 30 cm, 5 um,
Tosoh Bioscience, King of Prussia, PA) maintained at 25°C with a mobile phase consisting of
100 mM sodium phosphate buffer at pH 7 with 0.2 M NaCl and a flow rate of 1 mL/min. Protein
peaks were detected at 280 nm on an HPLC system (Model 1100, Agilent, Santa Clara, CA) with
software (ChemStation, Agilent) used to analyze the chromatograms. Percent soluble aggregate
is reported as the combined area of dimer and higher order aggregate peaks relative to the total
area of all peaks. In order to determine the physical stability and aggregation rates of the
formulations which will be used for rank ordering the formulation stability, samples were
analyzed immediately after lyophilization, and at 1, 3 and 6 months, for % soluble aggregates by
SEC.
Raman Spectra of Lyophilized HSA
Raman spectra were acquired as previously described (Chapter 2). Briefly, lyophilized solids (10
mg) were hand pressed into 4.5 mm pellets (Model 2811, Parr, Moline, IL). Raman spectra were
collected using a 785 nm diode laser and fiber optic PhAT probe (3 mm laser spot size) on a
calibrated RXN1 spectrometer (Kaiser Optical Systems, Ann Arbor, MI) utilizing iCRaman 4.1
software (Mettler Toledo/ Kaiser Optical Systems Inc). Acquisition times were 1 minute with six
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accumlations for each sample (3 on each side of the solid pellet). Spectra shown in plots are the
average of all 6 replicates.
Each Raman spectrum was pre-processed before principal component analysis as previously
described (Chapter 2). Briefly, the spectrum was truncated to the region of interest (600 - 1850
cm-1), adaptive baseline corrected at a 22% level, and normalized to the amide I (1650 cm-1) peak
intensity, all using Spectragryph-optical spectroscopy software (F. Menges, version 1.2.11d,
2018, http://www.effemm2.de/spectragryph/).
FTIR Spectra of Lyophilized HSA
Amorphous solid pellets for FTIR were formed by gently grinding 0.5 - 1.5 mg of protein solid
with 150 mg of dried potassium bromide (KBr; 99%, infrared grade, Acros Organics, Morris
Plains, NJ) followed by compression in a laboratory press (Carver Inc. Wabash, IN) at 10,000 psi
for 2 minutes using a 12 mm (1/2”) die [24]. FTIR spectra were acquired as previously
described. (Chapter 3) [24]. Briefly, Spectra of amorphous solid pellets for FTIR were collected
in transmission mode using a FTIR spectrometer (Nicolet Magma 560, Thermo Fisher Scientific,
Waltham, MA). Each FTIR spectral acquisition was performed in triplicate. Spectra were
processed using software (GRAMS/AI (9.3) Thermo Fisher Scientific, Waltham, MA) as
described previously. FTIR absorption spectra were area normalized to the amide I region (16001700 cm-1) as previously described, (Chapter 3). This region has been established to be sensitive
to protein secondary structural vibrations and is dominated by the C=O stretch of the peptide
bond [25].
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Results and Discussion
Traditionally, formulation development for freeze drying therapeutic proteins has been largely
empirical and heuristic [3-5]. Two disaccharides, sucrose and trehalose, have consistently been
able to stabilize lyophilized protein formulations, but their mechanism of action is still under
debate [6, 7, 13, 17, 26]. The specific mechanism of interaction between many stabilizers and the
protein is often unknown. Two proposed stabilization mechanisms exist, vitrification and
hydrogen bonding substitution; in theory, the disaccharides can stabilize via either mechanism
[5]. Current methods struggle to define the stabilization mechanism and predict the rank order of
the most stable formulations. The presently proposed Raman scattering method is intended to
supplement the array of existing techniques that provide information on which to base
formulation screening and mechanistic investigations. Raman scattering spectra of proteins in
solution has been shown to correlate with protein structural differences associated with
aggregation [27]. This study is intended to determine whether the method recently developed
(Chapter 3) ,with emphasis on tertiary structural analysis, can be extended to Raman spectral
analysis of a protein in the solid state based on preliminary studies [28]. In particular, this report
examines if Raman spectra of proteins in the solid state immediately after lyophilization can be
used to predict/understand/rank order the rate of protein aggregation that occurs due to storage.

Data Analysis
Principal component analysis (PCA) [29] and partial least squares (PLS) [30] regression models
were assembled from the mean centered preprocessed Raman spectra (MATLAB, R2017b, The
MathWorks Inc., Natick, MA with PLS_Toolbox 8.6.1 2018,Eigenvector Research Inc.,
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Manson, WA, http://www.eigenvector.com). PCA followed a previously described procedure
(Chapter 2). In addition, several PLS models using the SIMPLS algorithm were developed to
relate differences in the Raman spectra to protein aggregation rate. Two pellets from each vial
were prepared for the analysis. One pellet was included in the training or calibration data set, and
the other pellet was used in the test or validation set. Cross validation with a random subset (10
splits, 10 iterations) was used to internally validate the model within the calibration data set [31].
To evaluate model performance, Q residuals (reduced), Hotelling’s T2 (reduced), student
residuals, leverage, regression correlation coefficient (R2) and root mean square error (RMSE) of
calibration (RMSEC), cross validation (RMSECV) and prediction (RMSEP) were also calculated
using the PLS_Toolbox. The number of latent variables was optimized as a balance of physical
meaning (different formulations) and minimizing the model RMSE. A higher RMSE was chosen
over possible model overfitting, if physical meaning could not be interpreted to justify additional
latent variables (or principle components). However, due to interaction terms, chemical degrees
of freedom may exist in the system that are not able to be included when strictly evaluating
independent parameters in the study design.

Soluble Aggregate Formation Rate at Elevated Storage Temperatures
At 50°C with higher aggregation rates, the most stable formulations were HSA:Sucrose 1:1 and
HSA:Trehalose 1:1. Less stable were HSA:Sucrose 1:0.25, HSA:NaCl 1:1 and HSA:Trehalose
1:0.25. Finally, HSA alone was the least stable (Figure 1 and Table 3).
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Figure 1. Soluble aggregation as a function of square root of time at 40°C (A) and 50°C (B).
Soluble aggregation rate of formation during storage was calculated as the slope of the linear
trendline.
The aggregation rate of HSA at 50°C was 2-3 times that of the rate at 40°C. Based on an
ordinary one-way ANOVA with Tukey’s multiple comparisons test, the aggregation rates
determined have slight differences between each storage temperature. At 40°C rates of
aggregation were lower and some relationships were not as well defined. HSA alone (least stable
at 50°C) was significantly different than both HSA:SUC 1:1 (p value of 0.0009) and HSA:TRE
1:1 (p value of 0.0028). HSA:TRE 1:0.25 was also significantly different from both HSA:SUC
1:1 (p value of 0.0096) and HSA:TRE 1:1 (p value of 0.0338). However, NaCl 1:1 was only
significantly different from HSA:SUC 1:1 (p value of 0.0204) and not HSA:TRE 1:1. In addition
HSA:SUC 1:0.25 was in between the “stable” and “unstable” formulations as was therefore not
significantly different from any of the formulations. (Figure 1 and Table 3).

Table 3. Aggregation rate at 40°C and 50°C determined by SEC.
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Higher levels of disaccharides were also expected to provide a greater degree of stabilization
against aggregation [6]. The HSA:NaCl 1:1 formulation which contains 50% w/w NaCl was
originally intended as a destabilizing formulation and expected to have a higher aggregation rate
than pure HSA (without excipient) for two reasons. Firstly, if the NaCl remains amorphous
during the freeze-drying cycle, damage may occur if the formulation is freeze dried above the
Tg’, due to a depressed solution Tg’ value in the freeze concentrate caused by the presence of
sodium chloride which did not crystallize. In addition, high concentrations of NaCl in the
amorphous solid are known to lower the glass transition (Tg) temperature of the final solid freeze
dried formulation and possibly affect molecular mobility, especially at higher storage
temperatures, leading to aggregation [14]. However, here the NaCl crystalized during
lyophilization and phase separated from the amorphous protein. NaCl crystals were detected by
eye and not confirmed by experimental techniques, such as x-ray powder diffraction (XRPD) or
differential scanning calorimetry (DSC). NaCl crystallization in this system is not unexpected as
16.6% w/w in a HSA:Sucrose 1:1 formulations has been shown to crystallize during storage [14].
The system here without sucrose present would be expected to have a higher propensity for
crystallization. Therefore, the high ratio of NaCl, which was expected to cause instability, did
not. Instead, much of the NaCl was phase separated during crystallization, thereby it was
removed from intimate contact with the protein. The remaining reduced concentration of NaCl
was actually stabilizing. The stabilizing effect seen here was supported by literature showing that
low levels of salts which remain in the amorphous state with the protein are stabilizing [14]. The
higher aggregation rate at 50°C provided formulations with a wide range of aggregation rates,
which will prove useful for the PLS regression model (discussed below) to distinguish the rank
order of the formulations.
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Raman Spectra of Lyophilized Protein Formulations before Storage
The spectra of all 6 protein formulations immediately after lyophilization are visibly
distinguishable (Figure 2A). However, interpretation of small differences in peaks corresponding
to protein structure is challenging due to the presence of overlapping peaks from both sucrose
and trehalose below 1530 cm-1. For example, both stabilizers have strong peaks which overlap
the 830/850 cm-1 tyrosine fermi doublet peak associated with tertiary structure and the amide III
peak at 1230-1340 cm-1 associated with secondary structure (Figure 2B). Additionally, trehalose
has an intense peak near 900 cm-1 that is not present in the sucrose spectrum, so each
disaccharide overlaps the protein spectrum to a different extent. The large Raman scattering
contributions from sucrose and trehalose obscure small protein spectral features, differences in
which may be linked with stability. Differences in the position or intensity of peaks associated
with protein structure related to stability may be smaller than the pH-induced structural changes
in ALA shown previously (Chapter 3), all of which are notably smaller than the spectral
contributions of these excipients.
Tertiary structural peaks in the Raman spectra are due primarily to aromatic amino acid residues
and are integral to our ability to distinguish between protein structures in the solid-state using
Raman scattering (Chapter 2 & 3). Just as proteins have different levels of the three aromatic
residues, the peaks associated with the tertiary structure of proteins will have varying proteinspecific intensities (Figure 2C). HSA has 1 tryptophan, 20 tyrosines and 27 phenylalanines out of
a total of 585 amino acids [30]. In contrast, ALA has 4 tyrosines, 4 tryptophans and 4
phenylalanines out of 124 total amino acids and a MW of 14.2 kDa [32]. The number and
relative ratio of these aromatic amino acid residues to the total number of amino acid residues, in
addition to location within the protein structure (exposure to solvent), affect the signal intensity
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of their peaks in the Raman spectrum. Raman intensity may also be affected by local
hydrophobicity, differences in ion charge (protonation/deprotonation), and hydrogen bonding
[33]. Shifts in Raman peaks indicate differences in hydrogen bonding patterns, cation-π
interactions, and/or conformational differences. Thus, some interactions, such as hydrogen
bonding, may result in both a Raman shift and peak intensity change. In addition, the Raman
peaks of each aromatic residue, for example tryptophan, have contributions from all tryptophan
residues in the protein. If there are too few tryptophan residues, compared to the total number of
amino acids in the molecule, such as the case of only 1 tryptophan residue in HSA, not all peaks
assigned to Trp are detectable. Tryptophan peaks in HSA are much weaker than those in ALA.
On the other hand, if there are too many residues in very different environments in the protein,
such as phenylalanine in HSA, it may be more challenging to detect small structural differences
associated with a small fraction of the large number of phenylalanine residues. Raman peak
assignments have been extensively determined experimentally (Chapter 2). In previous work
(Chapter 3) on α-lactalbumin (ALA), which has 4 tryptophan residues out of 124 total residues,
several significant differences were observed in the peaks attributed to tryptophan. Tryptophan
peaks at 880, 1360, and 1585 cm-1 all demonstrated gradual changes with forced structural
differences induced pH. Differences in the strong tryptophan peaks of ALA at 760, 1130, and
1553 cm-1 did not show shifts with pH as clearly. The low concentration of tryptophan residues
in HSA reduces the intensity of its peaks (strong peaks at 760 and 1553 cm-1 and weak peaks at
880, 1130, 1360, and 1585 cm-1), which are useful for detecting differences in protein structure.
Only the weak tryptophan peaks at 1130 and 1585 cm-1 remain in the HSA spectra. Based on
observations from the ALA model, only the tryptophan peak at 1585 cm-1 is likely to display
structural differences in HSA. However, although present in HSA, this peak does not show
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visible differences in the Raman spectra of sugar or salt formulations. In addition, differences in
the 1585 cm-1 peak are not dominant in the difference spectra or LVs for the formulations.
Unfortunately, in the current study of HSA formulated with sugars, any differences in the 1130
cm-1 peak attributed to tryptophan will likely be swamped by large Raman scattering due to
sucrose or trehalose. An overlay of HSA and ALA shows the large differences observed in
Raman spectra from different protein structures (Figure 2C). The large number of tyrosine and
phenylalanine side chains in HSA result in stronger peaks associated with these tertiary
structures. However, these peaks are averages of all the various environments in which the many
residues are found. Thus, in the end, subtle differences in the peaks due to changes in the
environments of a few of the many residues may be obscured by averaging over so many
conformations. Finally, protein secondary structure content will also affect the Raman signal.
HSA is approximately 70% alpha helical secondary structure [34] resulting in more intense
secondary and backbone structural peaks under the same sampling conditions (10 mg pellet of
100% protein) than was observed in ALA, with less well-defined structure of approximately 43%
α-helix and 9 % β-sheet with the remaining structure unordered (Figure 2C) [35].
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Figure 2. (A) Raman spectra of HSA formulations normalized at 1650 cm-1. Average of 6
accumulations shown. The spectral range shown with the black arrow to the right of the black
dashed line will be discussed later. (B) Raman spectra of HSA (green) and pure excipients
sucrose (blue) and trehalose (red).(C) Overlay of HSA and ALA Raman spectra (not
normalized).

PCA was used to explore the potentially rich source of data contained in the full Raman spectra
of HSA formulations. In addition, partial least squares (PLS) regression analysis was used to
explore the relationship between the principle components and the aggregations rate for each
formulation. PLS minimizes the covariance in the spectral data (X) and the aggregation rate data
(Y) simultaneously. PLS generates latent variables (LVs) to describe the spread of the variance
in the data which are similar to the PCs previously described (Chapter 2). The LVs are numbered
according to the %X variance described, in a similar manner as PCA, although the minimization
criteria of the two approaches are different. Although the LV fitting is not fully optimized due to
only variance in Raman spectra (X) due to the PLS modeling covariance approach, the LV still
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correlates well with difference spectra (changes in X data) (Figure 3A-D), supporting the link
between spectral differences and aggregation rate (Y data).

A

B
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C

D

Figure 3. Difference spectra are subtraction of the spectra of two formulations. Overlay of the
LV loading and pertinent difference spectra are shown for: (A) LV1, (B) LV2, (C) LV3 and
(D) LV4 (Blue line representing spectral difference between sucrose and trehalose formulation
was divided by 4 and displayed on the secondary axis).
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Loading plots show the relationship between the latent variable and the Raman spectral
variations contributing to it (Figure 3). To interpret any physical meaning of LV loading
intensity, loading plots are overlaid with relevant difference spectra to identify the degree with
which any physical meaning can be assigned to the LV. The LV1 loading intensity aligns well
with the difference spectra representing spectral contributions of the sucrose and trehalose
excipient peaks (Figure 3A).
LV2 loading intensity trends with the difference spectrum representing differences in the protein
spectrum due to the presence of sodium chloride (Figure 3B). As mentioned, the HSA:NaCl 1:1
formulation spectra is visibly very different from the other formulations. Many of the peaks are
broader and more intense than HSA alone or the sugar formulations. That difference is reflected
in the Raman spectra in very wide “peaks” which can be detected in the difference spectra and
LV2 loading intensities. This is speculated to be due to the difference in types of stabilizing
interaction that proteins may have with the salt vs the sugars. The salt interaction may be more
ionic and change the protonation state of the protein, whereas the sugars are hypothesized to be
hydrogen bonding [26]. Salt interaction have also been linked with changed in the fast dynamics
motion [14].
LV3 loading intensity aligns with difference spectra representing spectral differences between
sucrose and trehalose peaks (Figure 3C). LV3 separates the spectral variability based on the type
of sugar (sucrose or trehalose) included in the formulation. Sugar type is the third largest spectral
difference in the system, demonstrated by large spectral differences between sucrose and
trehalose near 900 cm-1.
Latent variable 4 represents <2% of the variance in the Raman spectra (X), however PLS models
are formed iteratively and minimize the co-variance in both X and Y using least squares (Figure
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5B). Addition of LV4 to the model described 6% of the variance in the aggregation rate at 50°C
determined by SEC, which was almost twice as much as the Y variance described by LV2 and
LV3, and significantly reduced the RMSE of calibration from 0.85 % month-1/2 to 0.39 % month1/2

. However, LV4 captures more variance in Y (aggregation rate) than in X (Raman spectra),

making interpretation from Raman difference spectra, based on changes in X, complicated.
When LV4 loading intensity is compared to Raman difference spectra, there is good alignment
from 600 - 1300 cm-1 with the difference between HSA:SUC 1:1 and HSA:TRE 1:1 representing
spectral differences in the sugar excipients (Figure 3D). However, near the phenylalanine peak at
1000 cm-1 and from 1300-1850 cm-1, LV4 trends more closely with the difference between HSA
only and HSA:NaCl 1:1 formulations. Therefore, LV4 captures co-variance in multiple chemical
parameters at once. In fact, all four of the latent variables described above include co-variance
from multiple factors although some of the LVs are more strongly associated with Raman
spectral differences due to one chemical parameter (i.e., formulation change) in the system than
the others.
A two-dimensional LV score plot of LV1 vs LV2, capturing 88% of the data variance is able to
separate the formulations (Figure 4A). Calibration data sets (open triangles) used to “develop” the
model and the test data sets (solid circles) are both shown. The ellipses around the data points
represent the 95% confidence intervals for the clusters. LV1 (horizontal axis) primarily captures
spectral differences associated with sugar content due to the large spectral contributions from
sugar. Spectra of formulations with the highest sugar level have negative scores on LV1, while
spectra of formulations containing no sugar have positive scores of about 2 on LV1.
Formulations with intermediate levels of sugar have intermediate scores. In contrast, latent
variable 2 (vertical axis) appears to separate the formulation spectral variation largely due to the
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inclusion of sodium chloride in the formulation. While sodium chloride itself is not a Raman
scatterer in the spectral range explored here, it broadens many HSA peaks and results in more
intense peaks between 900-1300 cm-1. The difference in the Raman spectrum of HSA due to the
presence of NaCl is the second largest spectral difference in the system. It is postulated that these
spectral changes are directly due to protein conformational changes as the NaCl alone does not
have significant Raman scattering. These protein changes, both secondary and tertiary, may be
due to differing ionic interactions in the presence of NaCl. The amide I peak has been shown to
have a similar increase in lysozyme attributed to changes in the protonation state of COOH [36].
Additional studies are needed with salt-based formulations to investigate this mechanism. Scores
in LV1 trend well with aggregation rates (Figure 4C). This observation may be confounded by
the increasing sugar content as that has been well documented to stabilize proteins [4, 6, 26].
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Figure 4. Analysis of formulations directly after lyophilization. Rank order from highest
aggregation rate to lowest aggregation rate: HSA only (worst, green), HSA:NaCl 1:1 (orange),
HSA:TRE 1:0.25 (pink), HSA:SUC 1:0.25 (aqua), HSA:TRE 1:1 (red) and HSA:SUC 1:1
(best, blue) Calibration data: solid circles; Prediction data: open triangles. (A) Scores plots
show the relationship between sample formulations. Each class or sample type cluster (6
replicates) is surrounded by the 95% confidence ellipse.(B) Calibration curves (predicted vs.
measured): model prediction linear fit (red line) and an ideal scenario or 1:1 prediction line
(green line). (C) Scores on LV1 vs predicted aggregation rate constant.

PLS models of the Raman spectra collected immediately after freeze drying accurately predicted
formulation rank order for both storage temperatures, 40°C (data not shown) and 50°C (Figure
4B), and distinguished between formulations based on aggregation rates and excipients (both
type and level) in the score plots (Figure 4A). The rank order of the predicted aggregation rate is
the same as the experimentally determined rank order, meaning that Raman spectral differences
of protein formulations in the solid state immediately after lyophilization are predictive of
protein stability. However, due to the large effect seen by the Raman scattering of sucrose and
trehalose, this model is confounded. Sucrose and trehalose have been shown to stabilize proteins,
and this effect increases with the weight ratio of the sugar [3-6, 37]. Using the region from 6001850 cm-1, with large Raman scattering of sucrose and trehalose, includes Raman data in the
prediction which also will lead to approximate rank ordering based solely on the sugar spectral
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contributions increasing (Figure 4C). Within this region, it is not possible to separate these
effects.
The line of best fit, obtained by comparing the measured aggregation rate and the predicted
aggregation rate, has a slope of 0.994 (y = 0.994x +0.0127) which is very close to the ideal slope
of 1 (Figure 4B). PLS models were investigated for the calibration model, cross validation model
and for prediction (Figure 5). Random subset cross validation, which splits the calibration data
set, into smaller subsets, leaves one out and builds the PLS model from the remaining subsets, is
intended to challenge the ability of the calibration data set to predict values of new unknown
data. The calibration model, cross validation model and the prediction model all have a
coefficient of determination, R2 , >0.98 (R2 CAL = 0.989, R2 CV = 0.980, R2 PRED = 0.984)
(Figure 5C) which indicates a good model fit to the data, even with some calibration set data
missing (CV) or with predictions on new data from pellet 2 (PRED).

A
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C
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Figure 5. Model statistics, (A) Q residuals (reduced) vs Hotelling’s T (reduced) plot and (B)
Student Residual vs Leverage plot. (C) Percent variance table including LV X%, LV Y%, R2
and RMSE statistics. Formulations colors as described in Figure 2.

Model goodness of fit can be evaluated using model diagnostic plots. Examination of the Q
residuals vs Hotelling’s T2 plot confirms that all of the formulations are within the expected
variance described by the model (Figure 5A). In addition, due to the spectral differences
displayed by the HSA alone and all of the high weight ratio (1:1) formulations, these
formulations contain more leverage than the low weight ratio (1:0.25) sucrose and trehalose
containing formulations. Therefore, as expected, the more extreme spectral differences exert a
large influence over the model (Figure 5B).
The standard error of the model was high relative to measured aggregation rates obtained for the
most stable formulations. The aggregation rates of the HSA:sucrose 1:1 and HSA:trehalose 1:1
formulations at 50°C were 0.5 % month-1/2 and 1.3 % month-1/2, respectively. In comparison to
these results, the root mean square error (RMSE) of the model was 0.29 % month-1/2 (CAL), 0.39
% month-1/2 (CV), and 0.35 % month-1/2 (PRED). Model prediction of these very stable
formulations is quite challenging due to the small aggregation rate with large variances. The
success of the model prediction is based on resolving these very small protein structural
differences, among large excipient spectral differences, or due to the excipient spectral
differences. Thus, a limited spectral range that does not include significant spectral contributions
from these excipients was explored in the section “Assessment of Limited Raman Spectral Range”.
The use of 4 LVs included the largest contributions to the percent model variance and described
more than 98% of the cumulative variance for both X and Y. Although resolution at the lowest
aggregation rate investigated is challenging, similar RMSE obtained in both the calibration and
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cross validation model, in addition to the prediction model shows a robust model, capable of
application to new unknown data which will be explored in the section “Model Application for
Prediction of “Unknown” Formulations”. Equivalent values of calibration and cross validation
RMSE indicate that the sample order or number of samples included in the model is robust.
However, this initial investigatory model, in addition to the intense sugar peaks, is known to be
confounded by splitting one pellet into the “training” set and a replicate pellet in the “test” set. A
more robust method applied to routine analysis would need to be derived from independent
samples sets for calibration and prediction.
Assessment of Limited Raman Spectral Range
It was noted previously (Chapter 3), that the region from 1530-1780 cm-1 does not include
significant peak contributions from sucrose or trehalose (Figure 6A). This provides the
opportunity to evaluate spectral shifts due to differences in the protein, that are related to
alterations in its structure and/or interactions with the excipients, with less interference from the
Raman scattering of the excipient. This is especially important in light of the inability of the
model described above, which analyzed the larger 600-1850 cm-1 region, to separate aggregation
rate due to the addition of sugar “peaks” from smaller peak differences related to either protein
interaction with excipients or protein structural differences. The large intensity differences due to
the disaccharide excipients heavily weighted the model in the spectral range 600-1850 cm-1 to
detection of sugar content over detection of small protein related differences.
The PLS models, based on the Raman spectra from the truncated 1530-1780 cm-1 region,
accurately predicted formulation rank order based on aggregation rates at 50°C with the
experimentally determined rank order of excipient type (salt, sugar) and level (Figure 7A).
Without the overwhelming sucrose and trehalose peaks, the first latent variable corresponds to
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protein structural differences. LV1 loading intensity aligns with the difference spectrum
representing the broadening of the amide I peak by sodium chloride. The entire spectral response
for HSA:NaCl seems to have a higher baseline in this region from 1530-1780cm-1 (Figure 6C)
and in the many parts of the Raman spectrum from 600-1850cm-1 (Figure 2A).
The HSA:NaCl formulation clearly has different interactions with the protein than the sugar
based formulations. Sugar-containing formulations have a narrower amide I secondary structural
peak and decreased intensity of tertiary peaks at 1585 and 1619 cm-1. The width of the amide I
peak in the disaccharide formulations is closer to that found in the of “native state” solution state
of HSA (Figure 6A). A wider peak in the solid state of proteins suggests either a larger number
of configurational states or differences in hydrogen bonding. Shifts in the FTIR amide I and
amide II peaks of lysozyme to match the “hydrated” solid state have been attributed to hydrogen
bonding of the sugar stabilizer replacing the hydrogen bonds available with water [26].
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Figure 6. (A) Raman spectra of the 1530-1780 cm-1 region without excipient overlap. Overlay
of both solid and solution spectra (solutions: dashed; solids:solid). Latent variable loadings:
(C) LV1, (D) LV2 and (E) LV3, overlaid with difference spectra.

Thus, a narrowing of the amide I peak by disaccharides seen here may be due to i) the ability of
sucrose and trehalose to act as water substitutes [12, 38] or ii) an ability of the disaccharides to
allow the protein structure to be more conserved [37], regardless of the interactions. However,
differences in the width of the amide I peak alone do not explain formulation physical stability
rank order, as the HSA:NaCl 1:1 formulation does not follow this trend; if it did, the NaCl
formulation, which has the widest amide I band, would have the lowest aggregation rate of all
the formulations.
The Raman spectra of the four disaccharide-containing formulations are not visibly
distinguishable in this spectral region, despite their differences in aggregation rate. Without the
large spectral contributions of sucrose and trehalose found at lower wavenumbers, score plots,
that account for 97% of spectral variance, did not show complete separation of formulations
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(Figure 7B). In particular, the sucrose-containing and trehalose-containing formulations overlap.
The 1:1 formulation and the 1:0.25 formulation do not completely separate, but small differences
are apparent in the LV 2 scores. Loading plots for LV2 align well with differences in the spectra
due to the presence of disaccharide excipients (Figure 6D). As these excipients do not have direct
spectral contributions in the 1530-1780 cm-1 region, the spectral shifts are mainly due to the
narrowing of the amide I peak, as well as shifts in peaks assigned to aromatic residues (1585 and
1619 cm-1). Shifts in these tertiary peaks have been attributed to changes in the environment of
conformation of the aromatic side chains [39]. Shifts in the tertiary structural peaks are also
observed in pH induced structural changes in ALA solids (Chapter 3 Figure 10). However, in
ALA a decrease in peak intensity correlated with formation of the molten globule, whereas in
HSA a peak decrease correlates with increased stability.
Trends in aggregation rate with either LV1 or LV2 scores were explored directly (Figure 7 C &
D). As noted when analyzing the loading, LV1 is dominated by the variance in the HSA:NaCl
formulation caused by a very different spectral response (peak broadening) which is speculated
to have a different mechanism of protein: excipient interaction than the sugar formulations. Thus,
LV1 scores do not show a strong trend with aggregation rate but do show a separation of the
HSA:NaCl formulation. However, LV2, which is assumed to trend with small protein structural
changes, as none of the excipients have intense Raman scattering in this region, does trend with
aggregation rate.
Latent variable 3 was included in the model as it described almost 5 % of the variance in
aggregation rate (Y) even though it accounted for <1% of Raman spectral (X) variance. Due to
the stronger dependence of LV3 on aggregation rate than on the spectral variation, assessment of
loading plots with spectral features was challenging. There is some alignment with difference in
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protein structure due to the presence of salt. However, this loading vector has more noise than
LV1 or LV2 and may not be well correlated with Raman structural differences.
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Figure 7. Regression model (A) and scores plots (B) for Raman data from the focused region
(1530-1780 cm-1) in the model. (C) LV1 scores as a function of predicted aggregation rate. (D)
LV2 scores as a function of predicted aggregation rate. (E) Q residuals (reduced) vs
Hotelling’s T (reduced) plot and (F) Student Residual vs Leverage plot. (G) Model statistics
for the 1530-1780 cm-1 range.
Comparison of the PCA/PLS statistical analysis of the 1530-1780 cm-1 region, relative to the full
spectrum, shows how dominant the spectral features of the disaccharides are in the low
wavenumber region. Using data from the full spectrum, LV1 representing 51% of the spectral
variance in the full spectrum was largely due to the presence of the disaccharide, while LV2
representing only 37% of the spectral variance was mainly due to the broadening of peaks by
sodium chloride. In the smaller region, 1530-1780 cm-1, the features captured in LV2 in the
larger data set shifted to a new LV1 aligns with trends in the HSA:NaCl formulation, attributed
to protein structural differences due to the poor Raman scattering of NaCl. The near elimination
of the direct spectral contribution of sucrose and trehalose in the smaller region, 1530-1780 cm-1,
did not degrade the ability to identify the correct rank order prediction of protein aggregation rate
at 50°C (Figure 7). These results support the theory that small differences in the protein spectra
contribute significantly to the model. However, use of the focused region does not improve the
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model predictions and decreases the resolution between the formulations. The HSA:NaCl test
formulation displays high Q residuals indicating that spectral variation of the protein due to
sodium chloride is outside of the variance described based on the model data (Figure 7E). This
supports the theory that HSA:NaCl stabilization may proceed by a different mechanism. In
addition, due to the larger spectral differences displayed by the HSA alone and HSA:NaCl 1:1
formulations, these formulations have more leverage than the sucrose and trehalose containing
formulations (Figure 7F). Therefore, these samples exert a disproportionate influence on the
model in the limited region. In addition, comparison of the RMSE between the calibration model
and the cross-validation model reveals that the RMSEC < RMSECV by more than 20% which
indicates overfit (fitting noise) and a less robust model than found when utilizing the entire
region (Figure 7G). Thus, the smaller wavelength region does not provide an improved model.
However, evaluation of this region in which the excipients have no direct spectral contribution
provides support for the hypothesis that protein:excipient interactions causing protein structural
differences are contributing to the model in addition to the spectral response from the excipients.
Model Application for Prediction of “Unknown” Formulations
An additional set of HSA formulations was prepared as an independent batch from the
calibration batch with fresh solution preparation, formulation and lyophilization following the
methods outlined above (Sample Preparation). These samples will now be referred to as set 2.
New samples were prepared to target the same concentration levels of HSA solutions at 1:0.25,
and 1:1 protein to excipient weight ratios for sucrose, trehalose and sodium chloride (1:1 only) as
already studied. In addition, HSA:SUC 1:0.5 and HSA:TRE 1:05 formulations were prepared at
intermediate levels, falling between both the “low” (1:0.25) and the “high” (1:1) HSA:sugar
formulations in the calibration data set (set 1). Evaluating the power of the model to predict
independently prepared samples is a more robust challenge than the use of the second pellet test
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sample in set 1 because the second pellet was prepared and lyophilized in the same batch as the
first pellet used as the calibration set. Unfortunately, the aggregation rates at 50°C were not
measured for the set 2 samples, including the new 1:0.5 formulations. No data is available on
measured aggregation rates, so it is not possible to fully evaluate the prediction. The replicate
batch of formulations fell within the confidence intervals of the calibration data (Figure 8A). On
the 2-dimensional scores plot, the 1:0.5 formulations fell between the 1:0.25 and the 1:1
HSA:sugar formulations as expected. These formulations were also roughly within the expected
prediction of aggregation rate constant (Figure 8B). As discussed above, the wider Raman
spectrum of the HSA:NaCl had a different spectral trend than the other formulations in the model
data set. This formulation was overlapping the 95% confidence ellipse of the model (dashed
line), and the training sample formulation had high Q residuals (Figure 8C), implying this
formulation was slightly outside the spectral results used for model calibration.
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Figure 8. Analysis of the new batch of formulations directly after lyophilization with the
scores plot (A), Predicted aggregation rate at 50°C vs LV1 (B) and Q residuals vs Hotelling’s
T2 (C). Formulations shown as: HSA only (green), HSA:NaCl 1:1 (orange), HSA:TRE 1:0.25
(pink), HSA:SUC 1:0.25 (aqua), HSA:TRE 1:0.5 (light pink), HSA:SUC 1:0.5 (light blue),
HSA:TRE 1:1 (red) and HSA:SUC 1:1 (best, blue). Calibration data (original formulation):
solid circles; Prediction data: replicate formulations (open squares), new 1:05 formulation
(open diamonds).

A model in the range from 1530-1780cm-1, based on the second batch of formulations (set 2),
was applied to the same new batch of formulations (set 2), including both of the 1:0.5
HSA:Sugar formulations. Resolution of the new formulations (set 2) was not as clear cut in the
1530-1780 cm-1 range, with the HSA only and HSA:NaCl 1:1 formulations from the test batch
(set 2) score values farther outside the range of the model (Figure 9A), based on comparison with
the 95% confidence interval ellipse, than the equivalent calibration (set 1) formulations (Figure
8A).
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Figure 9. Analysis in the 1530-1780 cm-1 spectral range for the new batch of formulations with
the scores plot (A), Q residuals vs Hotelling’s T2 (B). Predicted aggregation rate at 50°C vs
LV1 (C) and LV2 (D).
In addition, LV1 score values, which were interpreted from the loadings as small differences in
protein structure, did not resolve the HSA:Sugar formulations even though they described 92%
of the variance in the model. This is similar to the model of limited range developed based on set
1. Although most formulations, including the additional 1:0.5 HSA:Sugar formulation were
predicted to have the appropriate rank order, there was a systematic shift to higher aggregation
rate predicted in the test batch (highest confidence ellipse >12% aggregation) compared to the
calibration data (highest confidence ellipse <12% aggregation). This was not attributed to the
presence of the 1:0.5 samples, as investigation of these formulations were only added to the test
or prediction sample set, which would not result in a shift. The HSA:NaCl shifted the most and
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exceeded the predicted aggregation rate for the HSA only formulation. This poor result may be
due to heterogeneity expected in the amount of NaCl crystallization within the formulation
during the lyophilization process. The lyophilization cycle was not optimized to reproducibly
induce NaCl crystallization, so % crystallized NaCl in different vials may have been different,
leading to a high variation in vial-to-vial protein stability. Further investigation into the %
crystallinity and a stability evaluation of the new batch would be necessary to confirm these
results. The difference in the sodium chloride-containing formulation compared to the other
formulations is highlighted by high Q residual and Hotelling’s T2 values for the NaCl
formulations (both calibration and prediction) (Figure 9B). This is also evidenced when
comparing the linearity of the LV score against the predicted aggregation rate at 50°C. The
HSA:NaCl formulations are separate from other formulations in both LV1 and LV2 scores
(Figure 9C&D).
Secondary Structural Differences in Solids by FTIR
FTIR spectra of proteins in the amide I and II region, the standard technique for assessing
structural differences in solids, previously (Chapter 3) detected pH-induced structural changes of
ALA. PCA was able to quantify differences in the FTIR absorbance spectra due to this forced
change (pH) in the system. PCA of FTIR spectra of the HSA lyophilized formulations is applied
here to compare with PCA of Raman spectra.
Differences in the spectra are easier to detect visually in a smaller wavenumber region such as in
1500-1800 cm-1 FTIR analysis or in the 153-1780 cm-1 spectral region in the Raman analysis due
to the decreased number of peaks in this range. Two large peaks appear in the FTIR absorbance
spectra, Amide II in the range (1500 - 1600 cm-1), is due to N-H vibrations of the peptide bond ,
and Amide I at 1600-1700 cm-1 is due to C=O vibrations in the peptide bond [26, 40, 41]. Both
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peaks are vibrations influenced largely by secondary structure. No peaks assigned to tertiary
structure are present in FTIR spectral analysis.
FTIR absorbance spectra were area-normalized and evaluated using PCA and PLS models to
interpret any secondary structural differences that might be related to physical stability
(aggregation). Interestingly, the HSA:NaCl 1:1 formulation was notably broader but lower in
intensity than the other formulations (Figure 10). The HSA:SUC 1:1 and HSA:TRE 1:1
formulations were the most narrow and intense, however the HSA:TRE 1:0.25 formulation
appeared to overlap them, suggesting no ability to separate and predict the formulation rank
order by amide I peak intensity.
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Figure 10. FTIR Absorbance (A) and LV loadings (LV1, B) (LV2, C).
A PLS model was developed to correlate the spectral differences with the aggregation rate at
50°C determined by SEC. Since only 3 FTIR spectra were acquired for each formulation, the
data set was too small to split into training and test date sets. Model fit was evaluated for
calibration and CV. The FTIR PLS model captured 97 % of the X variance of the data in the first
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two latent variables, compared to 88% by the PLS model based on Raman spectra using the
entire range (600-1850 cm-1) or 97% based on the limited region (Figure 11). However, the
specificity obtained using the entire Raman spectra was lacking in the FTIR spectra which
contained only 2 large peaks, and less data points for each sample. Therefore, the FTIR model R2
and RMSE values, were lower and not as precise. However, these were similar to the model fit
achieved with the Raman spectral differences when using limited data in the Amide I region
(1530-1780 cm-1) so may be a consequence of the information range rather than the method.
Scores from LV1 show a trend with sugar % composition, whereas, LV2 shows a trend with
sugar % composition with the exception of the HSA:NaCl 1:1 formulation.
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Figure 11 FTIR Regression model (A) and LV1 score plot showing trend with sugar
composition (B). LV2 score plot (C) and percent variance table (D).

Both LV1 and LV2 loading vectors (Figure 10) represented variance from a combination of
physical effects of sugar excipients and protein spectral differences due to the presence of NaCl.
Unlike the interpretation of the LVs from Raman spectral analysis, PLS models of FTIR spectra
did not separate the variance from the different chemical parameters into separate LVs.
Interestingly, although both FTIR and the 1530-1780 cm-1 spectral region for Raman did not
have direct spectral contributions from the excipients present, both PLS models were unable to
fully minimize these effects due to protein:sugar interactions. PLS models from FTIR spectra
established the correct rank order of the formulations based on the small differences present in
the FTIR absorbance spectra.

Conclusions
PLS models correlating differences in the Raman spectra, immediately after lyophilization, with
the rate of aggregation at 50°C accurately predicted formulation rank order. Formulations were
well resolved based on spectral characteristics of the different excipients using the spectral range
600-1850 cm-1. However, use of models in this range was limited due to strong Raman scattering
of both sucrose and trehalose excipients. In addition, these peaks confounded model predictions
based on spectral characteristics. Addition of sugar is well known to stabilize proteins and
detection of increasing sugar peaks confounded the results. The use of the entire spectral region
144

was not able to separate out small differences in spectra representative of protein structural
stabilization among the large contribution of increasing (and stabilizing) sugar content.
The region in the Raman spectra from 1530-1780 cm-1 presented an opportunity to examine
spectral differences without direct interference from the Raman scattering of sugars.
Examination of the amide I peak, revealed peak narrowing in the presence of sugar excipients,
attributed to protein sugar interactions. Solutions studies verified that the narrow peak was
representative of “native” structure in pre-lyophilized solutions. In FTIR, this narrowing and
shift toward “native” structure has been accepted to represent a stabilizing difference [26]. Thus,
PLS prediction of rank order in this region should be more representative of protein structural
differences and not driven by sugar content of the formulations.
However, the stability exhibited by the HSA:NaCl formulation, in comparison to HSA alone, is
not supported by the amide I peak observation. HSA:NaCl had a wider amide I peak, and most of
the spectrum of this formulation was elevated and not visually similar to other formulations in
the study. One reason for this difference may be due to different stabilization mechanisms of
salts and sugars. However, this study does not include other salts or the ability to investigate
these mechanisms more thoroughly. A more thorough study of this phenomena is required.
More to the point, none of the excipients in the Raman region from 1530-1780 cm-1 have
significant Raman scattering, so we can reasonable conclude that PLS models generated on the
Raman region from 1530-1780 cm-1 are representative of protein structural differences related to
stability. These PLS models are able to predict the rank order of aggregation rate compared to
experimental data based on protein structural differences as manifested in the Raman spectra.
Initial investigations into the use of Raman in the solid state to predict protein aggregation are
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promising but more work is needed to fully understand the spectral differences observed
phenomenologically and to develop the model applications.
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Chapter 5
Structural Changes in Lyophilized Proteins During Storage Identified
Through a Combination of Chemometrics and Raman Spectroscopy
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Introduction
Lyophilization is known to induce structural changes in proteins which are often destabilizing
[1, 2] and which have been detected by at least two methods, FTIR [3, 4] and ssHDX-MS [5].
Even if a dry product can be produced without significant degradation, adequate stability during
storage is not guaranteed. Many studies have been conducted which have yielded general
guidelines for successful formulation [1, 2, 6]. However, several apparent exceptions to these rules
have been noted [7]. For example, both sucrose and trehalose are commonly used stabilizers, which
easily form glasses with relatively high glass transitions temperatures; 75°C for sucrose and 118°C
for trehalose in dry solids [7]. They effectively hydrogen bond to proteins and should satisfy the
criteria for stabilization through both hypotheses: hydrogen bonding and vitrification [2]. Based
on the higher Tg value, trehalose should be the superior stabilizer with decreased mobility.
However, results are often mixed, with sucrose and trehalose showing similar storage stability
despite the higher Tg value of trehalose formulations. One such case was investigated in
lyophilized human growth hormone (hGH) at 5 mg/mL (pH 7.4, sodium phosphate 0.75 mg/mL)
formulated in sucrose or trehalose at weight ratios, relative to hGH, of 1:1, 3:1 and 6:1 [7]. The
stability studies, at 40°C for 6 months and 50°C for one month, focused on a direct comparison of
both sugars with analysis of stability trends in terms of both structure and molecular mobility. The
results demonstrated that sucrose systems were more stable than trehalose systems by almost a
factor of two, although they had greater mobility as measured by structural relaxation time, which
was quite unexpected. By the general rule greater mobility should be less stable. Secondary
structure, measured using FTIR, showed changes in the formulations but was equivalent in both
stable systems.
Human serum albumin (HSA) and IgG1 antibody storage stability in formulations of sucrose,
trehalose and sorbitol have been studied [8]. In one such case, HSA was formulated at 2 mg/mL
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(pH 7, 5mM phosphate buffer), with weight ratio of excipient to protein of 0.5:1, 1:1, 2:1 and
4:1. Stability studies were conducted at 40°C for 6 months and 50°C for one month. Retention of
native structure (FTIR) showed a good correlation with storage stability. FTIR spectra with
second derivative analysis, showed changes in structure in the solid state with time which
correlated well with protein aggregation for both proteins studied. In addition, molecular
mobility data from the Thermal Activity Monitor (TAM, τβ) did not correlate with protein
stability at high levels of sucrose. This may be due to the type of motion measured using TAM
[2]. A second example in which measures of increasing mobility did not correlate with the
observed storage stability and a reason to link structural change in solids with prediction of
aggregation after reconstitution in addition to mobility measures. IgG1 storage stability was also
studied when formulated with a mixture of sorbitol with sucrose or trehalose, in addition to
formulations with sucrose or trehalose alone. [9] Stability correlated well with structure again in
sucrose based formulations, but in the trehalose based formulations neither mobility (TAM) or
structure correlated well with stability leading the authors to postulate that additional measures
of both mobility and structure are needed to investigate the stability mechanisms of sugars in
these systems.
FTIR studies were applied to optimize development of a lyophilization cycle for Interleukin-2
(IL-2) [10]. Evaluation of the lyophilized cakes at the time of release correlated well with
differences from native structure, as indicated by the correlation coefficient (r). They demonstrated
a strong correlation between retention of protein secondary structure and increased stability.
However, at higher storage temperatures, the correlation of the FTIR spectrum of the protein
structure to that of native structure decreased. Suggesting that there were additional structural
factors that were not being measured in this study. Raman spectroscopy may be able to answer
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some of these questions as it will be able to show more detailed structural data regarding tertiary
changes than are usually monitored using FTIR spectroscopy.
Previously (in Chapter 4), the Raman spectra obtained immediately after lyophilization showed
small, but detectable, differences that can be interpreted as small structural changes in the protein.
A PLS model was developed, regressing aggregation rate against variation in Raman spectra of
several formulations (Chapter 4). The model showed that variation in the Raman spectra
immediately after lyophilization could provide the correct rank order of physical stability of the
protein over time. As an extension of those results that focused on “in process” changes in the
protein, the current analysis was aimed at detection of Raman spectral changes over time.
Specifically, the magnitude of these changes was compared to the lyophilization-induced spectral
changes. It was postulated that if large changes occurred during storage in the solid state, these
changes may correlate differently than those observed at time zero. If the spectral changes
measured are directly correlated with a partially unfolded and reactive state, which yields a larger
percentage of soluble aggregates after reconstitution, a better correlation was expected.

Materials and Methods
Materials
Sucrose (>99.5%) and trehalose (>99%) were purchased from Sigma-Aldrich (St. Louis,
Missouri). Potassium phosphate monobasic and potassium phosphate dibasic anhydrous (>98%,
ACS grade) were purchased from Thermo Fisher Scientific (Waltham, MA). Recombinant
human serum albumin stock solution (HSA, 50mg/mL >99%, Albagen Ultra Pure, >99%) was
purchased from Albumin Bioscience (Huntsville, AL). HSA formulations were prepared and
lyophilized at 3 mg/mL as previously described (Chapter 4). Briefly, the HSA solution as
received was concentrated and reformulated in 5 mM potassium phosphate pH 7 buffer. The
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resulting stock solution was diluted with various volumes of stock excipient solutions and buffer
to obtain target protein to excipient (sucrose and trehalose) weight ratios of 1:0.25 and 1:1 and
1:1 for sodium chloride. Solutions were filtered through a 0.45 μm PVDF syringe filter and
aliquots (1 mL) were filled into 10 mL glass tubing vials in a LyoStar 3 freeze dryer (SP
Scientific, Gardiner, NY). The lyophilization process involved cooling the shelves to 5°C,
initiating ice nucleation at -5°C and freezing to -40°C. Primary drying was carried out at 60
mTorr at a shelf temperature of -30°C until the capacitance manometer and pirani gauge vacuum
readings converged. Secondary drying was conducted at the same chamber pressure at 40°C for
5 hours. The chamber was backfilled with nitrogen prior to stoppering. After lyophilization,
samples were placed in ovens at 40°C or 50°C for 6 months to monitor stability of solid-state
formulations over time. Vials were removed at intervals and analyzed for aggregation (SEC), and
structural changes (Raman). Lyophilized protein formulations were stored in two separate
storage formats (Figure 1). The first standard storage format was of an amorphous cake in the
vial (“cake”), which was assayed for both Raman spectral changes and formation of soluble
aggregates in the reconstituted solution. A second storage format was investigated specifically
for Raman analysis, which involved re-using the pellet prepared for Raman spectral acquisition
(“re-used pellet”). After compression of the lyophilized solids into a pellet for the initial (t=0)
Raman scattering spectral acquisition, the pellet was placed into a vial, which was backfilled
with dry nitrogen and re-sealed. The vial containing the pellet was placed back into the stability
oven until the next time point, when the pellet was removed again for Raman analysis before resealing in a dry vial for further storage and analysis. This “reused pellet” method was used to
determine if this material-sparing, time-saving method could provide the same results as found
from analysis of lyophilized (not compressed) cakes stored for the same time and conditions.
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Figure 1. Example vials representing each storage format: (left) Lyophilized cake in the vial,
(right) solid pellet after analysis re-sealed in a “dry” vial.
Methods
Evaluation of Physical Stability of Lyophilized HSA Formulations During Storage
Formation of soluble aggregates after extended exposure of the lyophilized formulations
to elevated temperatures was monitored using size exclusion chromatography (SEC). Percent
soluble aggregate is reported as the area of dimer and higher order aggregate peaks relative to the
total peak area, as previously described (Chapter 4). Briefly, lyophilized cakes of each HSA
formulation were gently broken up and subsampled and reconstituted with water, providing a
final concentration of 3 mg/mL. The filtered (0.22 μm ) solution (50μL) was injected onto a
column (TSKgelTM G3000SWXL, 7.8 mm x 30 cm, 5 um, Tosoh Bioscience, King of Prussia,
PA) maintained at 25°C. High molecular weight aggregates were measured by absorbance at 280
nm, with a mobile phase of 100 mM sodium phosphate buffer with 0.2 M NaCl, pH 7 and flow
rate of 1 mL/min, on an HPLC system (Model 1100, Agilent, Santa Clara, CA).
Raman Spectral Acquisition of Lyophilized HSA Formulations
Raman scattering spectra were acquired as previously described (Chapter 2). Details are
reiterated here for completeness. Lyophilized solids (10 mg) were compressed into 4.5 mm
pellets using a hand press (Model 2811, Parr, Moline, IL). Raman spectra were collected using a
785 nm diode laser and fiber optic probe (3 mm laser spot size, PhAT probe, Kaiser Optical
154

Systems, Ann Arbor, MI) on a calibrated spectrometer (RXN1, Kaiser Optical Systems, Ann
Arbor, MI) utilizing software (iCRaman 4.1, Mettler Toledo/ Kaiser Optical Systems Inc). Six
replicate spectra from each pellet (3 per side of the solid pellet) were collected using a 1 minute
acquisition time.
Each Raman spectrum was pre-processed as previously described (Chapter 2). The
Raman spectrum was cut to 600 - 1850 cm-1, the adaptive baseline corrected was applied with
the 22% adaptive setting, and intensity was normalized at1650 cm-1 using Spectragryph-optical
spectroscopy software (F. Menges, version 1.2.11d, 2018,
http://www.effemm2.de/spectragryph/).
Data Analysis
As previously described (Chapter 3), Principal component analysis (PCA) [11] and
partial least squares (PLS) regression models [12] were built with mean-centered Raman spectral
data (MATLAB R2017b, The MathWorks Inc., Natick, MA, equipped with the PLS_Toolbox
8.6.1 2018,Eigenvector Research Inc., Manson, WA). Several PLS models were developed to
evaluate the relationship between the Raman spectra and protein aggregation rate using the
SIMPLS algorithm [13]. In this chapter those studies will be extended to also include PLS
models against % soluble aggregate changes with time. Two pellets were prepared from each
vial of lyophilized HSA formulation stored at each time point. The Raman spectra from the first
pellet were used for the training data set, the those from the second pellet for the test set. In the
case of “re-used” pellets, 2 pellets were compressed from one vials of each lyophilized HSA
formulation before storage (i.e., storage time = 0). These “re-used pellets” were designated
“pellet 1” and “pellet 2”, stored in separate vials upon return to the stability oven, and used for
the training and test set as described above. Model statistics to evaluate model performance were
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calculated using the PLS_Toolbox and included cross validation (CV) with random subsets (10
splits, 10 iterations), the regression correlation coefficient (R2) and the root mean square error of
calibration (RMSEC), of cross validation (RMSECV) and of prediction (RMSEP). The number
of latent variables was optimized for both physical interpretation (different formulations) and
minimization of the model RMSE. However, interaction terms in chemical systems can often
contribute to additional LVs above and beyond the number of degrees of freedom contained in
the study design.
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Results and Discussion
Lyophilization of proteins solutions is a well-accepted method to stabilize the proteins to
achieve “adequate” shelf life periods, determined by competing factors of product quality and
basic economics. However, lyophilization processes involve many factors known to cause
damage to the proteins during the process. Slight alterations in protein structure after the
lyophilization process have been observed repeatably. In addition to “in-process” structural
changes addressed in Chapter 4, numerous studies have shown additional alterations in the
protein structure over time with methods such as FTIR and ssHDX-MS. However, with the most
stable formulations, FTIR, which is commonly used to evaluate secondary structure in proteins
fails to correlate with storage stability. In other cases, measures of secondary structure are not
able to distinguish between two very stable formulations composed of common excipients,
sucrose or trehalose. Raman scattering has peaks attributed to both tertiary and secondary
structural vibrations. This method was able to determine differences in formulations immediately
after freeze drying (Chapter 4) and will now be applied to the study of structural changes with
time.
Formation of Soluble Aggregate During Storage of HSA Lyophilized Formulations
As described previously (Chapter 3), HSA formulations were evaluated for % soluble
aggregate in the reconstituted solutions of each formulation immediately after lyophilization, and
at 1, 3 and 6 months. The rate of formation of soluble aggregation was calculated from the slope
of the line of best fit for % soluble aggregate versus square root of time [14]. The HSA stability
at 40°C ranked from lowest to highest aggregation rate were in the order (best) (HSA:Sucrose
1:1 ≈ HSA:Trehalose 1:1) < (HSA:Sucrose 1:0.25 ≈HSA:NaCl 1:1 ≈ HSA:Trehalose 1:0.25) <
HSA alone (worst) (Figure 2). Aggregation rate at 50°C was 2 times that at 40°C.
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B

Figure 2 Aggregation rate and % aggregate values determined by SEC after 6 months at 40°C
(A) and 50°C (B).

In addition to aggregation rate, the % soluble aggregate at each storage time was recorded to
analyze how changes in the Raman spectra of each formulation relate to changes in % soluble
aggregate over time.
Raman Structural Changes Over Time
At 3 months, HSA formulations formed higher %soluble aggregate than at previous time
points at either 40 or 50°C. Aggregation was higher at 6 months, but no Raman spectra were
available at that time point. Therefore, the corresponding Raman spectra at 3 months were
expected to exhibit the largest spectral change with time that were available to study. The PLS
model developed using Raman spectra at 3 months (Figure 3) was not meaningfully better than
the model based on Raman spectra immediately after lyophilization (Chapter 4; Figure 3)
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Figure 3. Calibration curves (predicted vs. measured) are shown above for the PLS model
based on Raman spectra collected after 3 months storage as a solid cake in a vial at 50°C.
Calibration data: solid circles; Prediction data: open triangles. Rank order from highest
aggregation rate to lowest aggregation rate: HSA only (worst, green), HSA:NaCl 1:1 (orange),
HSA:TRE 1:0.25 (pink), HSA:SUC 1:0.25 (aqua), HSA:TRE 1:1 (red) and HSA:SUC 1:1
(best, blue). The red line is the model prediction linear fit and the green line represents an ideal
scenario or 1:1 prediction line.

There was no significant difference in the correlation coefficient (R2) or RMSE of the
models based on the spectra before storage and after 3 months (Figure 4C). The model from
Raman spectra analyzed from cakes stored for 3 months at 50°C had a slightly increased LV1
from 58% from 51% (Figure 5A), which was previously found to account for a major portion of
the spectral variation due to the percentage of sugar excipients in the formulation (Chapter 4).
Overlay plots of Raman difference spectra and LV1 loading intensity show good alignment
between the spectral difference due to the presence of a sugar excipient in the formulation and
LV1 from both models (Figure 5A).
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B

C

Figure 4. Model statistics, (A) Q residuals (reduced) vs Hotelling’s T (reduced) plot and (B)
Student Residual vs Leverage plot. (C) Percent variance table comparison of different PLS
model statistics. Formulations colors as described above.

The model obtained at 3 months had a slightly lower % variance (21.6% instead of
38.63% captured by LV2 and higher % variance by LV3 (16.41% versus 9.60%), with a shift
observed in the comparison of model loadings with difference spectra for in the initial model
(Figure 5B & C). LV2 loading intensity from 3-month data aligns better with the difference
between trehalose and sucrose formulations, with only a small portion attributed to difference in
protein structure (presence of NaCl) between 1500-1800 cm-1. In contrast the LV2 loading
intensity at T0 had a larger portion of variance that trended with difference due to the presence of
NaCl. Interestingly, the LV3 intensity for the 3 month study aligns better with the difference
between HSA and HSA:NaCl 1:1 formulations, whereas the T0 LV3 aligned better with the
differences in the sugar formulations.

160

A

B

161

C

D

Figure 5. Overlays plots of Raman difference spectra and LV loading intensity from PLS
models based on Raman spectra immediately after lyophilization (T0) and Raman spectra from
samples held at 50°C for 3 months.
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LV4 seems to contain variance that is more evenly distributed between sources from both
HSA:SUC minus HSA:TRE (600-1200 cm-1) and HSA minus HSA:NaCl (1200-1800 cm-1)
contributions. Overall, no significant changes were observed between loading intensity of either
model other than the relative % variance compared to the total variance. Although, some
variance seems to have portioned into different LVs, both models describe similar Raman
spectral changes and are capable of predicting the correct rank order of the formulations with
respect to aggregation rate at 50°C. However, the fact that the model based on Raman spectra
acquired after 3 months storage at 50°C implies that little to no structural changes occurred over
this storage temperature. The assertion of the study was that changes in structure have been
detected previously occur over time, therefore more in-depth studies are warranted. This
discussion will be further expanded in the section “Evaluation of Raman Spectral Changes
During Storage of Each Formulation”.
Effect of Storage Format on Analysis of Raman Spectra of Lyophilized HSA Formulations
Initial development efforts in the pharmaceutical industry are often restricted due to the
limited availability of investigational material and the destructive nature of many analyses. Here,
a material-sparing storage format is compared against the traditional format of lyophilized
protein formulations in vials, with vials being withdrawn at each time point for Raman spectral
acquisition. The proposed material-sparing storage format involves pelleting 10 mg of each
formulation before storage and analyzing the same pellet at each time point during storage. In
addition to using much less of the limited material available early in development, the proposed
“re-used” pellet format eliminates the time to prepare pellets from lyophilized cakes at each time
point. It is quite possible that exposure during sample handling may lead to changes in the
sample composition, including sample damage (laser) or change in crystallinity (moisture). It is
also possible that compression could lead to altered structures. However, a previous study
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(Chapter 3) showed no effect of compression on aggregation of reconstituted freshly prepared
pellets, so the process of compression itself is not a significant stress on the protein.
Since even material stored in vials as cakes was pelleted before collecting Raman
scattering spectra, a comparison of data immediately after lyophilization would find the trivial
result that there is no difference. However, if the pelleting and re-use of the pellets affected the
results, this would become apparent after 3 months of storage. Thus, a comparison of the analysis
of “re-used” pellets and lyophilized cakes at 3 months is more appropriate. Examination of the
predicted vs measured calibration curve (Figure 6) shows this to be true with formulation rank
order from highest aggregation rate to lowest aggregation rate defined previously. The
calibration curve (Figure 6), latent variable loading intensities and the model statistics (Figure 4)
were also essentially unchanged.

A

B

Figure 6. Calibration curves (predicted vs. measured) are shown above for the “re-used” pellet
sample at the initial timepoint (A, T0) and the 3-month timepoint (B, 3M). The red line is the
model prediction linear fit and the green line represents a 1:1 prediction line
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The largest differences observed in the model based on the “re-used” pellet spectra
obtained at 3 months, relative to storage as lyophilized cake for 3 months, were changes in the
percent of model variation described by latent variables and a slight shift alignment between the
Raman difference spectra and the LV2 loading intensities (Figure 7).

A
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Figure 7. Overlays plots of Raman difference spectra and LV loading intensity from PLS
models based on Raman spectra of “re-used” pellets immediately after lyophilization and
samples held at 50°C for 3 months. (A) LV1, (B) LV2, (C) LV3.
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The differences within the LV1 loading intensity across all 4 models is very small, yet the
3 month “re-used” pellet LV1 captured a larger percentage of variation in the system (64%)
within this LV. LV1 aligns strongly with the addition of sugar excipients to the formulation. The
loading intensity for LV2 for the 3 month “re-used” pellet aligns better with the spectral
differences than the LV2 from the 3 month “stored as cake” samples, yet captures a lower % of
the system variation possibly due to the increase in the total % variance described by LV1.
Latent variable 3 or LV4 (data not shown) loading intensity for either of the 3 month samples
had similar alignment. These changes do not seem to be significant as the model was still able to
accurately predict the rank order of aggregation rate in the formulations (Figure 6). Rough
formulation order is all that would be required during these early development studies in order to
eliminate the most unstable options.
Evaluation of Raman Spectral Changes During Storage of Each Formulation
Based on the lack of change observed when comparing the PLS models generated from
samples immediately after lyophilization and after 3 months storage at 50°C with aggregation
rate data, the data suggest there may be no detectable change in the Raman spectrum over time.
FTIR was able to show structural changes with time in relatively “unstable” formulations so
similar results were expected in the new solid-state Raman method for several of the
formulations studied. However, small changes in the spectrum of a single formulation may be
difficult detect in the presence of large “in process” effects of several formulations. Therefore,
changes in the Raman spectrum of during storage was analyzed separately for each formulation
using PCA. Within each formulation, principal component (PC) scores for the Raman spectra of
the formulation at each time point were plotted relative to the corresponding % soluble aggregate
at that time point. It should be noted that the relevant PCs for each formulation were formulation
dependent and did not always capture the largest portion of the variation in the data set; instead
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the most relevant PC for each formulation was found based on a meaningful trend with %
aggregate (Figure 8).
A

B

Figure 8. One dimensional view of the PCA models along the PC (vertical axis) which is the
most visually discriminating for % aggregation (horizontal axis) in the samples. (top) Raman
spectra were analyzed immediately after lyophilization (green), after 1 month at 40°C (blue)
and 3 months at 40°C (red). (bottom) Raman spectra were analyzed immediately after
lyophilization (green), after 1 month at 50°C (light blue) and 3 months at 50°C (pink).
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Pure lyophilized HSA, the most aggregated formulation, had separate score clusters on
PC2 (15%) for its Raman spectra at time zero and 3 months, showing a trend with aggregation
over the range of 1-8% soluble aggregate when stored at 40°C (Figure 8A). However, scores for
the 1 month and 3-month samples overlapped. At 50°C, pure HSA, which had a wider range of
%aggregates over time (1 to 16%) had separate PC2 (17%) score clusters for its Raman spectra
at each timepoint (Figure 8B). In contrast, the Raman spectra of the most stable formulation,
HSA:SUC 1:1, did not show a trend with aggregation in either PC1 or PC2. HSA:SUC 1:1 stored
at both 40°C and 50°C had mostly overlapping PC3 scores at all time points (7-8%). It should be
noted that the range of aggregation in these most stable samples was <1%, so one would not
expect a large spectral change. In addition, the average % soluble aggregates measured at 3
months of storage were slightly lower than at 1 month at both storage temperatures,
demonstrating that these samples were largely unchanged under the conditions of the study.
Similar results were obtained for HSA:TRE 1:1 formulations which were also very stable and
had lower SEC results at the 3 month point.
Evaluation of trends in PC scores versus % aggregate for the formulations with
intermediate stability (HSA:sugar 1:0.25 and HSA:NaCl 1:1) reveal a linear trend of PC2 (1828%) for HSA: SUC 1:0.25 (40°C, 50°C) and HSA:TRE 1:0.25 40°C with PC2 (18-28%). The %
soluble aggregate in these samples ranged from 1 to 5. Interestingly, the HSA:TRE 1:0.25
formulation stored at 50°C had soluble aggregates ranging from 1 to 9% but the scores for the 1
month Raman data were very broad and overlapped with the initial timepoint more than other
intermediate-stability formulations. HSA:NaCl 1:1 is the only formulation that shows a trend in
the first principal component (PC1, 46-57%) of the Raman spectrum with % soluble aggregate
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(1-8%), As discussed previously, the Raman spectrum of HSA:NaCl 1:1 is distinctly different
from other formulations in the study.
Loading intensity plots for the most relevant principal components from the PCA models
for each individual formulation (50°C data) were compared to determine whether the PCs
determined separately for each formulation and storage temperature corresponded to variations
in similar regions of the Raman spectra (Figure 9). After close examination, it was determined
that PC1, PC2, and PC3 for all of the formulations fell into three general data trends. The PC
loadings are presented below by trend groups. For the most relevant PC (trending with % soluble
aggregate) (Figure 9A), the highest loading intensity is associated with 1450 cm-1, which has
been assigned to CH2 and CH3 methylene asymmetric bending motions. A change in this peak
has been attributed to hydrophobic interactions or changes in the environment around aliphatic or
hydrocarbon side chains. This was postulated to occur during formation of protein complexes of
β-lactoglobulin and lysozyme after heating mixtures in solution to 90°C [15]. This peak is the
most intense peak of the model loading plots for PC1 of the most stable formulations (HSA:SUC
1:1, HSA:TRE 1:1), PC2 of the intermediate and lower stability formulations (HSA, HSA:SUC
1:0.25, HSA:TRE 1:0.25), and PC3 of the HSA:NaCl 1:1 formulation. When visually analyzing
Raman spectra of all formulations together, it is difficult to see changes in this peak, since both
sucrose and trehalose have spectral contributions that overlap this protein peak.
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Figure 9. Overlay of PC loading vector intensities for models of individual formulation
changes with time.

This peak also shows up to a lesser extent in the loading intensity plots (Figure 9B) for
PC1 of the intermediate and lower stability formulations (HSA, HSA:SUC 1:0.25, HSA:TRE
1:0.25, HSA:NaCl 1:1) and PC2 of the most stable formulations (HSA:SUC 1:1, HSA:TRE 1:1).
These plots also include peaks attributed to sodium chloride interactions or sucrose and trehalose
contributions. Interestingly, PC3 for most formulations, except the HSA:NaCl 1:1 formulation,
trends together for all formulations (Figure 9C). Based on this PC3 is speculated to include
systematic variance due to instrument noise that is not formulation dependent. The HSA:NaCl
1:1 PC2 also contains similar trends from 1000 - 1850 cm-1.
Based on the intensity of the 1450 cm-1 peak in the loading plots, the shape and intensity
of this peak in the Raman scattering spectrum was examined for changes that occurred with
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storage time (Figure 10). Since the peak had spectral contributions from sucrose or trehalose
which caused the shape to change, peak changes in each formulation were evaluated separately.

A

B

C

D

E

F

Figure 10. Spectral changes in the 1450cm-1 peak over time for individual formulations
(normalized, baseline corrected spectra). Each spectrum is an average of 6 replicate
measurements from each pellet. Changes with time are designated as follows: T0 (green), 1
month (blue), 3 month (red). Data from cakes stored in vial: solid lines; Data from “re-used”
pellets: dashed lines.
The 1450 peak from pure HSA, the least stable formulation, increases in the intensity
over time well outside of the variation seen at each time point (Figure 10A). An increase in this
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peak has been previously attributed to changes in the environment of aliphatic side chains, and
was observed in aggregated proteins in solution after heating and attributed to increased
hydrophobic interactions [15]. All of the formulations show this trend; however, the more stable
formulations have some overlap in the spectra from different storage times, which is expected
due to the smaller structural change expected in the protein in more stable formulations.
Furthermore, an absence of systematic difference between the spectra from the samples stored as
undisturbed lyophilized cakes versus those stored as pellets supports the use of the materialsparing pellets for further study.

Conclusions
Changes in Raman spectra over time were investigated as predictive measures of protein
aggregation in solution linked to protein structural differences in solid state. PLS models
calculated using Raman spectra from formulations stored at 50C for 3 months did not show
significant differences compared to PLS models based on spectral data acquired immediately
after lyophilization. This implied that little to no structural change occurred over this time.
Previous studies [3] demonstrated structural change in solid state over time at similar conditions.
Large Raman scattering from excipients used in the study, sucrose and trehalose, masked these
small differences when all formulations were combined in one PLS model.
PLS models were also evaluated for samples stored as “pellets” during the storage
portion of the study, instead of as conventional “cake” in vials. These studies supported the pellet
method was equivalent and material sparing. This option may be able to study changes with time
if the formulations did not contain large spectral interference. This study also supports the
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concept that pelleting the material does not affect the spectral data obtained, also discussed in
Chapter 4.
PCA was used to investigate small spectral changes in each formulation individually.
PCA scores and loading plots demonstrated that small spectral changes occurred in the least
stable formulations. The most stable formulations did not show any spectral difference in time
which agree with the reference method (SEC). Loading plots were able to highlight areas of
spectral differences so that trends may be observed visually.
Raman spectra were sensitive to spectral difference with time but are subject to
interference from formulation effects. PCA can be used to determine the regions of spectral
difference in order to aid mechanistic studies.

References
1.
2.
3.

4.

5.

6.
7.

8.

Tang, X. and M.J. Pikal, Design of Freeze-Drying Processes for Pharmaceuticals:
Practical Advice. Pharmaceutical Research, 2004. 21(2): p. 191-200.
Cicerone, M.T., M.J. Pikal, and K.K. Qian, Stabilization of proteins in solid form.
Advanced drug delivery reviews, 2015. 93: p. 14-24.
Chang, L., et al., Mechanism of protein stabilization by sugars during freeze‐drying and
storage: Native structure preservation, specific interaction, and/or immobilization in a
glassy matrix? Journal of Pharmaceutical Sciences, 2005. 94(7): p. 1427-1444.
Chang, L., et al., Effect of sorbitol and residual moisture on the stability of lyophilized
antibodies: Implications for the mechanism of protein stabilization in the solid state.
Journal of Pharmaceutical Sciences, 2005. 94(7): p. 1445-1455.
Moorthy, B.S., et al., Predicting Protein Aggregation during Storage in Lyophilized
Solids Using Solid State Amide Hydrogen/Deuterium Exchange with Mass Spectrometric
Analysis (ssHDX-MS). Molecular Pharmaceutics, 2014. 11(6): p. 1869-1879.
Carpenter, J.F., et al., Rational design of stable lyophilized protein formulations: some
practical advice. Pharmaceutical research, 1997. 14(8): p. 969-975.
Pikal, M.J., et al., Solid state chemistry of proteins: II. The correlation of storage stability
of freeze‐dried human growth hormone (hGH) with structure and dynamics in the glassy
solid. Journal of Pharmaceutical Sciences, 2008. 97(12): p. 5106-5121.
Chang, L.L., et al., Mechanism of Protein Stabilization by Sugars During Freeze-Drying
and Storage: Native Structure Preservation, Specific Interaction and/or Immobilization
in a Glassy Matrix. Journal of Pharmaceutical Sciences, 2005. 94(7): p. 1427-1444.
175

9.

10.

11.

12.
13.

14.

15.

Chang, L.L., et al., Effect of sorbitol and Residual Moisture on the Stability of
Lyophilized Antibodies: Implications for the Mechanism of Protein Stabilization in the
Solid State. Journal of Pharmaceutical Sciences, 2005. 94(7): p. 1445-1455.
Prestrelski, S.J., K.A. Pikal, and T. Arakawa, Optimization of Lyophilization Conditions
for Recombinant Human Interleukin-2 by Dried State Conformational Analysis Using
Fourier-Transform Infrared Spectroscopy. Pharmaceutical Research, 1995. 12(9): p.
1250-1259.
Wise, B.M., et al., A comparison of principal component analysis, multiway principal
component analysis, trilinear decomposition and parallel factor analysis for fault
detection in a semiconductor etch process. Journal of Chemometrics, 1999. 13(3‐4): p.
379-396.
Wold, S., M. Sjöström, and L. Eriksson, PLS-regression: a basic tool of chemometrics.
Chemometrics and intelligent laboratory systems, 2001. 58(2): p. 109-130.
Feng, H., et al., Investigation of the sensitivity of transmission Raman spectroscopy for
polymorph detection in pharmaceutical tablets. Applied spectroscopy, 2017. 71(8): p.
1856-1867.
Pikal, M.J. and D.R. Rigsbee, The stability of insulin in crystalline and amorphous
solids: Observation of greater stability for the amorphous form. Pharmaceutical research,
1997. 14(10): p. 1379-1387.
Howell, N. and E. Li‐Chan, Elucidation of interactions of lysozyme with whey proteins by
Raman spectroscopy. International journal of food science & technology, 1996. 31(5): p.
439-451.

176

Chapter 6
Summary
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Freeze drying is used to stabilize protein drugs that, in the liquid state, would have
inadequate storage stability. However, freeze drying processes themselves can also damage some
proteins. Relative to a protein’s solution state structure, changes in the secondary and tertiary
structure which occur due to the lyophilization process or during storage in the solid state may
contribute to protein aggregation of the reconstituted protein, impacting product quality and
safety.
Chapters 2 and 3 outline the development of a Raman method to quantify structural
differences in a model protein. In Chapter 2, the method, applied to protein solutions, was
adapted for use in a pharmaceutical formulation development lab for protein concentrations > 50
mg/mL. Sample handling, spectrometer, and data analysis methods were optimized. Protein
structural differences induced by pH were monitored by Raman scattering of the model protein,
α-lactalbumin. These studies were used to identify changes in peaks associated with tertiary and
secondary structural differences and link these spectral differences with known phenomena in a
“molten globule” conformation which is associated with aggregate formation in solution state.
Formation of the molten globule state at pH 2 was confirmed with CD. Differences in both
tertiary and secondary structural peaks of the Raman spectra between the “native” structure at pH
8 and the “molten globule” conformation at pH 2, in the range of 600-1850 cm-1 showed
formation of a molten globule structure using both techniques. Spectral differences at pH 2 had
more extreme tertiary peak changes than secondary peak changes in pH 4 or pH 6, in comparison
to pH 8. Interestingly, PCA was applied to both Raman and CD spectra with similar results. This
confirmed the Raman results while showing the application of PCA to other spectroscopic
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techniques, as shown with CD. This method was developed to aid interpretation of results in the
solid state in Chapter 3.
Sucrose is a commonly used excipient and strong Raman scatterer. The ability of the
Raman method to distinguish small protein changes in the presence of sucrose was evaluated.
Small Raman spectral changes induced by pH, representative of protein structural changes, were
visually obscured by excipient peaks in the range of 600-1530 cm-1. Principal component
analysis (PCA) was able to remove much of the spectral variance related to sucrose scattering so
that variance related to protein structural differences could still be identified. Truncating the
spectral range to 1530-1780 cm-1 removed the majority of Raman scattering from sucrose,
allowing more direct quantitation of protein spectral differences due to initial solution pH.
Sucrose-containing protein solutions at pH 2 could not be evaluated due to the Maillard reaction
which occurred at low pH. Additional work is needed at pH 6 or pH 4 in solution with sucrose to
corroborate the finding that PCA could largely remove the variance due to sucrose, thereby
allowing identification of protein structural differences.
Investigations in Chapter 3 into the observed difference in Raman spectra between
solution and solid sample formats concluded that differences were consistent, repeatable, and not
due to a math artifact from spectral pre-processing. However, spectral changes due to physical
state were larger than pH-induced changes, so mixed data sets containing both solution and solid
state (lyophilized) samples were not analyzed by PCA. Interestingly, in Chapter 3, the spectral
differences in the protein lyophilized from solutions over a pH range were not as large as those
in solutions (Chapter 2) at the same pH. Solid spectra at pH 8 trended more closely with
solution spectra at pH 2 than solution spectra at pH 8. This implies that the molten globule state
obtained in solution is partially present in some solid-state formulations. Alternatively, spectral
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differences may be due to changes in hydrogen bonding patterns within lyophilized low moisture
solid state proteins, which have a lower different dielectric constant environment than solutions.
Some spectral differences could also represent protein:excipient interactions in solids. PCA was
not able to remove as much of the variance related to sucrose in lyophilized protein solids as
compared to solution analysis (Chapter 2). Therefore, both tertiary and secondary protein
structural changes in the solid state were more difficult to analyze in the presence of sucrose.
This may stem from the fact that the spectral differences due to “pH” in solids were smaller than
in solution. Examination of PC loading vectors allowed small spectral changes barely perceptible
by eye to be identified. When including the sucrose formulations, truncating the spectral range to
1530-1780 cm-1 in solids allowed quantitation of protein spectral changes in solids and
emphasized the Raman spectral changes related to protein sucrose interactions. Normalization
within the Raman range below 1530 cm-1 would allow pure disaccharide spectra to be included
in the model, possibly allowing the variance from sucrose to be better separated from “pH 8”
effects in solids. PCA was also applied to corresponding FTIR spectral data to link spectral
changes in protein peaks with peak wavenumbers, which was not possible with the “spectral
correlation coefficient” analysis method that lacked specificity for individual wavenumbers.
In Chapter 3, the Raman solid state off-line method was found to be adjustable to
various freeze-dried solids with only the requirement for 10 mg of amorphous solids compressed
into a pellet. Analysis regions in solids included both tertiary and secondary structural peaks.
Development of this method adds an additional solid-state method for tertiary structural analysis
to support biologic process development groups. Raman scattering of glass impeded “in-vial”
measurements, but showed promise for analyzing high total solids formulations from the open
top of the vial. Future work to develop this sampling option would provide a non-destructive
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solid-state method, enabling the vial to be used for additional assays during formulation
development, a material sparing option. In future work, a non-destructive method could be
adapted for use in development scale lyophilization equipment to monitor process induced
structural changes “in-situ” during process development scale lyophilization cycles.
In Chapter 4 the Raman solid-state method was employed to study structural differences
in formulations due to the lyophilization process that impacts later storage stability. Partial least
squares (PLS) models were developed for predicting aggregation rate from Raman spectral
changes. Formulation rank order from PLS models agreed with analytical results from size
exclusion chromatography (SEC), considered the gold standard. Models were somewhat
confounded by Raman scattering of sucrose and trehalose. Higher weight ratios of these two
excipients are known to increase stability, yet they also increased spectral peaks in the region
from 600-1530 cm-1. As both protein stability and disaccharide ratios co-vary, they were not able
to be separated using PLS models of the Raman spectra. HSA:NaCl 1:1 formulation predictions
were tentatively accepted to be based on the Raman spectral differences, as sodium chloride does
not have significant Raman scattering. This implies that the model was not only basing
predictions on disaccharide content. However, more work is needed to verify this concept with
independent unknown samples and/or formulations composed of excipients that are not strong
Raman scatters to remove the confounding which occurred in this model system.
PLS models based on the region from 1530-1780 cm-1. with no direct Raman scattering
from excipients, reflected the formulation stability rank order from SEC. Since the Raman
scattering from disaccharides and sodium chloride in this region was negligible, all Raman
spectral differences were assumed to be based on protein structural changes. The narrowing of
the amide I peak suggested stabilizing interactions of the protein with both trehalose and sucrose.
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Loading vectors from PCA-PLS latent variables showed the regions where the interactions
occurred. This allows identification into the specific tertiary or secondary structure involved in
the interaction. Further studies can be performed to link these structural changes to stabilization
mechanism. This is advantageous in comparison to techniques that identify the extent of change
within a region but do not link to specific functional groups involved in protein:excipient
interactions.
Chapter 5 extended the work from Chapter 4 and followed spectral differences in the
formulations during storage. These differences were expected to be predictive of aggregation.
However, PLS models of Raman spectra acquired at 3 months, after storage at 50°C, were not
significantly improved from the models immediately after lyophilization. This led to the
conclusion that any structural changes that occur during storage were far smaller than the
structural changes that occur during freeze drying. Those structural changes due to processing
seemed to pre-dispose the formulations to higher or lower aggregation rates. Analyzing spectra
from single formulations of the protein, PCA models showed differences in the Raman spectra of
the least stable formulation that trended with % aggregation over storage time. However, stable
formulations did not have significant differences in either Raman spectra or % aggregate by SEC
during the storage interval, and therefore no significant trend could be identified.
There is opportunity for further development as tertiary analysis is sensitive to protein
sequence. Additional modalities and a broader range of model proteins is needed to assess the
sensitivity of the ratio of tertiary amino acids:total amino acids. Additional studies need to
include independent calibration and test sample sets. To confirm the current results, a study
design with only one disaccharide or excipients that are weak Raman scatterers is need to dispel
lingering doubts remaining about the trend with storage stability due to the presence of
182

excipients or small protein structural changes. Then more mechanistic studies investigating the
effect of water on formulation studies could be initiated.
The method as currently defined is still well developed to accommodate the current
industry trend for increasing protein concentration, with analysis in the same state as the final
drug product (>100 mg/mL in solution state or solid state). Each sample prep takes less than 20
minutes, with data available for processing instantly. The set up is also able to accommodate a
glove bag if there are concerns regarding sample exposure to room humidity.
In conclusion, this project has demonstrated the ability and limitations of using Raman
spectroscopy for studying protein stability in the solid state. Prediction of aggregation tendency
in the solid state has been shown, with the promise of a non-destructive or in-line method for the
future. PCA-PLS allowed analysis of very small details which have been shown to impact long
term storage and sets the stage for further mechanistic studies and future non-invasive analysis.
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